
<html lang="en"     class="pb-page"  data-request-id="0f6bf88c-4aa7-449d-898b-7f82e523b7f5"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2014.57.issue-4;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/jm4017224"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Design, Synthesis, and Evaluation of Conformationally Restricted Acetanilides as Potent and Selective β3 Adrenergic Receptor Agonists for the Treatment of Overactive Bladder" /></meta><meta name="dc.Creator" content="Christopher R.  Moyes" /></meta><meta name="dc.Creator" content="Richard  Berger" /></meta><meta name="dc.Creator" content="Stephen D.  Goble" /></meta><meta name="dc.Creator" content="Bart  Harper" /></meta><meta name="dc.Creator" content="Dong-Ming  Shen" /></meta><meta name="dc.Creator" content="Liping  Wang" /></meta><meta name="dc.Creator" content="Alka  Bansal" /></meta><meta name="dc.Creator" content="Patricia N.  Brown" /></meta><meta name="dc.Creator" content="Airu S.  Chen" /></meta><meta name="dc.Creator" content="Karen H.  Dingley" /></meta><meta name="dc.Creator" content="Jerry  Di Salvo" /></meta><meta name="dc.Creator" content="Aileen  Fitzmaurice" /></meta><meta name="dc.Creator" content="Loise N.  Gichuru" /></meta><meta name="dc.Creator" content="Amanda L.  Hurley" /></meta><meta name="dc.Creator" content="Nina  Jochnowitz" /></meta><meta name="dc.Creator" content="Randall R.  Miller" /></meta><meta name="dc.Creator" content="Shruty  Mistry" /></meta><meta name="dc.Creator" content="Hiroshi  Nagabukuro" /></meta><meta name="dc.Creator" content="Gino M.  Salituro" /></meta><meta name="dc.Creator" content="Anthony  Sanfiz" /></meta><meta name="dc.Creator" content="Andra S.  Stevenson" /></meta><meta name="dc.Creator" content="Katherine  Villa" /></meta><meta name="dc.Creator" content="Beata  Zamlynny" /></meta><meta name="dc.Creator" content="Mary  Struthers" /></meta><meta name="dc.Creator" content="Ann E.  Weber" /></meta><meta name="dc.Creator" content="Scott D.  Edmondson" /></meta><meta name="dc.Description" content="A series of conformationally restricted acetanilides were synthesized and evaluated as β3-adrenergic receptor agonists (β3-AR) for the treatment of overactive bladder (OAB). Optimization studies id..." /></meta><meta name="Description" content="A series of conformationally restricted acetanilides were synthesized and evaluated as β3-adrenergic receptor agonists (β3-AR) for the treatment of overactive bladder (OAB). Optimization studies id..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="February 5, 2014" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm4017224" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2014 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm4017224" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm4017224" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm4017224" /></link>
        
    
    

<title>Design, Synthesis, and Evaluation of Conformationally Restricted Acetanilides as Potent and Selective β3 Adrenergic Receptor Agonists for the Treatment of Overactive Bladder | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm4017224" /></meta><meta property="og:title" content="Design, Synthesis, and Evaluation of Conformationally Restricted Acetanilides as Potent and Selective β3 Adrenergic Receptor Agonists for the Treatment of Overactive Bladder" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm4017224/production/images/large/jm-2013-017224_0013.jpeg" /></meta><meta property="og:description" content="A series of conformationally restricted acetanilides were synthesized and evaluated as β3-adrenergic receptor agonists (β3-AR) for the treatment of overactive bladder (OAB). Optimization studies identified a five-membered ring as the preferred conformational lock of the acetanilide. Further optimization of both the aromatic and thiazole regions led to compounds such as 19 and 29, which have a good balance of potency and selectivity. These compounds have significantly reduced intrinsic clearance compared to our initial series of pyridylethanolamine β3-AR agonists and thus have improved unbound drug exposures. Both analogues demonstrated dose dependent β3-AR mediated responses in a rat bladder hyperactivity model." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm4017224"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm4017224">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm4017224&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm4017224&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm4017224&amp;href=/doi/10.1021/jm4017224" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2014</span><span class="cit-fg-volume">, 57</span><span class="cit-fg-issue">, 4</span><span class="cit-fg-pageRange">, 1437-1453</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/57/4" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm401680a" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm401753e" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Design, Synthesis, and Evaluation of Conformationally Restricted Acetanilides as Potent and Selective β<sub>3</sub> Adrenergic Receptor Agonists for the Treatment of Overactive Bladder</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher+R.++Moyes">Christopher R. Moyes</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Richard++Berger">Richard Berger</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stephen+D.++Goble">Stephen D. Goble</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bart++Harper">Bart Harper</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dong-Ming++Shen">Dong-Ming Shen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Liping++Wang">Liping Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alka++Bansal">Alka Bansal</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Patricia+N.++Brown">Patricia N. Brown</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Airu+S.++Chen">Airu S. Chen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Karen+H.++Dingley">Karen H. Dingley</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jerry++Di+Salvo">Jerry Di Salvo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Aileen++Fitzmaurice">Aileen Fitzmaurice</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Loise+N.++Gichuru">Loise N. Gichuru</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Amanda+L.++Hurley">Amanda L. Hurley</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nina++Jochnowitz">Nina Jochnowitz</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Randall+R.++Miller">Randall R. Miller</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shruty++Mistry">Shruty Mistry</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hiroshi++Nagabukuro">Hiroshi Nagabukuro</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gino+M.++Salituro">Gino M. Salituro</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anthony++Sanfiz">Anthony Sanfiz</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andra+S.++Stevenson">Andra S. Stevenson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Katherine++Villa">Katherine Villa</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Beata++Zamlynny">Beata Zamlynny</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mary++Struthers">Mary Struthers</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ann+E.++Weber">Ann E. Weber</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Scott+D.++Edmondson">Scott D. Edmondson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Early Development and Discovery Sciences, Merck and Co., Inc., 2000 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Early Development and Discovery Sciences, Merck and Co., Inc., 770 Sumneytown Pike, West Point, Pennsylvania 19486, United States</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Early Development and Discovery Sciences, Merck and Co., Inc., 126 East Lincoln Avenue, Rahway, New Jersey 07065, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: 908-740-4618. Fax: 908-740-3131. E-mail: <a href="/cdn-cgi/l/email-protection#086b607a617b7c6778606d7a576567716d7b48656d7a6b63266b6765"><span class="__cf_email__" data-cfemail="66050e140f151209160e0314390b091f0315260b0314050d4805090b">[email protected]</span></a>. Address: Merck Research Laboratories, Mail Code K15-A113B1, 2000 Galloping Hill Road, Kenilworth, New Jersey 07033, United States.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm4017224&amp;href=/doi/10.1021%2Fjm4017224" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2014</span></span><span class="cit-volume">, 57</span><span class="cit-issue">, 4</span><span class="cit-pageRange">, 1437–1453</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 17, 2014</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>8 November 2013</li><li><span class="item_label"><b>Published</b> online</span>5 February 2014</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 27 February 2014</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm4017224" title="DOI URL">https://doi.org/10.1021/jm4017224</a></div><div class="article_header-article-copyright"><strong>Copyright © 2014 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1437%26pageCount%3D17%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DChristopher%2BR.%2BMoyes%252C%2BRichard%2BBerger%252C%2BStephen%2BD.%2BGoble%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D57%26issueNum%3D4%26contentID%3Djm4017224%26title%3DDesign%252C%2BSynthesis%252C%2Band%2BEvaluation%2Bof%2BConformationally%2BRestricted%2BAcetanilides%2Bas%2BPotent%2Band%2BSelective%2B%25CE%25B23%2BAdrenergic%2BReceptor%2BAgonists%2Bfor%2Bthe%2BTreatment%2Bof%2BOveractive%2BBladder%26numPages%3D17%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D1453%26publicationDate%3DFebruary%2B2014">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm4017224"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2035</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">16</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm4017224" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Design, Synthesis, and Evaluation of Conformationally Restricted Acetanilides as Potent and Selective β3 Adrenergic Receptor Agonists for the Treatment of Overactive Bladder&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;R. Moyes&quot;},{&quot;first_name&quot;:&quot;Richard&quot;,&quot;last_name&quot;:&quot;Berger&quot;},{&quot;first_name&quot;:&quot;Stephen&quot;,&quot;last_name&quot;:&quot;D. Goble&quot;},{&quot;first_name&quot;:&quot;Bart&quot;,&quot;last_name&quot;:&quot;Harper&quot;},{&quot;first_name&quot;:&quot;Dong-Ming&quot;,&quot;last_name&quot;:&quot;Shen&quot;},{&quot;first_name&quot;:&quot;Liping&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Alka&quot;,&quot;last_name&quot;:&quot;Bansal&quot;},{&quot;first_name&quot;:&quot;Patricia&quot;,&quot;last_name&quot;:&quot;N. Brown&quot;},{&quot;first_name&quot;:&quot;Airu&quot;,&quot;last_name&quot;:&quot;S. Chen&quot;},{&quot;first_name&quot;:&quot;Karen&quot;,&quot;last_name&quot;:&quot;H. Dingley&quot;},{&quot;first_name&quot;:&quot;Jerry&quot;,&quot;last_name&quot;:&quot;Di Salvo&quot;},{&quot;first_name&quot;:&quot;Aileen&quot;,&quot;last_name&quot;:&quot;Fitzmaurice&quot;},{&quot;first_name&quot;:&quot;Loise&quot;,&quot;last_name&quot;:&quot;N. Gichuru&quot;},{&quot;first_name&quot;:&quot;Amanda&quot;,&quot;last_name&quot;:&quot;L. Hurley&quot;},{&quot;first_name&quot;:&quot;Nina&quot;,&quot;last_name&quot;:&quot;Jochnowitz&quot;},{&quot;first_name&quot;:&quot;Randall&quot;,&quot;last_name&quot;:&quot;R. Miller&quot;},{&quot;first_name&quot;:&quot;Shruty&quot;,&quot;last_name&quot;:&quot;Mistry&quot;},{&quot;first_name&quot;:&quot;Hiroshi&quot;,&quot;last_name&quot;:&quot;Nagabukuro&quot;},{&quot;first_name&quot;:&quot;Gino&quot;,&quot;last_name&quot;:&quot;M. Salituro&quot;},{&quot;first_name&quot;:&quot;Anthony&quot;,&quot;last_name&quot;:&quot;Sanfiz&quot;},{&quot;first_name&quot;:&quot;Andra&quot;,&quot;last_name&quot;:&quot;S. Stevenson&quot;},{&quot;first_name&quot;:&quot;Katherine&quot;,&quot;last_name&quot;:&quot;Villa&quot;},{&quot;first_name&quot;:&quot;Beata&quot;,&quot;last_name&quot;:&quot;Zamlynny&quot;},{&quot;first_name&quot;:&quot;Mary&quot;,&quot;last_name&quot;:&quot;Struthers&quot;},{&quot;first_name&quot;:&quot;Ann&quot;,&quot;last_name&quot;:&quot;E. Weber&quot;},{&quot;first_name&quot;:&quot;Scott&quot;,&quot;last_name&quot;:&quot;D. Edmondson&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2014&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;05&quot;,&quot;issue&quot;:&quot;4&quot;,&quot;volume&quot;:&quot;57&quot;,&quot;pages&quot;:&quot;1437-1453&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm4017224&quot;},&quot;abstract&quot;:&quot;A series of conformationally restricted acetanilides were synthesized and evaluated as β3-adrenergic receptor agonists (β3-AR) for the treatment of overactive bladder (OAB). Optimization studies identified a five-membered ring as the preferred conformational lock of the acetanilide. Further optimization of both the aromatic and thiazole regions led to compounds such as 19 and 29, which have a good balance of potency and selectivity. These compounds have significantly reduced intrinsic clearance compared to our initial series of pyridylethanolamine β3-AR agonists and thus have improved unbound drug exposures. Both analogues demonstrated dose dependent β3-AR mediated responses in a rat bladder hyperactivity model.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm4017224&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm4017224" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm4017224&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm4017224" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm4017224&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm4017224" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm4017224&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm4017224&amp;href=/doi/10.1021/jm4017224" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm4017224" /></input><a href="/doi/pdf/10.1021/jm4017224" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (731 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm4017224&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm4017224%26sid%3Dliteratum%253Aachs%26pmid%3D24437735%26genre%3Darticle%26aulast%3DMoyes%26date%3D2014%26atitle%3DDesign%252C%2BSynthesis%252C%2Band%2BEvaluation%2Bof%2BConformationally%2BRestricted%2BAcetanilides%2Bas%2BPotent%2Band%2BSelective%2B%25CE%25B23%2BAdrenergic%2BReceptor%2BAgonists%2Bfor%2Bthe%2BTreatment%2Bof%2BOveractive%2BBladder%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D57%26issue%3D4%26spage%3D1437%26epage%3D1453%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292444" title="Molecular structure">Molecular structure</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/57/4" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jmcmar.2014.57.issue-4/production/jmcmar.2014.57.issue-4.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm4017224/production/images/medium/jm-2013-017224_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm4017224/production/images/large/jm-2013-017224_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4017224&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">A series of conformationally restricted acetanilides were synthesized and evaluated as β<sub>3</sub>-adrenergic receptor agonists (β<sub>3</sub>-AR) for the treatment of overactive bladder (OAB). Optimization studies identified a five-membered ring as the preferred conformational lock of the acetanilide. Further optimization of both the aromatic and thiazole regions led to compounds such as <b>19</b> and <b>29</b>, which have a good balance of potency and selectivity. These compounds have significantly reduced intrinsic clearance compared to our initial series of pyridylethanolamine β<sub>3</sub>-AR agonists and thus have improved unbound drug exposures. Both analogues demonstrated dose dependent β<sub>3</sub>-AR mediated responses in a rat bladder hyperactivity model.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30242" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30242" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The discovery of the β<sub>3</sub>-adrenergic receptor (β<sub>3</sub>-AR) in the early 1980s<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> and the demonstration that activation of this receptor by small molecule agonists induced thermogenic<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> and antihyperglycaemic activity<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> in rodents led to a period of intense activity within the pharmaceutical industry aimed at novel treatments for type 2 diabeties and obesity.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> A number of compounds entered clinical studies, however, ultimately they were unsuccessful, either because of a lack of efficacy, an unfavorable cardiovascular side effect profile, or poor pharmacokinetics, which led to a downturn in interest in this receptor as a target.</div><div class="NLM_p">Overactive bladder (OAB) is a chronic and sometimes debilitating condition of the lower urinary tract that negatively impacts the quality of life of millions of people. A large multicountry survey recently estimated the prevalence of OAB at 11.8%, increasing with age.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Given that the elderly are the fastest-growing segment of the population, it is likely that this number will only increase. Muscarinic antagonists are the mainstay of pharmacotherapy for OAB,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> and these drugs have been demonstrated to improve urgency, frequency of micturition, and urge incontinence, all of which are primary symptoms of OAB. However, through their anticholinergic mechanism, these agents have also demonstrated adverse effects, most notably dry mouth and constipation. While tolerability may be improved by the use of extended release formulations and agents with differing muscarinic receptor selectivities,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> there remains a need for therapies with an improved side effect profile. Within the last 15 years, evidence for the presence of the β<sub>3</sub>-AR on human and rat detrusor muscle has emerged.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> In vitro studies have demonstrated that selective β<sub>3</sub>-AR agonists cause relaxation of isolated rat and human detrusor muscle strips, and compelling in vivo evidence to support a role for β<sub>3</sub>-AR in increasing bladder capacity in anesthetized rats has emerged.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> This has led to renewed activity within the pharmaceutical industry in an attempt to discover potent and selective β<sub>3</sub>-AR agonists as a potential new treatment for OAB, with the possibility for fewer side effect liabilities compared to antimuscarinics.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Several compounds such as <b>1</b> (YM-178, mirabegron)<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> and <b>2</b> (GW427353, solabegron),<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> as shown in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>, have entered the clinic and, in the case of <b>1</b>, have been approved for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm4017224/production/images/medium/jm-2013-017224_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm4017224/production/images/large/jm-2013-017224_0002.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of some of the β<sub>3</sub>-AR agonists to have entered the clinic.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm4017224/production/images/large/jm-2013-017224_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4017224&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Previous work in our laboratories has described the discovery of a series of pyridylethanolamine β<sub>3</sub>-AR agonists with excellent potency and selectivity and possessing moderate oral bioavailability, culminating in the discovery of our first-generation clinical candidate <b>3</b>.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> In an effort to address some of the liabilities associated with this series,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> we proceeded to report the design and synthesis of second generation β<sub>3</sub>-AR agonists containing a novel pyrrolidine scaffold, exemplified by acetanilide derivative <b>4</b>.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Compound <b>4</b> demonstrated potent human β<sub>3</sub>-AR agonist activity and was also very selective over the β<sub>1</sub> and β<sub>2</sub> receptors. We have also disclosed the structure–activity relationships (SAR) surrounding some acetanilide derivatives in a linear (nonpyrrolidine) series and demonstrated the beneficial effects on potency and selectivity of substitution at the position α to the amide carbonyl group.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> We now wish to report the incorporation and extension of this SAR into the novel pyrrolidine based series.</div><div class="NLM_p">We initially targeted simple substitution with a methyl group to establish if the previously observed SAR would translate to this series and then further elaborated with higher alkyl homologues (<b>5</b>) (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). We have previously demonstrated in the linear series that substitution with a methyl group on the thiazole-5-position also improved potency. We therefore realized that with an open C–H bond at the thiazole-5-position, there was the opportunity to form a tether between the thiazole and the α position (<b>6</b>). In principle, the introduction of this conformational constraint could have a positive effect on potency through a reduction in the entropic penalty required to achieve the optimal compound–receptor interaction.</div><div class="NLM_p">In this article, we will describe the synthesis and SAR of various ring size tethers as well as compounds with modifications to both the left-hand side (LHS) aromatic and to the thiazole-2-position. Finally, we explored an alternative to the thiazole by replacement with a pyrazole. These studies have led to the discovery of a novel series of conformationally restricted acetanilide derivatives. In this paper, we describe in vitro SAR, pharmacokinetic properties, and evaluation of certain compounds from this new series in an in vivo rat bladder hyperactivity model.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm4017224/production/images/medium/jm-2013-017224_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm4017224/production/images/large/jm-2013-017224_0003.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures of second-generation pyrrolidine based β<sub>3</sub>-AR agonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm4017224/production/images/large/jm-2013-017224_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4017224&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85864" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85864" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Thiazole acid intermediates <b>33a</b>–<b>g</b>, <b>35</b>, and <b>38a</b>–<b>d</b> were synthesized following the routes illustrated in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. Keto-esters (<b>30</b>) were brominated by the addition of bromine in chloroform at 0 °C. The initially formed α-brominated product is rearranged to the desired γ-brominated product by blowing wet air through the reaction mixture,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> and the resultant crude material is treated with thiourea in refluxing ethanol to afford amino thiazoles <b>31a</b>–<b>g</b>. <i>N</i>-Boc protection under standard conditions was performed in order to facilitate purification of later intermediates. Saponification of the esters <b>32a</b>–<b>g</b> afforded the acids <b>33a</b>–<b>g</b>. A similar sequence was performed on ethyl 2-oxocyclopentane carboxylate (<b>30e</b>), replacing thiourea with thioamides <b>36a</b>–<b>d</b> to yield the desired substituted thiazoles <b>37a</b>–<b>d</b>. Hydrolysis of the ester under standard conditions afforded acids <b>38a</b>–<b>d</b>. The unsubstituted thiazole <b>35</b> was prepared by direct deamination of amino-thiazole <b>31e</b> by heating with <i>tert</i>-butyl nitrite in DMF to give ester <b>34</b>, followed by hydrolysis to the acid <b>35</b>.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm4017224/production/images/medium/jm-2013-017224_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm4017224/production/images/large/jm-2013-017224_0005.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Preparation of RHS-Thiazole Intermediates<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm4017224/production/images/large/jm-2013-017224_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4017224&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) Br<sub>2</sub>, CHCl<sub>3</sub>, 0 °C; (b) thiourea, EtOH, reflux; (c) (Boc)<sub>2</sub>O, Et<sub>3</sub>N, DMAP, CH<sub>2</sub>Cl<sub>2</sub>; (d) LiOH, THF, MeOH, H<sub>2</sub>O; (e) <i>tert</i>-butylnitrite, DMF, 50 °C; (f) R<sup>3</sup>-thioamide <b>36a</b>–<b>e</b>, EtOH, reflux.</p></p></figure><div class="NLM_p">Intermediates with modifications to the LHS aromatic ring were prepared according to the procedure shown in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. 5-Hexynoic acid (<b>39</b>) was coupled with (<i>S</i>)-4-benzyl-2-oxazolidinione to afford the <i>N</i>-acyloxazolidinone <b>40</b>, which underwent magnesium chloride catalyzed anti-Aldol reaction<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> with benzaldehydes, followed by desilylation with TFA in methanol to give the adduct <b>41a</b>–<b>e</b> in high diastereoselectivity. Protection of the alcohol using TBS-triflate and 2,6-lutidine afforded products <b>42a</b>–<b>e</b>. Removal of the oxazolidinone auxiliary with LiOH in the presence of 30% H<sub>2</sub>O<sub>2</sub> provided acids <b>43a</b>–<b>e</b>, which underwent Curtius rearrangement in the presence of 4-methoxybenzyl alcohol to afford the Moz-protected amines <b>44a</b>–<b>e</b>. Sonogashira coupling of <b>44a</b>–<b>e</b> with 4-iodonitrobenzene provided the 4-nitrophenylacetylenes <b>45a</b>–<b>e</b>, which were converted to ketones <b>46a</b>–<b>e</b> using a procedure developed by Fukuyama.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Regioselective conjugate addition of pyrrolidine to the acetylene afforded an intermediate enamine, which was then hydrolyzed under acidic conditions to the ketone (<b>46a</b>–<b>e</b>). Removal of the Moz protecting group by treatment with TFA and concomitant cyclization afforded a 2,3-dihydropyrrole intermediate, which was reduced to a mixture of <i>cis</i> and <i>trans</i> pyrrolidine isomers using sodium cyanoborohydride. During the reductive amination step, selective formation of the <i>cis</i> over the <i>trans</i> pyrroline was always observed, with selectivities generally in the 80:20 range, although selectivity as low as 60:40 was observed. The desired <i>cis</i> pyrrolidine isomers <b>47a</b>–<b>e</b> could be readily separated from the <i>trans</i> isomers by silica gel chromatography. Boc protection under standard conditions gave the Boc-pyrrolidines <b>48a</b>–<b>e</b>. Anilines <b>50a</b>–<b>d</b> were prepared by reduction of nitro intermediates <b>48a</b>–<b>d</b> using either hydrogenolysis or zinc in acetic acid, followed by TBS deprotection. Hydrogenolysis of <b>48e</b> under pressure in the presence of potassium acetate reduced the nitro group and removed the pyridyl chlorine and following TBS deprotection afforded <b>50e</b>. Aniline <b>50a</b> was identical spectroscopically to the same intermediate prepared by a different route previously, and whose identity had been fully characterized by 2D NMR and X-ray analysis.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a></div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm4017224/production/images/medium/jm-2013-017224_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm4017224/production/images/large/jm-2013-017224_0006.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Preparation of LHS-Aromatic Intermediates<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm4017224/production/images/large/jm-2013-017224_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4017224&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) Trimethylacetyl chloride, Et<sub>3</sub>N, THF; (b) (<i>S</i>)-4-benzyl-2-oxazolidinone, LiCl, THF; (c) ArCHO, MgCl<sub>2</sub>, TMS-Cl, Et<sub>3</sub>N, EtOAc; (d) TFA, MeOH; (e) TBS-triflate, 2,6-lutidine, CH<sub>2</sub>Cl<sub>2</sub>; (f) H<sub>2</sub>O<sub>2</sub>, LiOH, THF, H<sub>2</sub>O; (g) DPPA, Et<sub>3</sub>N, 4-methoxybenzyl alcohol, toluene, 80 °C; (h) 4-iodonitrobenzene, PdCl<sub>2</sub>(dppf), CuI, Et<sub>3</sub>N, DMF; (i) pyrrolidine, DMF, 85 °C; (j) AcOH, H<sub>2</sub>O; (k) TFA, CH<sub>2</sub>Cl<sub>2</sub>; (l) NaCNBH<sub>3</sub>, MeOH; (m) (Boc)<sub>2</sub>O, i-Pr<sub>2</sub>NEt, CH<sub>2</sub>Cl<sub>2</sub>; (n) H<sub>2</sub>, 10% Pd/C, MeOH or Zinc, AcOH, EtOH 80 °C; (o) TBAF, THF; (p) H<sub>2</sub> 50 psi, 10% Pd/C, KOAc MeOH.</p></p></figure><div class="NLM_p">Standard EDC coupling of the anilines <b>50a</b>–<b>e</b> with thiazole acetic acids <b>33a</b>–<b>g</b>, <b>35</b>, and <b>38a</b>–<b>d</b> (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>) afforded the desired coupled products as a mixture of two diastereoisomers. The diastereoisomers were readily separated utilizing chiral preperative HPLC methodology, all mixtures being separated using an (<i>R</i>,<i>R</i>)-Whelk-O column with mixtures of IPA and heptanes as eluent. The resultant pure diastereoisomers were Boc deprotected under standard conditions to give the target agonists <b>7</b>–<b>26</b>.</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm4017224/production/images/medium/jm-2013-017224_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm4017224/production/images/large/jm-2013-017224_0007.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. General Synthesis Route to Targets <b>7</b>–<b>26</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm4017224/production/images/large/jm-2013-017224_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4017224&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) EDC, HOAt, i-Pr<sub>2</sub>NEt, DMF; (b) chiral HPLC separation, (<i>R</i>,<i>R</i>)-Whelk-O column, eluent IPA/heptanes; (c) TFA, CH<sub>2</sub>Cl<sub>2</sub>.</p></p></figure><div class="NLM_p">Assignment of an absolute configuration to the more active acid component in the final derivatives was determined by the following method. Separation of the enantiomers of acid <b>38a</b> was achieved utilizing chiral SFC HPLC. Coupling of the individual acids to aniline <b>50e</b> using standard EDC conditions (including Hunig’s Base) resulted in complete racemization of the thiazole component, however, EDC coupling with the omission of Hunig’s Base proceeded smoothly with no sign of racemization. Deprotection and biological evaluation of the individual diastereoisomers allowed us to determine which acid resulted in the more potent agonist. X-ray crystallographic analysis of this acid determined the absolute configuration to be <i>R</i>. By inference, given that the more potent agonist was always derived from the protected precursor which eluted from the (<i>R</i>,<i>R</i>)-Whelk-O column first, we have assigned this diastereoisomer as also having the <i>R</i> configuration.</div><div class="NLM_p">Preparation of the pyrazole derivatives <b>27</b>–<b>29</b> was achieved using similar methodology utilizing commercially available acids <b>57a</b>–<b>b</b> and the cyclic acid <b>56</b>, which was prepared as outlined in Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>. Glutaric anhydride (<b>51</b>) and bis(trimethylsilyl)acetylene was treated with anhydrous AlCl<sub>3</sub> to afford keto-acid <b>52</b>. Condensation of <b>52</b> with Boc-hydrazine gave hydrazone <b>53</b>, which following TMS deprotection and benzyl ester formation afforded pyrazole <b>54</b>. Formation of a trimethylsilylketene acetal followed by bromination and acidic removal of the Boc group, and then base induced cyclization generated the cyclic pyrazole <b>55</b>. Cleavage of the ester under hydrogenolyis conditions afforded acid <b>56</b>.</div><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm4017224/production/images/medium/jm-2013-017224_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm4017224/production/images/large/jm-2013-017224_0008.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis Route to Pyrazole Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm4017224/production/images/large/jm-2013-017224_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4017224&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) Bis(trimethylsilyl)acetylene, AlCl<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>; (b) Boc-hydrazine, i-PrOH; (c) TBAF, THF; (d) benzyl bromide, K<sub>2</sub>CO<sub>3</sub>, DMF; (e) (i) LiHMDS, TMS-Cl, THF, (ii) NBS, (iii) TFA, CH<sub>2</sub>Cl<sub>2</sub>, (iv) K<sub>2</sub>CO<sub>3</sub>, NaI, acetone 58 °C; (f) H<sub>2</sub>, Pd(C), EtOH; (g) EDC, HOAt, Hunig’s base, DMF; (h) chiral HPLC separation, (<i>R</i>,<i>R</i>)-Whelk-O column, eluent IPA/heptanes; (i) TFA, DCM.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28880" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28880" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All final compounds were evaluated as human β<sub>3</sub> adrenergic receptor agonists by measuring their ability to stimulate increases in intracellular cAMP in Chinese hamster ovary (CHO) cell lines stably expressing the human β<sub>3</sub> receptor. Selectivity over human β<sub>1</sub> and β<sub>2</sub>-AR was assessed by measuring the binding affinity of compounds for these receptors using membranes prepared from recombinant cells expressing either β<sub>1</sub> or β<sub>2</sub>-AR.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></div><div class="NLM_p">We initially investigated the effect of substitution with alkyl groups at the position α to the carbonyl in compound <b>4</b>. The results of this study are summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>. In line with previous observations in the nonpyrrolidine containing series of acetanilides, introduction of a methyl group α to the carbonyl improved potency.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> For example, diasteroisomer <b>7a</b> is 5-fold more potent than the unsubstituted analogue <b>4</b>. Increasing the size of the alkyl group gives compounds with decreasing activity over the methyl analogue; for example, the ethyl <b>8a</b> and <i>n</i>-propyl <b>9a</b> analogues are equipotent to the unsubstituted analogue <b>4</b>, and the iso-propyl analogue <b>10a</b> shows a loss in activity compared to <b>4</b>. Of note is that in all cases the receptor demonstrated a distinct stereochemical preference for one diastereomer over the other.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. SAR Results for Alkylated and Ring Constrained Amino-Thiazole Analogues</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm4017224/production/images/medium/jm-2013-017224_0009.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" align="center" char="±">human EC<sub>50</sub> (nM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a> (%Act)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">human IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center" char="±">β<sub>3</sub></th><th class="colsep0 rowsep0" align="center" char=".">β<sub>1</sub></th><th class="colsep0 rowsep0" align="center" char=".">β<sub>2</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">0.98 ± 0.59 (92)</td><td class="colsep0 rowsep0" align="char" char=".">>20000</td><td class="colsep0 rowsep0" align="char" char=".">>20000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7a</b> isomer 1</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">0.18 ± 0.04 (84)</td><td class="colsep0 rowsep0" align="char" char=".">>20000</td><td class="colsep0 rowsep0" align="char" char=".">>20000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7b</b> isomer 2</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">0.67 ± 0.02 (85)</td><td class="colsep0 rowsep0" align="char" char=".">>20000</td><td class="colsep0 rowsep0" align="char" char=".">>20000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8a</b> isomer 1<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">0.83 ± 0.13 (85)</td><td class="colsep0 rowsep0" align="char" char=".">>20000</td><td class="colsep0 rowsep0" align="char" char=".">>20000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9a</b> isomer 1<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left"><i>n</i>-Pr</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">0.88 ± 0.01 (66)</td><td class="colsep0 rowsep0" align="char" char=".">>20000</td><td class="colsep0 rowsep0" align="char" char=".">>20000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10a</b> isomer 1<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left"><i>iso</i>-Pr</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">1.60 ± 0.01 (85)</td><td class="colsep0 rowsep0" align="char" char=".">>20000</td><td class="colsep0 rowsep0" align="char" char=".">>20000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11a</b> isomer 1</td><td class="colsep0 rowsep0" colspan="2" align="left">–CH<sub>2</sub>CH<sub>2</sub>–</td><td class="colsep0 rowsep0" align="char" char="±">0.15 ± 0.03 (91)</td><td class="colsep0 rowsep0" align="char" char=".">>20000</td><td class="colsep0 rowsep0" align="char" char=".">>20000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11b</b> isomer 2</td><td class="colsep0 rowsep0" colspan="2" align="left">–CH<sub>2</sub>CH<sub>2</sub>–</td><td class="colsep0 rowsep0" align="char" char="±">44.2 ± 6.00 (91)</td><td class="colsep0 rowsep0" align="char" char=".">>20000</td><td class="colsep0 rowsep0" align="char" char=".">>20000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12a</b> isomer 1<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" colspan="2" align="left">–CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>–</td><td class="colsep0 rowsep0" align="char" char="±">0.21 ± 0.03 (103)</td><td class="colsep0 rowsep0" align="char" char=".">>20000</td><td class="colsep0 rowsep0" align="char" char=".">>20000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13a</b> isomer 1<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" colspan="2" align="left">–CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>–</td><td class="colsep0 rowsep0" align="char" char="±">1.86 ± 0.16 (70)</td><td class="colsep0 rowsep0" align="char" char=".">>20000</td><td class="colsep0 rowsep0" align="char" char=".">>20000</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Unless otherwise noted, the results are shown as the mean ± SD (<i>n</i> ≥ 3) or presented as the average of two experiments.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">% Activation defined as the fitted maximal value of the test compound concentration response expressed as a percent of the maximal response to <i>R</i>-(−)-isoproterenol.</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last"><i>n</i> = 1.</p></div><div class="footnote" id="t1fn4"><sup>d</sup><p class="last">Single diastereoisomer with only more potent isomer indicated.</p></div></div></div><div class="NLM_p">We next focused our attention on analogues in which a ring of various sizes has been formed between the thiazole-5-position and the α position. Constraining the side chain through formation of a five-membered (<b>11a</b>) or six-membered ring (<b>12a</b>) also improved β<sub>3</sub>-AR activity (4–5-fold) over the unsubstituted compound while also maintaining the excellent selectivity profile over the β<sub>1</sub> and β<sub>2</sub>-AR. Increasing the ring size to a seven-membered ring (<b>13a</b>) caused a 2-fold decrease in β<sub>3</sub>-AR activity over the unsubstituted compound. While compounds <b>11a</b> and <b>12a</b> were comparable to <b>4</b> in terms of potency, pharmacokinetic evaluation in the rat revealed that both compounds displayed an inferior pharmacokinetic (PK) profile compared to <b>4</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>), with both demonstrating increased clearance (Cl<sub>p</sub> = 50 mL/min/kg for <b>11a</b> and 185 mL/min/kg for <b>12a</b>), decreased bioavailability (<i>F</i> = 6% for <b>11a</b> and 0% for <b>12a</b>), and decreased unbound drug exposures. The five-membered analogue <b>11a</b> appeared slightly superior to the six-membered analogue, and thus all further studies focused on fused five-membered ring analogues.</div><div class="NLM_p">We next explored replacement of the LHS phenyl group in <b>11a</b> with several substituted phenyl groups (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Addition of a chlorine atom to the three position (such as that found in salabegron) resulted in a compound (<b>14</b>) equipotent to the phenyl analogue, however, selectivity over β<sub>2</sub>-AR and the human Ether-à-go-go Related Gene (hERG) potassium channel is reduced. Replacement of the chlorine with a fluorine (<b>15</b>) resulted in a 4-fold increase in β<sub>3</sub>-AR activity and also improved selectivity over hERG. Shift of the fluoro group to the 4-position (<b>16</b>) maintained β<sub>3</sub>-AR activity but also resulted in reduced selectivity over hERG. Finally, replacement of the phenyl moiety with a 3-pyridyl (<b>17</b>) group led to a slight reduction in potency (EC<sub>50</sub> = 0.37nM) with similar selectivity over hERG, however, this compound demonstrated no bioavailability (<i>F</i> = 0%).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. SAR Results of LHS Aromatic Variation</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm4017224/production/images/medium/jm-2013-017224_0010.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="." /></col><col align="center" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" align="center" char="±">human EC<sub>50</sub> (nM)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a> (%Act)<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">human IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center">Ar</th><th class="colsep0 rowsep0" align="center" char="±">β<sub>3</sub></th><th class="colsep0 rowsep0" align="center" char=".">β<sub>1</sub></th><th class="colsep0 rowsep0" align="center">β<sub>2</sub></th><th class="colsep0 rowsep0" align="center" char=".">hERG IC<sub>50</sub>(μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11a</b></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="char" char="±">0.15 ± 0.03 (103)</td><td class="colsep0 rowsep0" align="char" char=".">>20000</td><td class="colsep0 rowsep0" align="center">>20000</td><td class="colsep0 rowsep0" align="char" char=".">12.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">3-ClPh</td><td class="colsep0 rowsep0" align="char" char="±">0.15 ± 0.06 (93)</td><td class="colsep0 rowsep0" align="char" char=".">>20000</td><td class="colsep0 rowsep0" align="center">8451 ± 2368<a class="ref internalNav" href="#t2fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="char" char=".">1.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">3-FPh</td><td class="colsep0 rowsep0" align="char" char="±">0.04 ± 0.002 (94)</td><td class="colsep0 rowsep0" align="char" char=".">>20000</td><td class="colsep0 rowsep0" align="center">>20000</td><td class="colsep0 rowsep0" align="char" char=".">4.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">4-FPh</td><td class="colsep0 rowsep0" align="char" char="±">0.13 ± 0.02 (72)</td><td class="colsep0 rowsep0" align="char" char=".">>20000</td><td class="colsep0 rowsep0" align="center">>20000</td><td class="colsep0 rowsep0" align="char" char=".">5.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">3-Py</td><td class="colsep0 rowsep0" align="char" char="±">0.37 ± 0.02 (101)</td><td class="colsep0 rowsep0" align="char" char=".">>20000</td><td class="colsep0 rowsep0" align="center">>20000</td><td class="colsep0 rowsep0" align="char" char=".">23.3</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Unless otherwise noted, the results are shown as the mean ± SD (<i>n</i> ≥ 3) or presented as the average of two experiments.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">% Activation defined as the fitted maximal value of the test compound concentration response expressed as a percent of the maximal response to <i>R</i>-(−)-isoproterenol.</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last"><i>n</i> = 1.</p></div><div class="footnote" id="t2fn4"><sup>d</sup><p class="last">Single diastereoisomer with only more potent isomer indicated.</p></div><div class="footnote" id="t2fn5"><sup>e</sup><p class="last"><i>n</i> = 2.</p></div></div></div><div class="NLM_p">We sought to improve the bioavailability in both the phenyl and pyridyl series by further examination of the thiazole RHS. Of particular interest was the replacement of the amino-group from the 2-position of the thiazole based upon the metabolism-induced toxicity potential of this class of heterocycles.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Transformation of the amino group to either a hydrogen (<b>18</b> and <b>19</b>) or a methyl group (<b>20</b> and <b>21</b>) resulted in a 3–4-fold loss in activity in both the phenyl and pyridyl cases, however, this was counterbalanced by much improved rat bioavailability in the pyridyl LHS analogues (<i>F</i> = 41% for <b>19</b> and 46% for <b>21</b>). Further homologation to an ethyl (<b>22</b> and <b>23</b>) or a cyclopropyl group (<b>24</b>) decreased potency further but more importantly rendered these analogues partial agonists. Replacement with a 4-fluorophenyl group either decreased potency still further (<b>25</b>) or led to a dramatic loss in receptor activation (<b>26</b>) and in both cases showed decreased selectivity over β<sub>1/2</sub>-AR.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. SAR Results for Substitution at the Thiazole-2-Position</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm4017224/production/images/medium/jm-2013-017224_0011.gif" alt="" id="fx3" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" align="center" char="±">human EC<sub>50</sub> (nM)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a> (%Act)<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="rowsep1 colsep0" colspan="2" align="center">human IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd<a class="ref internalNav" href="#t3fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center">R<sup>3</sup></th><th class="colsep0 rowsep0" align="center" char="±">β<sub>3</sub></th><th class="colsep0 rowsep0" align="center">β<sub>1</sub></th><th class="colsep0 rowsep0" align="center">β<sub>2</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">0.64 ± 0.53 (101)</td><td class="colsep0 rowsep0" align="center">>20000</td><td class="colsep0 rowsep0" align="center">>20000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">1.36 ± 0.69 (103)</td><td class="colsep0 rowsep0" align="center">>20000</td><td class="colsep0 rowsep0" align="center">>20000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="char" char="±">0.48 ± 0.13 (96)</td><td class="colsep0 rowsep0" align="center">>20000</td><td class="colsep0 rowsep0" align="center">>20000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="char" char="±">1.15 ± 0.57 (89)</td><td class="colsep0 rowsep0" align="center">>20000</td><td class="colsep0 rowsep0" align="center">>20000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="char" char="±">1.95 ± 0.45 (37)</td><td class="colsep0 rowsep0" align="center">>20000</td><td class="colsep0 rowsep0" align="center">>20000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="char" char="±">13.6 ± 2.36 (49)</td><td class="colsep0 rowsep0" align="center">>20000</td><td class="colsep0 rowsep0" align="center">>20000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left"><i>c</i>-Pr</td><td class="colsep0 rowsep0" align="char" char="±">12.4 ± 4.74 (43)</td><td class="colsep0 rowsep0" align="center">>20000</td><td class="colsep0 rowsep0" align="center">>20000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">4-F-Ph</td><td class="colsep0 rowsep0" align="char" char="±">186 ± 114.6 (76)</td><td class="colsep0 rowsep0" align="center">4329 ± 140<a class="ref internalNav" href="#t3fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="center">2513 ± 539<a class="ref internalNav" href="#t3fn5" aria-label="e">e</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">4-F-Ph</td><td class="colsep0 rowsep0" align="char" char="±">8.78 ± 1.32 (15)</td><td class="colsep0 rowsep0" align="center">13340 ± 1183<a class="ref internalNav" href="#t3fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="center">2471 ± 585<a class="ref internalNav" href="#t3fn5" aria-label="e">e</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Unless otherwise noted, the results are shown as the mean ± SD (<i>n</i> ≥ 3) or presented as the average of two experiments.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">% Activation defined as the fitted maximal value of the test compound concentration response expressed as a percent of the maximal response to <i>R</i>-(−)-isoproterenol.</p></div><div class="footnote" id="t3fn3"><sup>c</sup><p class="last"><i>n</i> = 1.</p></div><div class="footnote" id="t3fn4"><sup>d</sup><p class="last">Single diastereoisomer with only more potent isomer indicated.</p></div><div class="footnote" id="t3fn5"><sup>e</sup><p class="last"><i>n</i> = 2.</p></div></div></div><div class="NLM_p">Finally, we examined replacement of the thiazole with alternative heterocycles (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). In our previous work, we demonstrated that a pyrazole was an effective replacement for the thiazole.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Given the improved rat bioavailability observed with the pyridyl LHS in the thiazole series, we chose to explore thiazole replacement in this series. The parent pyrazole acetamide (<b>27</b>) showed significantly reduced β<sub>3</sub>-AR potency (EC<sub>50</sub> = 77nM) compared to <b>4</b>, however, good selectivity over β<sub>1</sub>-AR and β<sub>2</sub>-AR was maintained. As expected, the introduction of a methyl group at the α position furnished a compound (<b>28</b>) with improved β<sub>3</sub>-AR activity (EC<sub>50</sub> = 16.7nM) and which also had good rat bioavailability (<i>F</i> = 29%). Fusion of the α position to the pyrazole 5-position through a five-membered ring resulted in <b>29</b>, which had a further gain in β<sub>3</sub>-AR activity (EC<sub>50</sub> = 3.7nM) and also maintained good rat bioavailability (<i>F</i> = 35%). To try and understand what was driving the differences observed in bioavailability with these analogues, we examined intrinsic clearance (Cl<sub>int</sub>) in liver microsomal (LM) incubations and passive permeability (<i>P</i><sub>app</sub>) in MDCKII cells (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). Examination of the in vitro intrinsic clearance alone did not appear to explain the differences in oral bioavailability in rats. Low passive permeability likely contributed to the low oral bioavailability of several compounds, however, compounds <b>19</b> and <b>29</b> had improved oral bioavailability despite low passive permeability, indicating the potential role of uptake transporters in absorption. In support of this hypothesis, a recent paper suggested mirabegron (<b>1</b>) also has low-to-moderate membrane permeability and P-gp is likely to be involved in its efflux and that it could be transported by intestinal influx transporters.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. SAR Results for Pyrazole Derivatives</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm4017224/production/images/medium/jm-2013-017224_0012.gif" alt="" id="fx4" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" align="center" char="±">human EC<sub>50</sub> (nM)<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a> (%Act)<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">human IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center" char="±">β<sub>3</sub></th><th class="colsep0 rowsep0" align="center" char=".">β<sub>1</sub></th><th class="colsep0 rowsep0" align="center" char=".">β<sub>2</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">76.7 ± 13.68 (72)</td><td class="colsep0 rowsep0" align="char" char=".">>20000</td><td class="colsep0 rowsep0" align="char" char=".">>20000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">16.7 ± 10.33 (102)</td><td class="colsep0 rowsep0" align="char" char=".">>20000</td><td class="colsep0 rowsep0" align="char" char=".">>20000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" colspan="2" align="left">–CH<sub>2</sub>CH<sub>2</sub>–</td><td class="colsep0 rowsep0" align="char" char="±">3.7 ± 2.86 (84)</td><td class="colsep0 rowsep0" align="char" char=".">>20000</td><td class="colsep0 rowsep0" align="char" char=".">>20000</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Unless otherwise noted, the results are shown as the mean ± SD (<i>n</i> ≥ 3) or presented as the average of two experiments.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">% Activation defined as the fitted maximal value of the test compound concentration response expressed as a percent of the maximal response to <i>R</i>-(−)-isoproterenol.</p></div><div class="footnote" id="t4fn3"><sup>c</sup><p class="last"><i>n</i> = 1.</p></div><div class="footnote" id="t4fn4"><sup>d</sup><p class="last">Single diastereoisomer with only more potent isomer indicated.</p></div></div></div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Mean Pharmacokinetic Parameters of Selected β<sub>3</sub> Adrenergic Agonists in Non Clinical Species<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="center" /></col><col align="center" /></col><col align="char" char="." /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center" char=".">Cl<sub>p</sub> mL/min/kg</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center">PO AUC <sub>total</sub> (nM·h/mpk)<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">PO AUC <sub>unbound</sub> (nM·h/mpk)<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char="."><i>F</i> (%)</th><th class="colsep0 rowsep0" align="center">% unbound</th><th class="colsep0 rowsep0" align="center">rat LM Cl<sub>int</sub> mL/min/kg</th><th class="colsep0 rowsep0" align="center"><i>P</i><sub>app</sub> (× 10<sup>–6</sup> cm/s)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b><a class="ref internalNav" href="#t5fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="char" char=".">62</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="center">70</td><td class="colsep0 rowsep0" align="center">1</td><td class="colsep0 rowsep0" align="char" char=".">17</td><td class="colsep0 rowsep0" align="center">2</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">dog</td><td class="colsep0 rowsep0" align="char" char=".">20</td><td class="colsep0 rowsep0" align="char" char=".">14</td><td class="colsep0 rowsep0" align="center">290</td><td class="colsep0 rowsep0" align="center">6</td><td class="colsep0 rowsep0" align="char" char=".">27</td><td class="colsep0 rowsep0" align="center">2</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">monkey</td><td class="colsep0 rowsep0" align="char" char=".">19</td><td class="colsep0 rowsep0" align="char" char=".">9</td><td class="colsep0 rowsep0" align="center">50</td><td class="colsep0 rowsep0" align="center">1</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="center">2</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="char" char=".">11</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="center">440</td><td class="colsep0 rowsep0" align="center">26</td><td class="colsep0 rowsep0" align="char" char=".">12</td><td class="colsep0 rowsep0" align="center">6</td><td class="colsep0 rowsep0" align="center">38</td><td class="colsep0 rowsep0" align="center">5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11a</b></td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="center">40</td><td class="colsep0 rowsep0" align="center">7</td><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="center">18</td><td class="colsep0 rowsep0" align="center">59</td><td class="colsep0 rowsep0" align="center">5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12a</b></td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="char" char=".">185</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="center"><LQ<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="center"><LQ<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="center">14</td><td class="colsep0 rowsep0" align="center">63</td><td class="colsep0 rowsep0" align="center">8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b><a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="char" char=".">32</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="center"><LQ<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="center"><LQ<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="center">unstable</td><td class="colsep0 rowsep0" align="center">57</td><td class="colsep0 rowsep0" align="center"><1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="char" char=".">80</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="center">60</td><td class="colsep0 rowsep0" align="center">6</td><td class="colsep0 rowsep0" align="char" char=".">12</td><td class="colsep0 rowsep0" align="center">10</td><td class="colsep0 rowsep0" align="center">68</td><td class="colsep0 rowsep0" align="center">24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="char" char=".">33</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="center">480</td><td class="colsep0 rowsep0" align="center">91</td><td class="colsep0 rowsep0" align="char" char=".">41</td><td class="colsep0 rowsep0" align="center">19</td><td class="colsep0 rowsep0" align="center"><15</td><td class="colsep0 rowsep0" align="center">13<a class="ref internalNav" href="#t5fn5" aria-label="e">e</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">dog</td><td class="colsep0 rowsep0" align="char" char=".">27</td><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="center">980</td><td class="colsep0 rowsep0" align="center">686</td><td class="colsep0 rowsep0" align="char" char=".">67</td><td class="colsep0 rowsep0" align="center">70</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">monkey</td><td class="colsep0 rowsep0" align="char" char=".">36</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="center">90</td><td class="colsep0 rowsep0" align="center">90</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="center">100</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="char" char=".">87</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="center">30</td><td class="colsep0 rowsep0" align="center">2</td><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="center">5</td><td class="colsep0 rowsep0" align="center">135</td><td class="colsep0 rowsep0" align="center">26</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="char" char=".">25</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="center">700</td><td class="colsep0 rowsep0" align="center">77</td><td class="colsep0 rowsep0" align="char" char=".">46</td><td class="colsep0 rowsep0" align="center">11</td><td class="colsep0 rowsep0" align="center">62</td><td class="colsep0 rowsep0" align="center">17</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="char" char=".">34</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="center">420</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="char" char=".">29</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="char" char=".">24</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="center">590</td><td class="colsep0 rowsep0" align="center">212</td><td class="colsep0 rowsep0" align="char" char=".">35</td><td class="colsep0 rowsep0" align="center">36</td><td class="colsep0 rowsep0" align="center">55</td><td class="colsep0 rowsep0" align="center">6<a class="ref internalNav" href="#t5fn5" aria-label="e">e</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">dog</td><td class="colsep0 rowsep0" align="char" char=".">34</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="center">1680</td><td class="colsep0 rowsep0" align="center">1176</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="center">70</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">monkey</td><td class="colsep0 rowsep0" align="char" char=".">36</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="center">120</td><td class="colsep0 rowsep0" align="center">120</td><td class="colsep0 rowsep0" align="char" char=".">11</td><td class="colsep0 rowsep0" align="center">100</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Dose: iv, 1 mpk; po, 2 mpk.</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">Cassette dosing: iv, 0.13 mpk; po, 0.25 mpk.</p></div><div class="footnote" id="t5fn3"><sup>c</sup><p class="last"><LQ = below limits of quantification.</p></div><div class="footnote" id="t5fn4"><sup>d</sup><p class="last">Data taken from ref <a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">24</a>.</p></div><div class="footnote" id="t5fn5"><sup>e</sup><p class="last">Transport was observed in control cells, hence permeability is likely overestimated. ND: not determined.</p></div></div></div><div class="NLM_p">On the basis of the β<sub>3</sub>-AR activity and rat pharmacokinetic profiles, compounds <b>19</b>, <b>21</b>, and <b>29</b> were selected for further evaluation. Further examination of these analogues against ancillary targets (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>) demonstrated a clean P450 inhibition profile for all three analogues, with compound <b>21</b> being the least selective, showing an IC<sub>50</sub> of 42 μM against CYP3A4. Binding at the hERG, human cardiac calcium channel, and human cardiac sodium channels was measured to examine possible cardiac liabilities of these compounds. All three compounds were clean (IC<sub>50</sub> > 30 μM) at the calcium and sodium channels, however, <b>19</b> and <b>21</b> do show some inhibition of the hERG potassium channel (IC<sub>50</sub> = 6 and 12 μM, respectively). Additional in vitro profiling in an extensive panel of receptor and ion channel binding and enzyme inhibition assays showed these compounds possessed activity at the serotonin transporter (SERT), the target of the selective serotonin reuptake inhibitor (SSRI) class of antidepressants. Compound <b>21</b> proved to be the least selective (77-fold), with compounds <b>19</b> and <b>29</b> being somewhat more selective (310- and 243-fold respectively).</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Off-Target Activities of Selected β<sub>3</sub> Adrenergic Agonists</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">P450 inhibition IC<sub>50</sub>s (μM)<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">ion channel IC<sub>50</sub>s (μM)</th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">2C9</th><th class="colsep0 rowsep0" align="center" char=".">2D6</th><th class="colsep0 rowsep0" align="center" char=".">3A4</th><th class="colsep0 rowsep0" align="center" char=".">hERG<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">hCa<sub>v</sub>1.2<a class="ref internalNav" href="#t6fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char=".">hNa<sub>v</sub>1.5<a class="ref internalNav" href="#t6fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center" char=".">SERT<a class="ref internalNav" href="#t6fn4" aria-label="d">d</a> IC<sub>50</sub> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="char" char=".">>100</td><td class="colsep0 rowsep0" align="char" char=".">2.2</td><td class="colsep0 rowsep0" align="char" char=".">>100</td><td class="colsep0 rowsep0" align="char" char=".">11.2</td><td class="colsep0 rowsep0" align="char" char=".">8.2</td><td class="colsep0 rowsep0" align="char" char=".">>30</td><td class="colsep0 rowsep0" align="char" char=".">1613</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11a</b></td><td class="colsep0 rowsep0" align="char" char=".">>100</td><td class="colsep0 rowsep0" align="char" char=".">18.3</td><td class="colsep0 rowsep0" align="char" char=".">86</td><td class="colsep0 rowsep0" align="char" char=".">12.7</td><td class="colsep0 rowsep0" align="char" char=".">>30</td><td class="colsep0 rowsep0" align="char" char=".">5.6</td><td class="colsep0 rowsep0" align="char" char=".">1218</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="char" char=".">>100</td><td class="colsep0 rowsep0" align="char" char=".">78.8</td><td class="colsep0 rowsep0" align="char" char=".">>100</td><td class="colsep0 rowsep0" align="char" char=".">6.1</td><td class="colsep0 rowsep0" align="char" char=".">>30</td><td class="colsep0 rowsep0" align="char" char=".">>30</td><td class="colsep0 rowsep0" align="char" char=".">422</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="char" char=".">67.2</td><td class="colsep0 rowsep0" align="char" char=".">>100</td><td class="colsep0 rowsep0" align="char" char=".">41.8</td><td class="colsep0 rowsep0" align="char" char=".">12</td><td class="colsep0 rowsep0" align="char" char=".">>30</td><td class="colsep0 rowsep0" align="char" char=".">>30</td><td class="colsep0 rowsep0" align="char" char=".">89</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="char" char=".">>100</td><td class="colsep0 rowsep0" align="char" char=".">>100</td><td class="colsep0 rowsep0" align="char" char=".">>100</td><td class="colsep0 rowsep0" align="char" char=".">>30</td><td class="colsep0 rowsep0" align="char" char=".">>30</td><td class="colsep0 rowsep0" align="char" char=".">>30</td><td class="colsep0 rowsep0" align="char" char=".">898</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">Human liver microsome P450 marker enzyme activities with diclofenac α′-hydroxylation for 2C9, dextromethorphan <i>O</i>-demethylation for 2D6, and testosterone 6β-hydroxylation for 3A4.</p></div><div class="footnote" id="t6fn2"><sup>b</sup><p class="last">IKr binding assay, ref <a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">23</a>.</p></div><div class="footnote" id="t6fn3"><sup>c</sup><p class="last">Binding assay with [<sup>3</sup>H]-diltiazem, ref <a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">23</a>.</p></div><div class="footnote" id="t6fn4"><sup>d</sup><p class="last">Reference <a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">23</a>.</p></div></div></div><div class="NLM_p">The dog pharmacokinetic profiles of <b>19</b> and <b>29</b> revealed good oral bioavailabilities (<i>F</i><sub>dog</sub> = 67–100%). However, both compounds exhibit poor biovailability in rhesus monkeys (8–11%). Examination of the stability of these compounds in liver microsomes across a range of species (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>) indicates that <b>19</b> and <b>29</b> both have a much higher in vitro intrinsic clearance in monkey liver microsomes than in rat, dog, and human liver microsomes, which may lead to greater hepatic extraction in this species.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. In Vitro Intrinisc Clearance of Compounds <b>19</b> and <b>29</b> in Liver Microsomes</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center" char=".">intrinsic clearance (mL/min/kg body weight)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">human</th><th class="colsep0 rowsep0" align="center" char=".">rat</th><th class="colsep0 rowsep0" align="center" char=".">dog</th><th class="colsep0 rowsep0" align="center" char=".">monkey</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="char" char="."><10</td><td class="colsep0 rowsep0" align="char" char="."><15</td><td class="colsep0 rowsep0" align="char" char="."><10</td><td class="colsep0 rowsep0" align="char" char=".">205</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="char" char=".">19</td><td class="colsep0 rowsep0" align="char" char=".">55</td><td class="colsep0 rowsep0" align="char" char=".">31</td><td class="colsep0 rowsep0" align="char" char=".">261</td></tr></tbody></table></div></div><div class="NLM_p">A metabolism and excretion study was conducted in bile duct cannulated rats after oral dosing with <sup>3</sup>H-labeled <b>29</b> at 10 mg/kg. Urine and bile were collected for up to 48 h and analyzed by LC/MS/MS. <b>29</b> was well absorbed, with 73% of the administered dose recovered in urine and bile. <b>29</b> was eliminated renally (∼50% of recovered dose) and through metabolism (∼50% of recovered dose). This differs significantly from <b>3</b>, which was poorly absorbed and metabolized extensively, and hepatic extraction was the major route for clearance of this compound in rats.<a onclick="showRef(event, 'ref14 ref24'); return false;" href="javascript:void(0);" class="ref ref14 ref24">(14, 24)</a></div><div class="NLM_p">In comparison to our first-generation pyridylethanolamine β<sub>3</sub>-AR agonist, <b>3</b>, both <b>19</b> and <b>29</b> demonstrated significantly different properties such as lower Log <i>D</i> (4.6 for <b>3</b>, compared to 0.9–1.2 for <b>19</b> and <b>29</b> at pH 7.3) reduced plasma protein binding (∼2% unbound for <b>3</b>, compared to 20–100% unbound for <b>19</b> and <b>29</b>) and reduced in vivo intrinsic clearance (in rats estimated as ∼4000 mL/min/kg for <b>3</b> compared to less than 200 mL/min/kg for <b>19</b> and <b>29</b>). The lower intrinsic clearance results in significantly improved unbound drug exposures in vivo for <b>19</b> and <b>29</b> compared to <b>3</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>).</div><div class="NLM_p">Compounds <b>19</b> and <b>29</b> were evaluated in an acetic acid induced bladder hyperactivity model in anesthetized rats (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25, 26)</a> Before conducting in vivo experiments, we confirmed the in vitro potency of these compounds at β<sub>3</sub>-AR across a number of species as shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a>. We observed significant differences between human and rat β<sub>3</sub>-AR activity with <b>19</b> and <b>29</b>, which is expected based on previous observations.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> The EC<sub>50</sub> values for the rat β<sub>3</sub>-AR of compounds <b>19</b> and <b>29</b> showed significantly reduced potency (<b>19</b>, 20-fold; <b>29</b>, 100-fold) relative to human β<sub>3</sub>-AR activity. After intravenous dosing, both <b>19</b> and <b>29</b> caused a reduction in micturition pressure with a trend for dose dependence (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). Reductions in micturition pressure are an indirect measure of detrusor muscle relaxation. As anticipated by its greater potency at the rat β<sub>3</sub>-AR, the thiazole analogue <b>19</b> showed a reduction in micturation pressure (59%) at a lower unbound plasma level (1.2 μM) than the pyrazole analogue <b>29</b>. Compound <b>29</b> was able to elicit a greater reduction in micturation pressure overall (69%) but at an unbound plasma level of 27 μM.</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. β<sub>3</sub>-AR Activity of Selected in Compounds in Different Species</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center" char="±">EC<sub>50</sub> (nM)<a class="ref internalNav" href="#t8fn1" aria-label="a">a</a> (%Act)<a class="ref internalNav" href="#t8fn2" aria-label="b">b</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char="±">human</th><th class="colsep0 rowsep0" align="center" char="±">rat</th><th class="colsep0 rowsep0" align="center">dog</th><th class="colsep0 rowsep0" align="center">Rhesus</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11a</b></td><td class="colsep0 rowsep0" align="char" char="±">0.15 ± 0.03 (103)</td><td class="colsep0 rowsep0" align="char" char="±">1.3 ± 0.39 (100)</td><td class="colsep0 rowsep0" align="center">0.19 (102)<a class="ref internalNav" href="#t8fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="center">0.06 (78)<a class="ref internalNav" href="#t8fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="char" char="±">1.4 ± 0.69 (103)</td><td class="colsep0 rowsep0" align="char" char="±">27.6 ± 6.9 (89)</td><td class="colsep0 rowsep0" align="center">5.0 (82)<a class="ref internalNav" href="#t8fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="center">2.0 (98)<a class="ref internalNav" href="#t8fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="char" char="±">3.7 ± 2.86 (84)</td><td class="colsep0 rowsep0" align="char" char="±">434 ± 171 (98)</td><td class="colsep0 rowsep0" align="center">22 (86) ± 12.41</td><td class="colsep0 rowsep0" align="center">4.7 (93) ± 3.19</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup>a</sup><p class="last">Unless otherwise noted, the results are shown as the mean ± SD (<i>n</i> ≥ 3) or presented as the average of two experiments.</p></div><div class="footnote" id="t8fn2"><sup>b</sup><p class="last">% Activation defined as the fitted maximal value of the test compound concentration response expressed as a percent of the maximal response to <i>R</i>-(−)-isoproterenol.</p></div><div class="footnote" id="t8fn3"><sup>c</sup><p class="last"><i>n</i> = 1.</p></div></div></div><figure id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm4017224/production/images/medium/jm-2013-017224_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm4017224/production/images/large/jm-2013-017224_0004.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Reduction in micturation pressure produced by increasing doses of <b>19</b> and <b>29</b> in acetic acid induced bladder hyperactivity model with unbound plasma levels. *, <i>P</i> < 0.05, and **, <i>P</i> < 0.01, versus vehicle group. Each bar represents mean ± SEM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm4017224/production/images/large/jm-2013-017224_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4017224&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25153" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25153" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, we have investigated changes to both the LHS aromatic and RHS heterocycle of a series of pyrrolidine containing β<sub>3</sub> adrenergic receptor agonists with the aim of addressing issues related to pharmacokinetics (e.g., low rat oral bioavailability) and potential metabolic/toxicological issues (e.g., toxicity potential of amino-thiazole, ion channel inhibition). To accomplish these goals, we developed a novel route to the pyrrolidine core to allow modification of the LHS aromatic ring. We also expanded the SAR in the pyrrolidine series by preparing conformationally restricted acetanilide RHS heterocycles. Excellent on-target potency was maintained with a number of examples; compounds <b>19</b> and <b>29</b> no longer contain an amino-thiazole group and demonstrate marked improvements in rat in vivo intrinsic clearance and unbound drug exposures compared to our original clinical candidate, <b>3</b>. Both compounds also demonstrated a good selectivity profile in vitro against a panel of receptors, ion channels and enzymes, which made them suitable candidates for additional in vivo preclinical studies. For the first time in this series, we were able to demonstrate an in vivo pharmocodynamic effect. In rats, compounds <b>19</b> and <b>29</b> were able to dose-dependently reduce bladder pressure following intravenous dosing, albeit at unbound plasma concentrations above their intrinsic EC<sub>50s</sub>. This model is able to afford a rank order of potency which agrees with differences in in vitro activity. Additional SAR analysis, as well as in vivo efficacy of related compounds, will be disclosed in future articles.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62082" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62082" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> General</h3><div class="NLM_p last">Unless otherwise stated, all reactions were carried out under an atmosphere of dry argon or nitrogen in dried glassware. Indicated reaction temperatures refer to those of the reaction bath, while room temperature (rt) is noted as 25 °C. All solvents and reagents were obtained from commercial sources and were used as received. Analytical thin layer chromatography (TLC) was performed with Whatman TLC plates (Partisil K6F, 60 Å, 250 μm). Visualization was accomplished by irradiation under a 254 nm UV lamp. Strong cation exchange was performed using Varian Bond Elut SCX columns. Chromatography on silica gel was carried out using prepacked silica gel cartridges using the indicated solvent system on either a Biotage Horizon flash chromatography system or a Teledyne ISCO Combiflash Companion flash chromatography system. If needed, products were purified by reverse phase chromatography, which was performed using a Gilson purification system employing a YMC Pro-Pac C18 column (5 μm, 20 mm × 100 mm). The mobile phase was a mixture of acetonitrile and H<sub>2</sub>O, each containing 0.1% trifluoroacetic acid. If needed, products were purified by preparative TLC on silica gel gf precoated 20 cm × 20 cm 1000 μm from Analech. <sup>1</sup>H NMR spectra were recorded on a Varian Unity Inova AS500 500 MHz spectrometer. The reported compounds are of ≥95 HPLC area % purity, unless otherwise noted. Purity analysis was carried out by LC/MS analysis using an Agilent 1100 system fitted with a Waters Micromass ZQ2000 quadrupole spectrometer.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div></div><div id="sec5_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> (<i>R</i>)-2-(2-Aminothiazol-4-yl)-<i>N</i>-(4-(((2<i>S</i>,5<i>R</i>)-5-((<i>R</i>)-hydroxy(phenyl)methyl)pyrrolidin-2-yl)methyl)phenyl)propanamide (<b>7a</b>) and (<i>S</i>)-2-(2-Aminothiazol-4-yl)-<i>N</i>-(4-(((2<i>S</i>,5<i>R</i>)-5-((<i>R</i>)-hydroxy(phenyl)methyl)pyrrolidin-2-yl)methyl)phenyl)propanamide (<b>7b</b>)</h3><div class="NLM_p last">To a solution of (2<i>S</i>,5<i>R</i>)-<i>tert</i>-butyl 2-(4-aminobenzyl)-5-((<i>R</i>)-hydroxy(phenyl)methyl)pyrrolidine-1-carboxylate (<b>50a</b>) (100 mg, 0.26 mmol) and 2-(2-((<i>tert</i>-butoxycarbonyl)amino)thiazol-4-yl)propanoic acid (<b>33a</b>) (71 mg, 0.26 mmol) in DMF (3 mL) was added EDC (100 mg, 0.52 mmol), HOBt (60 mg, 0.39 mmol), and triethylamine (0.146 mL, 1.05 mmol), and the resulting mixture stirred at room temperature for 4 h. The mixture was poured into water (15 mL) and extracted with ethyl acetate (3 × 5 mL). The combined extracts were washed with brine (15 mL), dried (MgSO<sub>4</sub>), and evaporated. The residue was purified by silica gel column chromatography (Biotage Horizon: SNAP 10g: elution with gradient 0–50% ethyl acetate in hexanes) to give (2<i>S</i>,5<i>R</i>)-<i>tert</i>-butyl 2-(4-(2-(2-((<i>tert</i>-butoxycarbonyl)amino)thiazol-4-yl)propanamido)benzyl)-5-((<i>R</i>)-hydroxy(phenyl)methyl)pyrrolidine-1-carboxylate. The diastereoisomers were separated by preparative HPLC (Pirkle (R,R)-Whelk-O column: eluent 25% isopropyl alcohol in heptanes) to give first eluting isomer (2<i>S</i>,5<i>R</i>)-<i>tert</i>-butyl 2-(4-((<i>R</i>)-2-(2-((<i>tert</i>-butoxycarbonyl)amino)thiazol-4-yl)propanamido)benzyl)-5-((<i>R</i>)-hydroxy(phenyl)methyl)pyrrolidine-1-carboxylate (34 mg, 20%) and second eluting isomer (2<i>S</i>,5<i>R</i>)-<i>tert</i>-butyl 2-(4-((<i>S</i>)-2-(2-((<i>tert</i>-butoxycarbonyl)amino)thiazol-4-yl)propanamido)benzyl)-5-((<i>R</i>)-hydroxy(phenyl)methyl)pyrrolidine-1-carboxylate (26 mg, 16%). A mixture of (2<i>S</i>,5<i>R</i>)-<i>tert</i>-butyl 2-(4-((<i>R</i>)-2-(2-((<i>tert</i>-butoxycarbonyl)amino)thiazol-4-yl)propanamido)benzyl)-5-((<i>R</i>)-hydroxy(phenyl)methyl)pyrrolidine-1-carboxylate (34 mg, 0.053 mmol) was dissolved in dichloromethane (0.5 mL) and trifluoroacetic acid (0.1 mL, 1.3 mmol) and the resulting mixture stirred at room temperature for 2 h. The mixture was evaporated and the free base formed by eluting through an SCX cartridge with 2 M ammonia in methanol and concentrating the filtrate. The residue was purified by preparative thin layer chromatography (elution with 0.5% ammonium hydroxide and 10% methanol in dichloromethane) and afforded the title compound <b>7a</b> (9.3 mg, 40%). LC/MS <i>m</i>/<i>e</i> 437.1 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 1.49 (d, <i>J</i> = 7.1 Hz, 3H), 1.49–1.60 (m, 3H), 1.78–1.85 (m, 1H), 2.78 (dd, <i>J</i> = 13.0 and 6.8 Hz, 1H), 2.85 (dd, <i>J</i> = 13.0 and 7.3 Hz, 1H), 3.30–3.40 (m, 2H), 3.70 (q, <i>J</i> = 7.1 Hz, 1H), 4.47 (d, <i>J</i> = 8.0 Hz, 1H), 6.35 (s, 1H), 7.19 (d, <i>J</i> = 8.5 Hz, 2H), 7.27 (t, <i>J</i> = 6.9 Hz, 1H), 7.31–7.37 (m, 4H), 7.50 (d, <i>J</i> = 8.5 Hz, 2H). In a similar manner, (2<i>S</i>,5<i>R</i>)-<i>tert</i>-butyl 2-(4-((<i>S</i>)-2-(2-((<i>tert</i>-butoxycarbonyl)amino)thiazol-4-yl)propanamido)benzyl)-5-((<i>R</i>)-hydroxy(phenyl)methyl)pyrrolidine-1-carboxylate (26 mg, 0.04 mmol) was deprotected to afford <b>8a</b> (6 mg, 34%). LC/MS <i>m</i>/<i>e</i> 437.1 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 1.49 (d, <i>J</i> = 7.1 Hz, 3H), 1.49–1.60 (m, 3H), 1.78–1.85 (m, 1H), 2.78 (dd, <i>J</i> = 13.0 and 6.8 Hz, 1H), 2.85 (dd, <i>J</i> = 13.0 and 7.3 Hz, 1H), 3.30–3.40 (m, 2H), 3.70 (q, <i>J</i> = 7.1 Hz, 1H), 4.47 (d, <i>J</i> = 8.0 Hz, 1H), 6.35 (s, 1H), 7.19 (d, <i>J</i> = 8.5 Hz, 2H), 7.27 (t, <i>J</i> = 6.9 Hz, 1H), 7.31–7.37 (m, 4H), 7.50 (d, <i>J</i> = 8.5 Hz, 2H).</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> (<i>R</i>)-2-(2-Aminothiazol-4-yl)-<i>N</i>-(4-(((2<i>S</i>,5<i>R</i>)-5-((<i>R</i>)-hydroxy(phenyl)methyl)pyrrolidin-2-yl)methyl)phenyl)butanamide (<b>8a</b>)</h3><div class="NLM_p last">Starting from aniline <b>50a</b> and intermediate <b>33b</b>, the procedures summarized above provided <b>8a</b>. LC/MS <i>m</i>/<i>e</i> 451.2 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 0.87 (t, <i>J</i> = 7.5 Hz, 3H), 1.27–1.34 (m, 2H), 1.38–1.44 (m, 1H), 1.57–1.64 (m, 1H), 1.74–1.82 (m, 1H), 1.84–1.93 (m, 1H), 2.58 (dd, <i>J</i> = 13.0 and 7.0 Hz, 1H), 2.67 (dd, <i>J</i> = 13.0 and 6.5 Hz, 1H), 3.12 (q, <i>J</i> = 7.5 Hz, 1H), 3.22 (quint, <i>J</i> = 7.0 Hz, 1H), 3.45 (dd, <i>J</i> = 9.0 and 6.5 Hz, 1H), 4.26 (d, <i>J</i> = 7.5 Hz, 1H), 6.26 (s, 1H), 6.88 (br s, 2H), 7.13 (d, <i>J</i> = 8.5 Hz, 2H), 7.22 (t, <i>J</i> = 7.0 Hz, 1H), 7.27–7.33 (m, 4H), 7.52 (d, <i>J</i> = 8.5 Hz, 2H), 9.94 (s, 1H).</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> (<i>R</i>)-2-(2-Aminothiazol-4-yl)-<i>N</i>-(4-(((2<i>S</i>,5<i>R</i>)-5-((<i>R</i>)-hydroxy(phenyl)methyl)pyrrolidin-2-yl)methyl)phenyl)pentanamide (<b>9a</b>)</h3><div class="NLM_p last">Starting from aniline <b>50a</b> and intermediate <b>33c</b>, the procedures summarized above provided <b>9a</b>. LC/MS <i>m</i>/<i>e</i> 465.2 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 0.89 (t, <i>J</i> = 7.0 Hz, 3H), 1.22–1.36 (m, 4H), 1.38–1.46 (m, 1H), 1.56–1.65 (m, 1H), 1.68–1.76 (m, 1H), 1.82–1.90 (m, 1H), 2.58 (dd, <i>J</i> = 13.0 and 6.5 Hz, 1H), 2.68 (dd, <i>J</i> = 13.0 and 7.0 Hz, 1H), 3.14 (q, <i>J</i> = 7.0 Hz, 1H), 3.22 (quint, <i>J</i> = 7.0 Hz, 1H), 3.56 (t, <i>J</i> = 8.5 and 6.0 Hz, 1H), 4.27 (d, <i>J</i> = 7.5 Hz, 1H), 6.25 (s, 1H), 6.88 (br s, 2H), 7.12 (d, <i>J</i> = 8.5 Hz, 2H), 7.22 (t, <i>J</i> = 7.0 Hz, 1H), 7.27–7.34 (m, 4H), 7.51 (d, <i>J</i> = 8.5 Hz, 2H), 9.95 (s, 1H).</div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> (<i>R</i>)-2-(2-Aminothiazol-4-yl)-<i>N</i>-(4-(((2<i>S</i>,5<i>R</i>)-5-((<i>R</i>)-hydroxy(phenyl)methyl)pyrrolidin-2-yl)methyl)phenyl)-3-methylbutanamide (<b>10a</b>)</h3><div class="NLM_p last">Starting from aniline <b>50a</b> and intermediate <b>33d</b>, the procedures summarized above provided <b>10a</b>. LC/MS <i>m</i>/<i>e</i> 465.3 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 0.80 (d, <i>J</i> = 4.5 Hz, 3H), 0.93 (d, <i>J</i> = 4.5 Hz, 3H), 1.32–1.41 (m, 2H), 1.41–1.49 (m, 1H), 1.60–1.68 (m, 1H), 2.23–2.32 (m, 1H), 2.63 (dd, <i>J</i> = 13.0 and 7.0 Hz, 1H), 2.76 (dd, <i>J</i> = 13.0 and 6.0 Hz, 1H), 3.18–3.25 (m, 2H), 3.28 (t, <i>J</i> = 6.5 Hz, 1H), 4.36 (d, <i>J</i> = 7.0 Hz, 1H), 6.32 (d, <i>J</i> = 2.0 Hz, 1H), 6.90 (br s, 2H), 7.12 (d, <i>J</i> = 8.0 Hz, 2H), 7.24 (t, <i>J</i> = 6.5 Hz, 1H), 7.27–7.35 (m, 4H), 7.51 (d, <i>J</i> = 8.0 Hz, 2H), 9.94 (s, 1H).</div></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> (<i>R</i>)-2-Amino-<i>N</i>-(4-(((2<i>S</i>,5<i>R</i>)-5-((<i>R</i>)-hydroxy(phenyl)methyl)pyrrolidin-2-yl)methyl)phenyl)-5,6-dihydro-4<i>H</i>-cyclopenta[<i>d</i>]thiazole-4-carboxamide (<b>11a</b>)</h3><div class="NLM_p last">Starting from aniline <b>50a</b> and intermediate <b>33e</b>, the procedures summarized above provided <b>11a</b>. LC/MS <i>m</i>/<i>e</i> 449.1 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.25–1.33 (m, 2H), 1.36–1.44 (m, 1H), 1.55–1.63 (m, 1H), 2.45–2.53 (m, 1H), 2.53–2.60 (m, 2H), 2.62–2.70 (m, 2H), 2.74–2.81 (m, 1H), 3.10 (q, <i>J</i> = 7.0 Hz, 1H), 3.21 (quint, <i>J</i> = 7.0 Hz, 1H), 3.78 (dd, <i>J</i> = 8.0 and 6.0 Hz, 1H), 4.23 (d, <i>J</i> = 7.5 Hz, 1H), 6.86 (br s, 2H), 7.12 (d, <i>J</i> = 8.5 Hz, 2H), 7.21 (t, <i>J</i> = 7.0 Hz, 1H), 7.27–7.32 (m, 4H), 7.51 (d, <i>J</i> = 8.5 Hz, 2H), 10.00 (s, 1H).</div></div><div id="sec5_1_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> (<i>S</i>)-2-Amino-<i>N</i>-(4-(((2<i>S</i>,5<i>R</i>)-5-((<i>R</i>)-hydroxy(phenyl)methyl)pyrrolidin-2-yl)methyl)phenyl)-5,6-dihydro-4<i>H</i>-cyclopenta[<i>d</i>]thiazole-4-carboxamide (<b>11b</b>)</h3><div class="NLM_p last">Starting from aniline <b>50a</b> and intermediate <b>33e</b>, the procedures summarized above provided <b>11b</b>. LC/MS <i>m</i>/<i>e</i> 449.1 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.20–1.35 (m, 2H), 1.35–1.45 (m, 1H), 1.51–1.64 (m, 1H), 2.43–2.60 (m, 3H), 2.60–2.72 (m, 2H), 2.74–2.85 (m, 1H), 3.08 (q, <i>J</i> = 7.0 Hz, 1H), 3.19 (quint, <i>J</i> = 7.0 Hz, 1H), 3.78 (m, 1H), 4.21 (d, <i>J</i> = 7.5 Hz, 1H), 6.86 (br s, 2H), 7.12 (d, <i>J</i> = 8.5 Hz, 2H), 7.21 (t, <i>J</i> = 7.0 Hz, 1H), 7.27–7.32 (m, 4H), 7.51 (d, <i>J</i> = 8.5 Hz, 2H), 10.00 (s, 1H).</div></div><div id="sec5_1_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> (<i>R</i>)-2-Amino-<i>N</i>-(4-(((2<i>S</i>,5<i>R</i>)-5-((<i>R</i>)-hydroxy(phenyl)methyl)pyrrolidin-2-yl)methyl)phenyl)-4,5,6,7-tetrahydrobenzo[<i>d</i>]thiazole-4-carboxamide (<b>12a</b>)</h3><div class="NLM_p last">Starting from aniline <b>50a</b> and intermediate <b>33f</b>, the procedures summarized above provided <b>12a</b>. LC/MS <i>m</i>/<i>e</i> 463.0 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.27–1.37 (m, 2H), 1.39–1.48 (m, 1H), 1.57–1.69 (m, 2H), 1.87–1.98 (m, 3H), 2.44–2.54 (m, 2H), 2.59 (dd, <i>J</i> = 13.0 and 7.5 Hz, 1H), 2.71 (dd, <i>J</i> = 13.0 and 6.5 Hz, 1H), 3.17 (t, <i>J</i> = 7.5 Hz, 1H), 3.25 (quint, <i>J</i> = 7.0 Hz, 1H), 3.55 (m, 1H), 4.29 (d, <i>J</i> = 7.0 Hz, 1H), 6.74 (br s, 2H), 7.12 (d, <i>J</i> = 8.5 Hz, 2H), 7.22 (t, <i>J</i> = 6.5 Hz, 1H), 7.28–7.32 (m, 4H), 7.52 (d, <i>J</i> = 8.5 Hz, 2H), 10.03 (s, 1H).</div></div><div id="sec5_1_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> (<i>R</i>)-2-Amino-<i>N</i>-(4-(((2<i>S</i>,5<i>R</i>)-5-((<i>R</i>)-hydroxy(phenyl)methyl)pyrrolidin-2-yl)methyl)phenyl)-5,6,7,8-tetrahydro-4<i>H</i>-cyclohepta[<i>d</i>]thiazole-4-carboxamide (<b>13a</b>)</h3><div class="NLM_p last">Starting from aniline <b>50a</b> and intermediate <b>33g</b>, the procedures summarized above provided <b>13a</b>. LC/MS <i>m</i>/<i>e</i> 477.0 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 1.46–1.60 (m, 3H), 1.60–1.69 (m, 1H), 1.77–1.95 (m, 5H), 2.29–2.37 (m, 1H), 2.61 (dd, <i>J</i> = 13.5 and 6.0 Hz, 1H), 2.73–2.81 (m, 2H), 2.85 (dd, <i>J</i> = 13.5 and 7.0 Hz, 1H), 3.32–3.40 (m, 2H), 3.85 (dd, <i>J</i> = 6.5 and 2.5 Hz, 1H), 4.47 (d, <i>J</i> = 8.0 Hz, 1H), 7.19 (d, <i>J</i> = 8.5 Hz, 2H), 7.26 (t, <i>J</i> = 7.0 Hz, 1H), 7.31–7.36 (m, 4H), 7.48 (d, <i>J</i> = 8.5 Hz, 2H).</div></div><div id="sec5_1_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> (<i>R</i>)-2-Amino-<i>N</i>-(4-(((2<i>S</i>,5<i>R</i>)-5-((<i>R</i>)-(3-chlorophenyl)(hydroxy)methyl)pyrrolidin-2-yl)methyl)phenyl)-5,6-dihydro-4<i>H</i>-cyclopenta[<i>d</i>]thiazole-4-carboxamide (<b>14</b>)</h3><div class="NLM_p last">Starting from aniline <b>50b</b> and intermediate <b>33e</b>, the procedures summarized above provided <b>14</b>. LC/MS <i>m</i>/<i>e</i> 483.3/485.3 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.19–1.28 (m, 1H), 1.30–1.38 (m, 1H), 1.38–1.46 (m, 1H), 1.54–1.61 (m, 1H), 2.44–2.58 (m, 3H), 2.61–2.69 (m, 2H), 2.73–2.80 (m, 1H), 3.11 (dd, <i>J</i> = 7.0 Hz, 1H), 3.19 (quint, <i>J</i> = 6.5 Hz, 1H), 3.77 (t, <i>J</i> = 6.0 Hz, 1H), 4.29 (d, <i>J</i> = 6.5 Hz, 1H), 6.85 (br s, 2H), 7.10 (d, <i>J</i> = 8.5 Hz, 2H), 7.25–7.33 (m, 3H), 7.38 (s, 1H), 7.50 (d, <i>J</i> = 8.5 Hz, 2H), 9.99 (s, 1H).</div></div><div id="sec5_1_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> (<i>R</i>)-2-Amino-<i>N</i>-(4-(((2<i>S</i>,5<i>R</i>)-5-((<i>R</i>)-(3-fluorophenyl)(hydroxy)methyl)pyrrolidin-2-yl)methyl)phenyl)-5,6-dihydro-4<i>H</i>-cyclopenta[<i>d</i>]thiazole-4-carboxamide (<b>15</b>)</h3><div class="NLM_p last">Starting from aniline <b>50c</b> and intermediate <b>33e</b>, the procedures summarized above provided <b>15</b>. LC/MS <i>m</i>/<i>e</i> 467.3 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.25–1.38 (m, 2H), 1.41–1.48 (m, 1H), 1.56–1.63 (m, 1H), 2.44–2.60 (m, 3H), 2.62–2.70 (m, 2H), 2.73–2.80 (m, 1H), 3.12 (q, <i>J</i> = 7.0 Hz, 1H), 3.21 (quint, <i>J</i> = 7.5 Hz, 1H), 3.77 (m, 1H), 4.31 (d, <i>J</i> = 6.5 Hz, 1H), 6.85 (br s, 2H), 7.03 (td, <i>J</i> = 8.5 and 2.0 Hz, 1H), 7.11 (d, <i>J</i> = 8.5 Hz, 2H), 7.12–7.18 (m, 2H), 7.30–7.35 (m, 1H), 7.51 (d, <i>J</i> = 8.5 Hz, 2H), 10.01 (s, 1H).</div></div><div id="sec5_1_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> (<i>R</i>)-2-Amino-<i>N</i>-(4-(((2<i>S</i>,5<i>R</i>)-5-((<i>R</i>)-(4-fluorophenyl)(hydroxy)methyl)pyrrolidin-2-yl)methyl)phenyl)-5,6-dihydro-4<i>H</i>-cyclopenta[<i>d</i>]thiazole-4-carboxamide (<b>16</b>)</h3><div class="NLM_p last">Starting from aniline <b>50d</b> and intermediate <b>33e</b>, the procedures summarized above provided <b>16</b>. LC/MS <i>m</i>/<i>e</i> 467.3 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.21–1.33 (m, 2H), 1.34–1.42 (m, 1H), 1.55–1.62 (m, 1H), 2.44–2.59 (m, 3H), 2.62–2.69 (m, 2H), 2.73–2.80 (m, 1H), 3.10 (q, <i>J</i> = 7.0 Hz, 1H), 3.21 (quint, <i>J</i> = 7.0 Hz, 1H), 3.77 (m, 1H), 4.27 (d, <i>J</i> = 7.0 Hz, 1H), 6.85 (br s, 2H), 7.07–7.13 (m, 4H), 7.34 (dd, <i>J</i> = 8.5 and 6.0 Hz, 2H), 7.50 (d, <i>J</i> = 8.5 Hz, 2H), 10.00 (s, 1H).</div></div><div id="sec5_1_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> (<i>R</i>)-2-Amino-<i>N</i>-(4-(((2<i>S</i>,5<i>R</i>)-5-((<i>R</i>)-hydroxy(pyridin-3-yl)methyl)pyrrolidin-2-yl)methyl)phenyl)-5,6-dihydro-4<i>H</i>-cyclopenta[<i>d</i>]thiazole-4-carboxamide (<b>17</b>)</h3><div class="NLM_p last">Starting from aniline <b>50e</b> and intermediate <b>33e</b>, the procedures summarized above provided <b>15</b>. LC/MS <i>m</i>/<i>e</i> 450.1 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.19–1.26 (m, 1H), 1.30–1.44 (m, 2H), 1.56–1.62 (m, 1H), 2.45–2.58 (m, 3H), 2.62–2.70 (m, 2H), 2.74–2.81 (m, 1H), 3.15–3.25 (m, 2H), 3.77 (m, 1H), 4.34 (d, <i>J</i> = 7.0 Hz, 1H), 6.86 (br s, 2H), 7.11 (d, <i>J</i> = 8.5 Hz, 2H), 7.32 (dd, <i>J</i> = 8.0 and 5.0 Hz, 1H), 7.51 (d, <i>J</i> = 8.5 Hz, 2H), 7.72 (dt, <i>J</i> = 8.0 and 2.0 Hz, 1H), 8.43 (dd, <i>J</i> = 5.0 and 1.5 Hz, 1H), 8.53 (d, <i>J</i> = 2.0 Hz, 1H), 10.00 (s, 1H).</div></div><div id="sec5_1_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> (<i>R</i>)-<i>N</i>-(4-(((2<i>S</i>,5<i>R</i>)-5-((<i>R</i>)-Hydroxy(phenyl)methyl)pyrrolidin-2-yl)methyl)phenyl)-5,6-dihydro-4<i>H</i>-cyclopenta[<i>d</i>]thiazole-4-carboxamide (<b>18</b>)</h3><div class="NLM_p last">Starting from aniline <b>50a</b> and intermediate <b>35</b>, the procedures summarized above provided <b>18</b>. LC/MS <i>m</i>/<i>e</i> 434.1 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.26–1.34 (m, 2H), 1.38–1.45 (m, 1H), 1.57–1.64 (m, 1H), 2.58 (dd, <i>J</i> = 13.5 and 7.0 Hz, 1H), 2.66–2.76 (m, 3H), 2.85–2.92 (m, 1H), 2.97–3.04 (m, 1H), 3.12 (q, <i>J</i> = 7.0 Hz, 1H), 3.23 (quin, <i>J</i> = 7.0 Hz, 1H), 4.06 (t, <i>J</i> = 7.5 Hz, 1H), 4.26 (d, <i>J</i> = 7.0 Hz, 1H), 7.14 (d, <i>J</i> = 8.5 Hz, 2H), 7.21 (t, <i>J</i> = 6.5 Hz, 1H), 7.27–7.33 (m, 4H), 7.53 (d, <i>J</i> = 8.5 Hz, 2H), 8.92 (s, 1H), 10.20 (s, 1H).</div></div><div id="sec5_1_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> (<i>R</i>)-<i>N</i>-(4-(((2<i>S</i>,5<i>R</i>)-5-((<i>R</i>)-Hydroxy(pyridin-3-yl)methyl)pyrrolidin-2-yl)methyl)phenyl)-5,6-dihydro-4<i>H</i>-cyclopenta[<i>d</i>]thiazole-4-carboxamide (<b>19</b>)</h3><div class="NLM_p last">Starting from aniline <b>50e</b> and intermediate <b>35</b>, the procedures summarized above provided <b>19</b>. LC/MS <i>m</i>/<i>e</i> 435.2 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.35–1.54 (m, 3H), 1.64–1.71 (m, 1H), 2.66 (dd, <i>J</i> = 13.0 and 7.5 Hz, 1H), 2.73 (q, <i>J</i> = 7.0 Hz, 2H), 2.81 (dd, <i>J</i> = 13.0 and 5.5 Hz, 1H), 2.86–2.92 (m, 1H), 2.97–3.04 (m, 1H), 4.06 (t, <i>J</i> = 7.0 Hz, 1H), 4.51 (d, <i>J</i> = 7.0 Hz, 1H), 7.15 (d, <i>J</i> = 8.0 Hz, 2H), 7.35 (dd, <i>J</i> = 7.5 and 5.0 Hz, 1H), 7.55 (d, <i>J</i> = 8.0 Hz, 2H), 7.75 (d, <i>J</i> = 7.5 Hz, 1H), 8.46 (d, <i>J</i> = 5.0 Hz, 1H), 8.56 (s, 1H), 8.92 (s, 1H), 10.24 (s, 1H).</div></div><div id="sec5_1_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> (<i>R</i>)-<i>N</i>-(4-(((2<i>S</i>,5<i>R</i>)-5-((<i>R</i>)-Hydroxy(phenyl)methyl)pyrrolidin-2-yl)methyl)phenyl)-2-methyl-5,6-dihydro-4<i>H</i>-cyclopenta[<i>d</i>]thiazole-4-carboxamide (<b>20</b>)</h3><div class="NLM_p last">Starting from aniline <b>50a</b> and intermediate <b>38a</b>, the procedures summarized above provided <b>20</b>. LC/MS <i>m</i>/<i>e</i> 448.1 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.25–1.33 (m, 2H), 1.36–1.44 (m, 1H), 1.56–1.63 (m, 1H), 2.57 (dd, <i>J</i> = 13.5 and 6.5 Hz, 1H), 2.60 (s, 3H), 2.63–2.69 (m, 3H), 2.80–2.87 (m, 1H), 2.91–2.99 (m, 1H), 3.10 (q, <i>J</i> = 7.0 Hz, 1H), 3.21 (quint, <i>J</i> = 7.0 Hz, 1H), 3.98 (t, <i>J</i> = 7.5 Hz, 1H), 4.23 (d, <i>J</i> = 7.5 Hz, 1H), 7.13 (d, <i>J</i> = 8.5 Hz, 2H), 7.21 (t, <i>J</i> = 7.0 Hz, 1H), 7.27–7.32 (m, 4H), 7.53 (d, <i>J</i> = 8.5 Hz, 2H), 10.16 (s, 1H).</div></div><div id="sec5_1_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> (<i>R</i>)-<i>N</i>-(4-(((2<i>S</i>,5<i>R</i>)-5-((<i>R</i>)-Hydroxy(pyridin-3-yl)methyl)pyrrolidin-2-yl)methyl)phenyl)-2-methyl-5,6-dihydro-4<i>H</i>-cyclopenta[<i>d</i>]thiazole-4-carboxamide (<b>21</b>)</h3><div class="NLM_p last">Starting from aniline <b>50e</b> and intermediate <b>38a</b>, the procedures summarized above provided <b>21</b>. LC/MS <i>m</i>/<i>e</i> 449.1 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.17–1.16 (m, 1H), 1.29–1.36 (m, 1H), 1.36–1.44 (m, 1H), 1.55–1.62 (m, 1H), 2.55 (dd, <i>J</i> = 13.0 and 7.0 Hz, 1H), 2.60 (s, 3H), 2.61–2.69 (m, 3H), 2.80–2.87 (m, 1H), 2.91–2.99 (m, 1H), 3.14–3.24 (m, 2H), 3.98 (t, <i>J</i> = 7.5 Hz, 1H), 4.34 (d, <i>J</i> = 7.5 Hz, 1H), 7.13 (d, <i>J</i> = 8.5 Hz, 2H), 7.32 (dd, <i>J</i> = 7.5 and 5.0 Hz, 1H), 7.53 (d, <i>J</i> = 8.5 Hz, 2H), 7.71 (d, <i>J</i> = 7.5 Hz, 1H), 8.43 (dd, <i>J</i> = 5.0 and 1.5 Hz, 1H), 8.53 (d, <i>J</i> = 1.5 Hz, 1H), 10.16 (s, 1H).</div></div><div id="sec5_1_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> (<i>R</i>)-2-Ethyl-<i>N</i>-(4-(((2<i>S</i>,5<i>R</i>)-5-((<i>R</i>)-hydroxy(phenyl)methyl)pyrrolidin-2-yl)methyl)phenyl)-5,6-dihydro-4<i>H</i>-cyclopenta[<i>d</i>]thiazole-4-carboxamide (<b>22</b>)</h3><div class="NLM_p last">Starting from aniline <b>50a</b> and intermediate <b>38b</b>, the procedures summarized above provided <b>22</b>. LC/MS <i>m</i>/<i>e</i> 462.0 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 1.33 (t, <i>J</i> = 7.5 Hz, 3H), 1.48–1.61 (m, 3H), 1.79–1.87 (m, 1H), 2.70–2.95 (m, 5H), 2.98 (q, <i>J</i> = 7.5 Hz, 2H), 3.01–3.09 (m, 1H), 3.34–3.43 (m, 2H), 3.98 (m, 1H), 4.49 (d, <i>J</i> = 7.5 Hz, 1H), 7.21 (d, <i>J</i> = 8.5 Hz, 2H), 7.26 (m, 1H), 7.31–7.38 (m, 4H), 7.54 (d, <i>J</i> = 8.5 Hz, 2H).</div></div><div id="sec5_1_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> (<i>R</i>)-2-Ethyl-<i>N</i>-(4-(((2<i>S</i>,5<i>R</i>)-5-((<i>R</i>)-hydroxy(pyridin-3-yl)methyl)pyrrolidin-2-yl)methyl)phenyl)-5,6-dihydro-4<i>H</i>-cyclopenta[<i>d</i>]thiazole-4-carboxamide (<b>23</b>)</h3><div class="NLM_p last">Starting from aniline <b>50e</b> and intermediate <b>38b</b>, the procedures summarized above provided <b>23</b>. LC/MS <i>m</i>/<i>e</i> 463.3 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.19–1.27 (m, 1H), 1.23 (t, <i>J</i> = 7.5 Hz, 3H), 1.30–1.44 (m, 2H), 1.55–1.62 (m, 1H), 2.55 (dd, <i>J</i> = 13.0 and 7.0 Hz, 1H), 2.62–2.68 (m, 3H), 2.79–2.86 (m, 1H), 2.91 (q, <i>J</i> = 7.5 Hz, 2H), 2.92–2.99 (m, 1H), 3.16–3.25 (m, 2H), 3.98 (t, <i>J</i> = 7.0 Hz, 1H), 4.35 (d, <i>J</i> = 7.0 Hz, 1H), 7.12 (d, <i>J</i> = 8.5 Hz, 2H), 7.31 (dd, <i>J</i> = 7.5 and 5.0 Hz, 1H), 7.52 (d, <i>J</i> = 8.5 Hz, 2H), 7.71 (dd, <i>J</i> = 7.5 and 2.0 Hz, 1H), 8.43 (dd, <i>J</i> = 5.0 and 1.5 Hz, 1H), 8.52 (d, <i>J</i> = 2.0 Hz, 1H), 10.16 (s, 1H).</div></div><div id="sec5_1_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> (<i>R</i>)-2-Cyclopropyl-<i>N</i>-(4-(((2<i>S</i>,5<i>R</i>)-5-((<i>R</i>)-hydroxy(pyridin-3-yl)methyl)pyrrolidin-2-yl)methyl)phenyl)-5,6-dihydro-4<i>H</i>-cyclopenta[<i>d</i>]thiazole-4-carboxamide (<b>24</b>)</h3><div class="NLM_p last">Starting from aniline <b>50e</b> and intermediate <b>38c</b>, the procedures summarized above provided <b>24</b>. LC/MS <i>m</i>/<i>e</i> 475.3 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 0.81–0.88 (m, 2H), 1.00–1.06 (m, 2H), 1.18–1.30 (m, 2H), 1.31–1.46 (m, 2H), 1.56–1.64 (m, 1H), 2.25–2.32 (m, 1H), 2.52–2.71 (m, 3H), 2.76–2.83 (m, 1H), 2.87–2.96 (m, 1H), 3.18–3.27 (m, 2H), 3.93 (dd, <i>J</i> = 7.5 and 6.0 Hz, 1H), 4.38 (d, <i>J</i> = 7.0 Hz, 1H), 7.12 (d, <i>J</i> = 8.5 Hz, 2H), 7.32 (dd, <i>J</i> = 8.0 and 5.0 Hz, 1H), 7.52 (d, <i>J</i> = 8.5 Hz, 2H), 7.72 (dt, <i>J</i> = 8.0 and 2.0 Hz, 1H), 8.43 (dd, <i>J</i> = 5.0 and 1.5 Hz, 1H), 8.53 (d, <i>J</i> = 2.0 Hz, 1H), 10.13 (s, 1H).</div></div><div id="sec5_1_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> (<i>R</i>)-2-(4-Fluorophenyl)-<i>N</i>-(4-(((2<i>S</i>,5<i>R</i>)-5-((<i>R</i>)-hydroxy(phenyl)methyl)pyrrolidin-2-yl)methyl)phenyl)-5,6-dihydro-4<i>H</i>-cyclopenta[<i>d</i>]thiazole-4-carboxamide (<b>25</b>)</h3><div class="NLM_p last">Starting from aniline <b>50a</b> and intermediate <b>38d</b>, the procedures summarized above provided <b>25</b>. LC/MS <i>m</i>/<i>e</i> 528.1 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.22–1.31 (m, 2H), 1.35–1.42 (m, 1H), 1.54–1.62 (m, 1H), 2.56 (dd, <i>J</i> = 13.0 and 6.5 Hz, 1H), 2.63 (dd, <i>J</i> = 13.0 and 6.5 Hz, 1H), 2.67–2.77 (m, 2H), 2.90–2.99 (m, 1H), 3.03–3.10 (m, 1H), 3.19 (quint, <i>J</i> = 6.5 Hz, 1H), 4.09 (t, <i>J</i> = 7.5 Hz, 1H), 4.21 (d, <i>J</i> = 7.5 Hz, 1H), 7.14 (d, <i>J</i> = 8.5 Hz, 2H), 7.21 (t, <i>J</i> = 7.0 Hz, 1H), 7.26–7.32 (m, 6H), 7.55 (d, <i>J</i> = 8.5 Hz, 2H), 7.90 (dd, <i>J</i> = 8.5 and 5.5 Hz, 2H), 10.24 (s, 1H).</div></div><div id="sec5_1_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> (<i>R</i>)-2-(4-Fluorophenyl)-<i>N</i>-(4-(((2<i>S</i>,5<i>R</i>)-5-((<i>R</i>)-hydroxy(pyridin-3-yl)methyl)pyrrolidin-2-yl)methyl)phenyl)-5,6-dihydro-4<i>H</i>-cyclopenta[<i>d</i>]thiazole-4-carboxamide (<b>26</b>)</h3><div class="NLM_p last">Starting from aniline <b>50e</b> and intermediate <b>38d</b>, the procedures summarized above provided <b>25</b>. LC/MS <i>m</i>/<i>e</i> 529.0 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 1.45–1.62 (m, 3H), 1.77–1.85 (m, 1H), 2.75 (dd, <i>J</i> = 13.0 and 7.0 Hz, 1H), 2.79–2.92 (m, 3H), 2.96–3.04 (m, 1H), 3.10–3.18 (m, 1H), 3.30–3.38 (m, 2H), 4.12 (t, <i>J</i> = 7.0 Hz, 1H), 4.56 (d, <i>J</i> = 7.5 Hz, 1H), 7.18 (t, <i>J</i> = 9.0 and 8.5 Hz, 2H), 7.21 (d, <i>J</i> = 8.5 Hz, 2H), 7.42 (dd, <i>J</i> = 7.5 and 5.0 Hz, 1H), 7.56 (d, <i>J</i> = 8.5 Hz, 2H), 7.86 (d, <i>J</i> = 8.0 Hz, 1H), 7.92 (dd, <i>J</i> = 8.5 and 5.0 Hz, 2H), 8.44 (d, <i>J</i> = 5.0 Hz, 1H), 8.55 (s, 1H).</div></div><div id="sec5_1_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> <i>N</i>-(4-(((2<i>S</i>,5<i>R</i>)-5-((<i>R</i>)-Hydroxy(pyridin-3-yl)methyl)pyrrolidin-2-yl)methyl)phenyl)-2-(1<i>H</i>-pyrazol-1-yl)acetamide, TFA Salt (<b>27</b>)</h3><div class="NLM_p last">Starting from aniline <b>50e</b> and 1<i>H</i>-pyrazol-1-ylacetic acid <b>57a</b>, the procedures summarized above provided <b>27</b>. LC/MS <i>m</i>/<i>e</i> 392.1 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 1.81–1.90 (m, 1H), 1.90–2.00 (m, 2H), 2.05–2.14 (m, 1H), 2.96 (dd, <i>J</i> = 13.7 and 8.7 Hz, 1H), 3.13 (dd, <i>J</i> = 13.7 and 6.5 Hz, 1H), 3.73–3.81 (m, 1H), 3.84–3.91 (m 1H), 5.00 (m, 3H), 6.55 (t, <i>J</i> = 2.2 Hz, 1H), 7.24 (d, <i>J</i> = 8.5 Hz, 2H), 7.55 (m, 3H), 7.71 (d, <i>J</i> = 2.2, 1H), 7.86 (dd, <i>J</i> = 8.0 and 5.4 Hz, 1H), 8.41 (d, <i>J</i> = 8.0 Hz, 1H), 8.72 (dd, <i>J</i> = 5.4 and 1.0 Hz, 1H), 8.85 (d, <i>J</i> = 1.9 Hz, 1H).</div></div><div id="sec5_1_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> (<i>S</i>)-<i>N</i>-(4-(((2<i>S</i>,5<i>R</i>)-5-((<i>R</i>)-Hydroxy(pyridin-3-yl)methyl)pyrrolidin-2-yl)methyl)phenyl)-2-(1<i>H</i>-pyrazol-1-yl)propanamide, TFA Salt (<b>28</b>)</h3><div class="NLM_p last">Starting from aniline <b>50e</b> and 2-(1<i>H</i>-pyrazol-1-yl)propanoic acid <b>57b</b>, the procedures summarized above provided <b>27</b>. LC/MS <i>m</i>/<i>e</i> 406.2 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 1.62–1.78 (m, 3H), 1.67 (d, <i>J</i> = 7.0 Hz, 3H), 1.82–1.90 (m, 1H), 2.84 (dd, <i>J</i> = 13.5 and 9.4 Hz, 1H), 3.07 (dd, <i>J</i> = 13.5 and 5.5 Hz, 1H), 3.56–3.66 (m, 1H), 3.68–3.78 (m 1H), 4.83 (d, <i>J</i> = 8.2 Hz, 1H), 5.19 (q, <i>J</i> = 7.0 Hz, 1H), 6.28 (t, <i>J</i> = 2.1 Hz, 1H), 7.18 (d, <i>J</i> = 8.4 Hz, 2H), 7.44 (d, <i>J</i> = 1.4 Hz, 1H), 7.53 (d, <i>J</i> = 8.4 Hz, 2H), 7.57 (dd, <i>J</i> = 8.0 and 5.1 Hz, 1H), 7.85 (d, <i>J</i> = 2.1 Hz, 1H), 7.99 (d, <i>J</i> = 8.0 Hz, 1H), 8.50 (q, <i>J</i> = 8.2 Hz, 1H), 8.62 (q, <i>J</i> = 5.1 and 1.4 Hz, 1H) 8.70 (d, <i>J</i> = 1.8 Hz, 1H), 9.47 (t, <i>J</i> = 4.8 Hz, 1H), 10.33 (s, 1H).</div></div><div id="sec5_1_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> (<i>S</i>)-<i>N</i>-(4-(((2<i>S</i>,5<i>R</i>)-5-((<i>R</i>)-Hydroxy(pyridin-3-yl)methyl)pyrrolidin-2-yl)methyl)phenyl)-5,6-dihydro-4<i>H</i>-pyrrolo[1,2-<i>b</i>]pyrazole-6-carboxamide, TFA Salt (<b>29</b>)</h3><div class="NLM_p last">Starting from aniline <b>50e</b> and intermediate <b>56</b>, the procedures summarized above provided <b>27</b>. LC/MS <i>m</i>/<i>e</i> 418.4 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 1.81–1.95 (m, 3H), 2.06–2.13 (m, 1H), 2.70–2.77 (m, 1H), 2.89–3.08 (m, 4H), 3.14 (dd, <i>J</i> = 13.5 and 6.1 Hz, 1H), 3.78 (quint, <i>J</i> = 7.1 Hz, 1H), 3.85 (q, <i>J</i> = 8.2 Hz, 1H), 4.94 (d, <i>J</i> = 8.0 Hz, 1H), 5.01 (dd, <i>J</i> = 8.2 and 4.4 Hz, 1H), 6.06 (d, <i>J</i> = 1.6 Hz, 1H), 7.26 (d, <i>J</i> = 8.5 Hz, 2H), 7.53 (d, 1.6 Hz, 1H), 7.58 (d, <i>J</i> = 8.5 Hz, 2H), 7.71 (dd, <i>J</i> = 8.0 and 5.3 Hz, 1H), 8.22 (d, <i>J</i> = 8.0 Hz, 1H), 8.65 (dd, <i>J</i> = 5.3 and 1.4 Hz, 1H), 8.76 (d, <i>J</i> = 1.9 Hz, 1H).</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> General Procedure for the Synthesis of Thiazole Acids <b>33a</b>–<b>g</b></h3><div id="sec5_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> Step A: Synthesis of <b>31a</b>–<b>g</b></h4><div class="NLM_p last">Bromine was added in a dropwise manner to a solution of keto-esters (<b>30a</b>–<b>g</b>) in chloroform at 0 °C and the resulting mixture stirred at 0 °C for 30 min. Air was blown through the mixture for 1 h, and the mixture was dried over MgSO<sub>4</sub> and concentrated under reduced pressure. The residue was dissolved in ethanol and thiourea added and the resulting mixture heated at reflux overnight. The mixture was cooled and concentrated under reduced pressure and the residue partitioned between CH<sub>2</sub>Cl<sub>2</sub> and satd NaHCO<sub>3</sub>, and the organic layer was dried over MgSO<sub>4</sub> and concentrated under reduced pressure. The crude material was purified by flash chromatography on a Biotage Horizon system (silica gel, 100% hexanes to 100% EtOAc gradient) to afford thiazoles <b>31a</b>–<b>g</b>.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> Step B: Synthesis of Boc-amino-thiazoles (<b>32a</b>–<b>g</b>)</h4><div class="NLM_p last">To a solution of aminothiazoles <b>31a</b>–<b>g</b> in CH<sub>2</sub>Cl<sub>2</sub> was added Boc-anhydride, Et<sub>3</sub>N, and DMAP and the resulting mixture stirred at room temperature overnight. The reaction mixture was washed with 1N HCl and satd NaCl, dried over MgSO<sub>4</sub>, and concentrated under reduced pressure. The crude residue was purified by flash chromatography on a Biotage Horizon system (silica gel, 100% hexanes to 40% EtOAc gradient) to afford the products <b>32a</b>–<b>g</b>.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> Step C: Synthesis of Thiazole Acids (<b>33a</b>–<b>g</b>)</h4><div class="NLM_p">To a solution of ethyl esters <b>32a</b>–<b>g</b> in a mixture of THF and methanol was added lithium hydroxide solution and the resulting mixture stirred at room temperature overnight. The organics solvents were removed by evaporation and the aqueous residue diluted with more water and extracted with EtOAc. The aqueous layer acidified by the addition of conc HCl, extracted with EtOAc, and the organic layer dried over MgSO<sub>4</sub> and concentrated under reduced pressure. The residue was triturated with acetonitrile, filtered, and dried to give the products <b>33a</b>–<b>g</b>.</div><div id="sec5_4_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i47" class="anchor-spacer"></div><h5 class="article-section__title" id="_i47"> 2-(2-((<i>tert</i>-Butoxycarbonyl)amino)thiazol-4-yl)propanoic Acid (<b>33a</b>)</h5><div class="NLM_p last">Starting from ethyl 2-methyl-3-oxo-butanoate <b>30a</b> and following the procedures above provided compound <b>33a</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.56 (s, 9H), 1.57 (d, <i>J</i> = 7.4 Hz, 3H), 3.84 (q, <i>J</i> = 7.4 Hz, 1H), 6.69 (s, 1H), 11.05 (br s, 1H).</div></div><div id="sec5_4_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i48" class="anchor-spacer"></div><h5 class="article-section__title" id="_i48"> 2-(2-((<i>tert</i>-Butoxycarbonyl)amino)thiazol-4-yl)butanoic Acid (<b>33b</b>)</h5><div class="NLM_p last">Starting from ethyl 2-ethyl-3-oxobutyrate <b>30b</b> and following the procedures above provided compound <b>33b</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 0.98 (t, <i>J</i> = 7.5 Hz, 3H), 1.54 (s, 9H), 1.92 (m, 1H), 2.13 (m, 1H), 3.67 (t, <i>J</i> = 7.5 Hz, 1H), 6.74 (s, 1H), 11.58 (br s, 1H).</div></div><div id="sec5_4_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i49" class="anchor-spacer"></div><h5 class="article-section__title" id="_i49"> 2-(2-((<i>tert</i>-Butoxycarbonyl)amino)thiazol-4-yl)pentanoic Acid (<b>33c</b>)</h5><div class="NLM_p last">Starting from ethyl 2-propyl-3-oxobutanoate <b>30c</b> and following the procedures above provided compound <b>33c</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 0.93 (t, <i>J</i> = 7.5 Hz, 3H), 1.36 (m, 2H), 1.55 (s, 9H), 1.86 (m, 1H), 2.06 (m, 1H), 3.73 (t, <i>J</i> = 7.5 Hz, 1H), 6.72 (s, 1H), 11.70 (br s, 1H).</div></div><div id="sec5_4_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i50" class="anchor-spacer"></div><h5 class="article-section__title" id="_i50"> 2-(2-((<i>tert</i>-Butoxycarbonyl)amino)thiazol-4-yl)-3-methylbutanoic Acid (<b>33d</b>)</h5><div class="NLM_p last">Starting from ethyl 2-isopropyl-3-oxobutanoate <b>30d</b> and following the procedures above provided compound <b>33d</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 0.88 (d, <i>J</i> = 6.5 Hz, 3H), 1.10 (d, <i>J</i> = 6.5 Hz, 3H), 1.54 (s, 9H), 2.41 (m, 1H), 3.48 (d, <i>J</i> = 9.5 Hz, 1H), 6.81 (s, 1H), 10.70 (br s, 1H).</div></div><div id="sec5_4_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i51" class="anchor-spacer"></div><h5 class="article-section__title" id="_i51"> 2-((<i>tert</i>-Butoxycarbonyl)amino)-5,6-dihydro-4<i>H</i>-cyclopenta[<i>d</i>]thiazole-4-carboxylic Acid (<b>33e</b>)</h5><div class="NLM_p last">Starting from ethyl 2-oxo-cyclopentanecarboxylate <b>30e</b> and following the procedures above provided compound <b>33e</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.55 (s, 9H), 2.71 (m, 1H), 2.88 (m, 2H), 3.05 (m, 1H), 3.97 (m, 1H), 10.98 (br s, 1H).</div></div><div id="sec5_4_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i52" class="anchor-spacer"></div><h5 class="article-section__title" id="_i52"> 2-((<i>tert</i>-Butoxycarbonyl)amino)-4,5,6,7-tetrahydrobenzo[<i>d</i>]thiazole-4-carboxylic Acid (<b>33f</b>)</h5><div class="NLM_p last">Starting from ethyl 2-oxo-cyclohexanecarboxylate <b>30f</b> and following the procedures above provided compound <b>33f</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.55 (s, 9H), 1.87 (m, 1H), 2.00 (m, 1H), 2.06 (m, 1H), 2.25 (m, 1H), 2.65 (m, 1H), 2.72 (m, 1H), 3.70 (t, <i>J</i> = 5.5 Hz, 1H), 11.53 (br s, 1H).</div></div><div id="sec5_4_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i53" class="anchor-spacer"></div><h5 class="article-section__title" id="_i53"> 2-((<i>tert</i>-Butoxycarbonyl)amino)-5,6,7,8-tetrahydro-4<i>H</i>-cyclohepta[<i>d</i>]thiazole-4-carboxylic Acid (<b>33g</b>)</h5><div class="NLM_p last">Starting from ethyl 2-oxo-cycloheptanecarboxylate <b>30g</b> and following the procedures above provided compound <b>33g</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.54 (s, 9H), 1.57 (m, 1H), 1.85 (m, 1H), 2.00 (m, 3H), 2.31 (m, 1H), 2.74 (m, 1H), 2.86 (m, 1H), 4.00 (t, <i>J</i> = 4.6 Hz, 1H), 11.23 (br s, 1H).</div></div></div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> Ethyl 5,6-Dihydro-4<i>H</i>-cyclopenta[<i>d</i>]thiazole-4-carboxylate (<b>34</b>)</h3><div class="NLM_p last">To a solution of amino-thiazole <b>31e</b> (9g, 42.4 mmol) in anhydrous DMF (100 mL) warmed at 50 °C was added dropwise a solution of <i>tert</i>-butyl nitrite (5.5 mL, 46.6 mmol). After addition was complete, the mixture was heated at 50 °C and continued for 30 min. The mixture was cooled and partitioned between EtOAc (300 mL) and water (500 mL); the aqueous layer was separated and washed with water (2 × 400 mL) and satd NaCl (100 mL), dried over MgSO<sub>4</sub>, and concentrated in vacuo. Purification flash chromatography on a Biotage Horizon system (silica gel, 100% hexanes to 50% EtOAc in hexanes gradient) gave the desired product (1.8 g, 21% yield). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.31 (t, <i>J</i> = 7.0 Hz, 3H), 2.87 (m, 2H), 2.94 (m, 1H), 3.10 (m, 1H), 4.05 (t, <i>J</i> = 7.0 Hz, 1H), 4.23 (q, <i>J</i> = 7.0 Hz, 2H), 8.69 (s, 1H).</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> 5,6-Dihydro-4<i>H</i>-cyclopenta[<i>d</i>]thiazole-4-carboxylic Acid (<b>35</b>)</h3><div class="NLM_p last">To a solution of thiazole ester <b>34</b> (1.8g, 9.13 mmol) in a mixture of THF (30 mL) and methanol (10 mL) was added lithium hydroxide (10 mL of a 1 M aqueous solution, 10 mmol) and the resulting mixture stirred at room temperature for 2 h. The organics were removed by evaporation in vacuo and the aqueous residue diluted with water (25 mL). The mixture was extracted with EtOAc (×2) and the organic layes discarded. The remaining aqueous was acidified to pH ∼ 4 with 1N HCl and extracted with EtOAc (×3). The combined EtOAc layers were washed with satd NaCl, dried over MgSO<sub>4</sub>, and concentrated in vacuo. The crude residue was triturated with acetonitrile, filtered, and dried to give 900 mg (58%) as an off white solid. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 2.64 (m, 1H), 2.74 (m, 1H), 2.86 (m, 1H), 2.96 (m, 1H), 3.86 (t, <i>J</i> = 7.0 Hz, 1H), 8.92 (s, 1H), 12.44 (s, 1H).</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> General Procedure for the Synthesis of Thiazole Acids <b>38a</b>–<b>d</b></h3><div id="sec5_7_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> Step A: Synthesis of <b>37a</b>–<b>d</b></h4><div class="NLM_p last">To a solution of ethyl 2-oxocyclopentanecarboxylate in anhydrous chloroform cooled at 0 °C was added bromine dropwise over 15 min. After complete addition the mixture was allowed to warm to room temperature and stirred overnight. Air was bubbled through mixture for 1 h and then washed with satd NaHCO<sub>3</sub> and satd NaCl, dried over MgSO<sub>4</sub>, and concentrated under reduced pressure. The residue was taken up in ethanol (100 mL) and thioacetamide added and the resulting mixture stirred at room temperature for 1 h then heated at reflux overnight. The mixture was cooled evaporated in vacuo and the residue partitioned between satd NaHCO<sub>3</sub> and CH<sub>2</sub>Cl<sub>2</sub>. The organic layer was dried over MgSO<sub>4</sub> and concentrated under reduced pressure. Purification by flash chromatography on a Biotage Horizon system (silica gel, 100% hexanes to 20% EtOAc in hexanes gradient) afforded thiazoles <b>37a</b>–<b>d</b>.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> Step B</h4><div class="NLM_p">To a solution of esters <b>37a</b>–<b>d</b> in a mixture of THF and methanol was added lithium hydroxide solution and the resulting mixture stirred at room temperature for 5 h. Organic solvents removed by evaporation and the remaining aqueous extracted with diethyl ether (100 mL). The aqueous layer was acidified by the addition of 1N HCl and extracted with CH<sub>2</sub>Cl<sub>2</sub> (3×); combined CH<sub>2</sub>Cl<sub>2</sub> extracts dried over MgSO<sub>4</sub> and concentrated in vacuo. The residue was triturated with acetonitrile, filtered, and dried to give thiazole acids <b>38a</b>–<b>d</b>.</div><div id="sec5_8_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i59" class="anchor-spacer"></div><h5 class="article-section__title" id="_i59"> 2-Methyl-5,6-dihydro-4<i>H</i>-cyclopenta[<i>d</i>]thiazole-4-carboxylic Acid (<b>38a</b>)</h5><div class="NLM_p last">Starting from thioacetamide (<b>36a</b>) following the procedures above provided compound <b>38a</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 2.73 (s, 3H), 2.82 (m, 3H), 3.04 (m, 1H), 4.03 (m, 1H), 8.53 (br s, 1H).</div></div><div id="sec5_8_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i60" class="anchor-spacer"></div><h5 class="article-section__title" id="_i60"> 2-Ethyl-5,6-dihydro-4<i>H</i>-cyclopenta[<i>d</i>]thiazole-4-carboxylic Acid (<b>38b</b>)</h5><div class="NLM_p last">Starting from thiopropionamide (<b>36b</b>) following the procedures above provided compound <b>38b</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.38 (t, <i>J</i> = 7.5 Hz, 3H), 2.84 (m, 3H), 2.82 (m, 3H), 3.06 (m, 3H), 4.04 (dd, <i>J</i> = 8.5 and 7.0 Hz, 1H), 10.14 (br s, 1H).</div></div><div id="sec5_8_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i61" class="anchor-spacer"></div><h5 class="article-section__title" id="_i61"> 2-Cyclopropyl-5,6-dihydro-4<i>H</i>-cyclopenta[<i>d</i>]thiazole-4-carboxylic Acid (<b>38c</b>)</h5><div class="NLM_p last">Starting from cyclopropanethiocarboxamide (<b>36c</b>) following the procedures above provided compound <b>38c</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.04 (m, 2H), 1.14 (m, 2H), 2.32 (m, 1H), 2.80 (m, 2H), 2.88 (m, 1H), 3.02 (m, 1H), 4.01 (t, <i>J</i> = 8.0 and 6.0 Hz, 1H), 7.83 (br s, 1H).</div></div><div id="sec5_8_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i62" class="anchor-spacer"></div><h5 class="article-section__title" id="_i62"> 2-(4-Fluorophenyl)-5,6-dihydro-4<i>H</i>-cyclopenta[<i>d</i>]thiazole-4-carboxylic Acid (<b>38d</b>)</h5><div class="NLM_p last">Starting from 4-fluorothiobenzamide (<b>36d</b>) following the procedures above provided compound <b>38d</b>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 2.62 (m, 1H), 2.68 (m, 1H), 2.87 (m, 1H), 2.98 (m, 1H), 4.04 (dd, <i>J</i> = 8.5 and 5.5 Hz, 1H), 7.29 (t, <i>J</i> = 9.0 and 8.5 Hz, 2H), 7.90 (dd, <i>J</i> = 9.0 and 5.5 Hz, 2H).</div></div></div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> (4<i>S</i>)-3-Hex-5-ynoyl-4-benzyl-1,3-oxazolidin-2-one (<b>40</b>)</h3><div class="NLM_p last">To a stirred solution of 5-hexynoic acid (69 g, 0.62 mol) and triethylamine (214 mL, 1.54 mol) in THF (1.0 L) at −25 °C was added neat 2,2-dimethylpropanoyl chloride (83 mL, 0.68 mol) dropwise over 20 min. The resulting mixture was stirred at −25 °C for 2 h, then solid lithium chloride (28.7 g, 0.677 mol) was added followed by (<i>S</i>)-4-benzyl-1,3-oxazolidin-2-one (101 g, 0.615 mol). The reaction mixture then allowed to warm to room temperature, stirred for an additional 12 h, then evaporated in vacuo to remove all volatiles. The off-white residue was diluted with water (400 mL) and extracted with ethyl acetate (3 × 300 mL). The combined organic layers were washed with brine, dried over magnesium sulfate, filtered, and evaporated in vacuo to afford an off-white solid. The solid was recrystallized from an ethyl acetate and hexanes mixture to afford the desired compound as a white solid (135 g, 85%). LC/MS (EI) <i>m</i>/<i>e</i>: 272.3 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.89–1.95 (m, 2H), 1.99 (t, <i>J</i> = 2.8 Hz, 1H), 2.32 (td, <i>J</i> = 7.1 and 2.8 Hz, 2H), 2.77 (dd, <i>J</i> = 13.5 and 9.6 Hz, 1H), 3.01–3.13 (m, 2H), 3.28 (dd, <i>J</i> = 13.2 and 3.2 Hz, 1H), 4.16–4.22 (m, 2H), 4.65–4.69 (m, 1H), 7.20 (d, <i>J</i> = 7.1 Hz, 2H), 7.27 (m, 1H), 7.33 (t, <i>J</i> = 7.6 and 6.8 Hz, 2H).</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> General Procedure for the Synthesis of Anilines <b>50a</b>–<b>d</b></h3><div id="sec5_10_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> Step A: Synthesis of <b>41a</b>–<b>e</b></h4><div class="NLM_p last">To a stirred solution of (4<i>S</i>)-3-hex-5-ynoyl-4-benzyl-1,3-oxazolidin-2-one <b>40</b> in ethyl acetate at room temperature was added sequentially triethylamine, solid magnesium(II) chloride, benzaldehyde, and chlorotrimethylsilane. After complete addition, the resulting mixture was stirred for 3 days. The reaction mixture was filtered through silica gel, which was subsequently washed with ethyl acetate. The filtrate was evaporated in vacuo, and the residue was suspended in a a mixture of ethyl acetate and methanol and stirred for 5 h, during which time all solids dissolved. The reaction mixture was concentrated in vacuo and the residue purified by flash column chromatography on a Biotage Horizon system (silica gel, 10% EtOAc in hexanes to 25% EtOAc in hexanes gradient) to afford the pure addition products <b>41a</b>–<b>e</b> as yellow/orange oils.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> Step B: General Procedure for <i>tert</i>-Butyl-dimethylsilyl (TBS) Protection</h4><div class="NLM_p last">To a solution of alcohols <b>41a</b>–<b>e</b> in CH<sub>2</sub>Cl<sub>2</sub> cooled at 0 °C was added 2,6-lutidine followed by <i>tert</i>-butyldimethylsilyl trifluoromethanesulfonate and the resulting mixture allowed to warm to room temperature and stirred overnight, diluted with satd NH<sub>4</sub>Cl, and washed with 1N HCl, water and satd NaCl, dried (MgSO<sub>4</sub>), filtered, and evaporated. The residue was purified by column chromatography on a Biotage Horizon system (silica gel, 5% EtOAc in hexanes to 10% EtOAc in hexanes gradient) to give protected alcohols <b>42a</b>–<b>e</b> as oils.</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> Step C: General Procedure for Oxazolidinone Cleavage</h4><div class="NLM_p last">To a solution of oxazolidinones <b>42a</b>–<b>e</b> in a mixture of THF and water cooled at 0 °C was added slowly 35% H<sub>2</sub>O<sub>2</sub>, keeping the internal temperature below 5 °C, followed by slow addition of an aqueous solution of LiOH. The resulting mixture was stirred overnight warming up to 15 °C in the process. The reaction was quenched by the addition of Na<sub>2</sub>SO<sub>3</sub>. The THF was removed by evaporation and the remaining aqueous cooled (a precipitate formed on cooling) and acidified to pH = 5 with 1N HCl, extracted with EtOAc (3×), combined EtOAc layers washed with satd NaCl, dried (MgSO<sub>4</sub>), and evaporated in vacuo. A solid formed in the residue on standing which was diluted with hexanes and filtered. The filtrate evaporated and residue purified by column chromatography on a Biotage Horizon system (silica gel, 10% EtOAc in hexanes + 3% AcOH) to afford acids <b>43a</b>–<b>e</b> as a colorless oils.</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> Step D: General Procedure for Curtius Rearrangement</h4><div class="NLM_p last">To a solution of acid <b>43a</b>–<b>e</b> in toluene was added triethylamine then diphenyl azidophosphate, and the resulting solution was stirred at ambient temperature for 5 h. Neat (4-methoxyphenyl)methanol was then added, and the reaction mixture was slowly heated to 80 °C for 1 h, during which time a vigorous evolution of nitrogen gas was observed. The reaction was then heated to 110 °C for 12 h, cooled to room temperature, and diluted with a saturated aqueous sodium bicarbonate solution. The phases were separated, and the aqueous layer was extracted with ethyl acetate (2 × 250 mL). The combined organic layers were washed with brine, dried over magnesium sulfate, filtered, and evaporated in vacuo. The crude residue was purified by flash column chromatography on a Biotage Horizon system (silica gel, 100% hexanes to 25% EtOAc in hexanes gradient) to afford the desired compounds <b>44a</b>–<b>e</b> as colorless oils.</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> Step E: General Procedure for Sonagashira Coupling</h4><div class="NLM_p last">To a solution of acetylenes <b>44a</b>–<b>e</b> and 1-bromo-4-nitrobenzene in DMF was added triethylamine, tetrakis(triphenylphosphine)palladium(0), and copper iodide. The mixture was degassed, flushed with nitrogen three times, then heated to 80 °C for 2 h. The reaction mixture was cooled, diluted with water, and extracted with ethyl acetate (3×). The combined organic layers were washed with brine, dried over magnesium sulfate, filtered, and evaporated in vacuo. The residue was purified by flash column chromatography on a Biotage Horizon system (silica gel, 100% hexanes to 25% EtOAc in hexanes, gradient) to afford the desired coupled products <b>45a</b>–<b>e</b> as a orange oils.</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> Step F: General Procedure for Ketone Formation</h4><div class="NLM_p last">To a solution of acetylenes <b>45a</b>–<b>e</b> in DMF was added pyrrolidine, and the resulting mixture was heated to 80 °C for 2 h. The reaction mixture was cooled to room temperature, diluted with a 10% aqueous acetic acid solution, and stirred for 3 h. The reaction mixture was then added to water and extracted with ethyl acetate (3×). The combined organic layers were washed with water and brine, dried over MgSO<sub>4</sub>, filtered, and evaporated in vacuo. The residue was purified by flash column chromatography on a Biotage Horizon system (silica gel, 100% hexanes to 25% EtOAc in hexanes, gradient) to afford the desired ketones <b>46a</b>–<b>e</b> as yellow oils.</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> Step G: General Procedure for Pyrrolidine Formation</h4><div class="NLM_p last">To a solution of ketones <b>46a</b>–<b>e</b> in dichloromethane was added trifluoroacetic acid and the resulting mixture stirred at room temperature for 1.5 h. The resulting mixture was evaporated in vacuo and the residue partitioned between dichloromethane and a saturated aqueous sodium bicarbonate solution. The phases were separated and the aqueous phase extracted with dichloromethane (2×). The combined organic phases were dried over MgSO<sub>4</sub> and evaporated in vacuo. The residue was then dissolved in dichloromethane cooled to 0 °C, and solid sodium triacetoxyborohydride was then added. The resulting mixture was allowed to warm to room temperature with stirring for 12 h. The reaction mixture was then carefully quenched with a saturated aqueous sodium bicarbonate solution, and the biphasic solution was stirred for 6 h. The phases were separated, and the aqueous phase extracted with dichloromethane (2×). The combined organic phases were dried over MgSO<sub>4</sub> and evaporated in vacuo. The residue was purified by flash column chromatography on a Biotage Horizon system (silica gel, 100 hexanes to 20% EtOAc in hexanes gradient) to afford the desired pyrrolidines <b>47a</b>–<b>e</b> as clear oils.</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> Step H: General Procedure for <i>tert</i>-Butyloxycarbonyl (Boc)-Protection</h4><div class="NLM_p last">To a solution of pyrrolidines <b>47a</b>–<b>e</b> in dichloromethane was added di-<i>tert</i>-butyl dicarbonate and <i>N</i>,<i>N</i>-diisopropylethylamine and the resulting mixture stirred at room temperature overnight. The reaction was then washed sequentially with a 1.0 M aqueous citric acid solution, water, a saturated aqueous sodium bicarbonate solution, and brine. The organic phase was dried over MgSO<sub>4</sub> and evaporated in vacuo. The residue was purified by flash column chromatography on a Biotage Horizon system (silica gel, 100% hexanes to 15% EtOAc in hexanes gradient) to afford the desired protected pyrrolidines <b>48a</b>–<b>e</b> as white foams.</div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> Step I: General Procedure for Nitro Group Reduction</h4><div class="NLM_p last">To a nitrogen flushed solution of nitro compounds <b>44a</b>,<b>c</b>–<b>d</b> in methanol was added 10% palladium on carbon and the resulting mixture stirred under a balloon of hydrogen gas for 12 h. The reaction mixture was filtered through a plug of Celite, and the plug was washed with methanol. The combined filtrates were concentrated in vacuo to afford the desired anilines <b>49a</b>,<b>c</b>–<b>d</b> as a white foam.</div></div><div id="sec5_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> Step J: General Procedure for <i>tert</i>-Butyl(dimethyl)silyl (TBS) Deprotection</h4><div class="NLM_p">To a solution of <i>tert</i>-butyl(dimethyl)silyl protected alcohols <b>49a</b>–<b>d</b> in tetrahydrofuran was added a 1.0 M solution of tetrabutylammonium fluoride in tetrahydrofuran and the resulting mixture heated at 55 °C for 2 h. After cooling to room temperature, the mixture was evaporated in vacuo and partitioned between ethyl acetate and water. The aqueous phase was extracted with ethyl acetate (2×), and the combined organic layers were washed with brine, dried over MgSO<sub>4</sub>, and concentrated in vacuo. The residue was purified by flash column chromatography on a Biotage Horizon system (silica gel, 100% hexanes to 75% EtOAc in hexanes gradient) to afford the desired alcohols <b>50a</b>–<b>d</b> as white foams.</div><div id="sec5_19_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i75" class="anchor-spacer"></div><h5 class="article-section__title" id="_i75"> (2<i>S</i>,5<i>R</i>)-<i>tert</i>-Butyl 2-(4-Aminobenzyl)-5-((<i>R</i>)-hydroxy(phenyl)methyl)pyrrolidine-1-carboxylate (<b>50a</b>)</h5><div class="NLM_p last">Starting from benzaldehyde, the procedures summarized above provided compound <b>50a</b>. LC/MS (EI) <i>m</i>/<i>e</i>: 383.2 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.49–1.48 (m, 2H), 1.55 (s, 9H), 1.70–1.63 (m, 2H), 2.51 (dd, <i>J</i> = 13.3 and 8.9 Hz, 1H), 3.01 (br d, <i>J</i> = 2.1 Hz, 1H), 3.62 (br s, 2H), 4.13–4.06 (m, 2H), 4.43 (br s, 1H), 6.19 (br s, 1 H), 6.67 (d, <i>J</i> = 8.2 Hz, 2H), 7.00 (d, <i>J</i> = 8.2 Hz, 2H), 7.36–7.29 (m, 5H).</div></div><div id="sec5_19_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i76" class="anchor-spacer"></div><h5 class="article-section__title" id="_i76"> (2<i>S</i>,5<i>R</i>)-<i>tert</i>-Butyl 2-(4-Aminobenzyl)-5-((<i>R</i>)-(3-chlorophenyl)(hydroxy)methyl)pyrrolidine-1-carboxylate (<b>50b</b>)</h5><div class="NLM_p last">Starting from 3-chlorobenzaldehyde, the procedures summarized above provided compound <b>50b</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.46 (m, 2H), 1.55 (s, 9H), 1.67 (m, 2H), 2.51 (dd, <i>J</i> = 13.5 and 9.0 Hz, 1H), 2.96 (br d, <i>J</i> = 10.0 Hz, 1H), 3.64 (br s, 2H), 4.06 (m, 2H), 4.39 (m, 1H), 6.33 (br s, 1 H), 6.67 (d, <i>J</i> = 8.0 Hz, 2H), 6.99 (d, <i>J</i> = 8.0 Hz, 2H), 7.22–7.30 (m, 3H), 7.37 (s, 1H).</div></div><div id="sec5_19_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i77" class="anchor-spacer"></div><h5 class="article-section__title" id="_i77"> (2<i>S</i>,5<i>R</i>)-<i>tert</i>-Butyl 2-(4-Aminobenzyl)-5-((<i>R</i>)-(3-fluorophenyl)(hydroxy)methyl)pyrrolidine-1-carboxylate (<b>50c</b>)</h5><div class="NLM_p last">Starting from 3-fluorobenzaldehyde, the procedures summarized above provided compound <b>50c</b>. LC/MS (EI) <i>m</i>/<i>e</i>: 401 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 1.24–1.54 (m, 11H), 1.60–1.81 (m, 2H), 2.62 (m, 1H), 3.86 (s, 1H), 4.03 (d, <i>J</i> = 6.0 Hz, 2H), 4.84 (m, 1H), 6.57 (d, <i>J</i> = 7.8 Hz, 2H), 6.74 (d, <i>J</i> = 7.3 Hz, 2H), 6.96 (t, <i>J</i> = 8.4 Hz, 2H), 7.03 (d, <i>J</i> = 10.0 Hz, 1H) 7.10 (d, <i>J</i> = 7.5 Hz, 2H), 7.30 (t, <i>J</i> = 7.8 Hz, 1H).</div></div><div id="sec5_19_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i78" class="anchor-spacer"></div><h5 class="article-section__title" id="_i78"> (2<i>S</i>,5<i>R</i>)-<i>tert</i>-Butyl 2-(4-Aminobenzyl)-5-((<i>R</i>)-(4-fluorophenyl)(hydroxy)methyl)pyrrolidine-1-carboxylate (<b>50d</b>)</h5><div class="NLM_p last">Starting from 4-fluorobenzaldehyde, the procedures summarized above provided compound <b>50d</b>. LC/MS (EI) <i>m</i>/<i>e</i>: 401 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 1.49–1.55 (m, 11H), 1.57 (m, 2H), 1.98 (m, 1H), 2.70 (s, 1H), 3.93 (s, 1H), 4.07 (s, 1H), 4.80 (m, 1H), 6.63 (d, <i>J</i> = 7.0 Hz, 2H), 6.81 (d, <i>J</i> = 7.0 Hz, 2H), 7.05 (t, <i>J</i> = 8.6 Hz, 2H), 7.35 (t, <i>J</i> = 8.6 Hz, 2H).</div></div><div id="sec5_19_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i79" class="anchor-spacer"></div><h5 class="article-section__title" id="_i79"> (2<i>S</i>,5<i>R</i>)-<i>tert</i>-Butyl 2-(4-Aminobenzyl)-5-((<i>R</i>)-hydroxy(pyridin-3-yl)methyl)pyrrolidine-1-carboxylate (<b>50e</b>)</h5><div class="NLM_p last">To a 500 mL Parr bottle was added 10% palladium on carbon (1.8g, 1.7 mmol) followed by a solution of <i>tert</i>-butyl (2<i>R</i>,5<i>S</i>)-2-[(<i>R</i>)-{[<i>tert</i>-butyl(dimethyl)silyl]oxy}(6-chloropyridin-3-yl)methyl]-5-(4-nitrobenzyl)pyrrolidine-1-carboxylate <b>48e</b> (19.2g, 34.2 mmol) and potassium acetate (5.03 g, 51.3 mmol) in ethanol (150 mL). The resulting mixture was agitated under a 50 psi atmosphere of hydrogen gas for 12 h. The reaction mixture was then filtered through a plug of Celite, the plug was washed with ethanol (200 mL), and the combined filtrates concentrated in vacuo. The residue was dissolved in tetrahydrofuran (100 mL), and a 1.0 M solution of tetrabutylammonium fluoride in tetrahydrofuran (67 mL, 67 mmol) was then added. The resulting mixture was heated at 55 °C for 2 h. After cooling to room temperature, the mixture was evaporated in vacuo and partitioned between ethyl acetate and water. The aqueous phase was extracted with ethyl acetate (2 × 150 mL), and the combined organic layers were washed with brine (100 mL), dried over MgSO<sub>4</sub>, and evaporated in vacuo. The residue was purified by flash column chromatography on a Biotage Horizon system (silica gel, 100% hexanes to 100% EtOAc in hexanes gradient) to afford the desired compound as white foam (11 g, 84%). LC/MS (EI) <i>m</i>/<i>e</i>: 384.2 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.40–1.47 (m, 2H), 1.55 (s, 9H), 1.66–1.72 (m, 2H), 2.55 (dd, <i>J</i> = 13.5, 8.7, 1H), 2.95 (m, 1H), 2.95 (m, 1H), 3.64 (br s, 2H), 4.06–4.13 (m, 2H), 4.43 (br s, 1H), 6.45 (br s, 1H), 6.68 (d, <i>J</i> = 8.3 Hz, 2H), 7.00 (d, <i>J</i> = 8.3 Hz, 2H), 7.30 (m, 2H), 8.53 (br d, <i>J</i> = 3.7 Hz, 1H), 8.54 (m, 2H).</div></div></div></div><div id="sec5_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> 7-(Trimethylsilyl)-5-oxohept-6-ynoic Acid (<b>52</b>)</h3><div class="NLM_p last">To a stirred solution of glutamic anhydride (32g, 280 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (1500 mL) at 0 °C was added bis(trimethylsilyl)acetylene (65.8 mL, 293 mmol) followed by slow addition of solid aluminum chloride (39.3g, 294 mmol) over 25 min. The resulting suspension was stirred for 3 h at 0 °C and then allowed to gradually warm to room temperature overnight. After cooling to 0 °C, the reaction was quenched slowly with 1 N aq HCl (500 mL) so as to keep the internal temperature below 10 °C. The layers were then separated, and the aqueous phase was extracted with DCM (2×). The combined organics were washed with 1 N HCl, water, and then brine and dried over MgSO<sub>4</sub> and evaporated in vacuo. The residue was purified by flash column chromatography on a Biotage Horizon system (silica gel, eluent 50% EtOAc in hexanes) to afford the title compound (43.4g, 72.9% yield) as a yellow/brown oil. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 0.24 (s, 9H), 1.97 (m, 2H), 2.42 (t, <i>J</i> = 7.3 Hz, 2H), 2.66 (t, <i>J</i> = 7.3 Hz, 2H).</div></div><div id="sec5_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> (5<i>Z</i>)-5-[(<i>tert</i>-Butoxycarbonyl)hydrazono]-7-(trimethylsilyl)hept-6-ynoic Acid (<b>53</b>)</h3><div class="NLM_p last">To a stirred solution of 7-(trimethylsilyl)-5-oxohept-6-ynoic acid <b>52</b> (54.0g, 0.254 mol) in isopropyl alcohol (750 mL) was added <i>tert</i>-butyl carbazate (33.6g, 0.254 mol). The reaction mixture was stirred for 4 h at ambient temperature then evaporated in vacuo to remove all volatiles. This afforded the title compound as a yellow gum which was used without further purification (77g, 93%). LC/MS (EI) <i>m</i>/<i>e</i>: 327.2 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 0.27 (s, 9H), 1.51 (s, 9H), 1.95 (m, 2H), 2.40 (t, <i>J</i> = 7.5 Hz, 2H), 2.46 (t, <i>J</i> = 7.5 Hz, 2H), 8.42 (br s, 1H).</div></div><div id="sec5_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> <i>tert</i>-Butyl 3-[4-(Benzyloxy)-4-oxobutyl]-1<i>H</i>-pyrazole-1-carboxylate (<b>54</b>)</h3><div class="NLM_p">To a stirred solution of <b>53</b> (77.0g, 0.236Mol) in THF (500 mL) was added a 1.0 M solution of tetrabutylammonium fluoride in THF (350 mL, 0.35 mol) over 30 min, and the resulting mixture was stirred at ambient temperature for 48 h. The reaction mixture was evaporated to dryness in vacuo, and the residue was diluted with a 5% aqueous acetic acid solution (1 L). The aqueous phase was extracted with ethyl acetate (3 × 350 mL), and the combined organic layers were washed with water (2 × 100 mL) and brine (150 mL). The organic layers were dried over MgSO<sub>4</sub> and evaporated to dryness in vacuo. The crude residue was purified by flash column chromatography on a Biotage Horizon system (silica gel, eluent 35% EtOAc in hexanes containing 3% acetic acid) to afford 4-[1-(<i>tert</i>-butoxycarbonyl)-1<i>H</i>-pyrazol-3-yl]butanoic acid as (60 g, quantitative yield) as a yellow oil.</div><div class="NLM_p last">To a solution of the above acid (60.0 g, 0.236 mol) in DMF (200 mL) was added potassium carbonate (48.9g, 0.354 mol) followed by dropwise addition of benzyl bromide (40 mL, 0.30 mol) over 30 min. The resulting mixture was stirred for 24 h, quenched with water (1 L), and extracted with ethyl acetate (3 × 300 mL). The combined organic layers were washed with brine (150 mL), dried over MgSO<sub>4</sub>, and evaporated to dryness in vacuo. The residue was purified by flash column chromatography on a Biotage Horizon system (silica gel, 100% hexanes to 4% EtOAc in hexanes gradient) to afford the desired compound as a yellow oil (56 g, 68%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.63 (s, 9H), 2.02 (quintet, <i>J</i> = 7.5 Hz, 2H), 2.42 (t, <i>J</i> = 7.5 Hz, 2H), 2.73 (t, <i>J</i> = 7.5 Hz, 2H), 5.11 (s, 2H), 6.19 (d, <i>J</i> = 2.5 Hz, 1H), 7.34 (m, 5H), 7.95 (d, <i>J</i> = 2.5 Hz, 1H).</div></div><div id="sec5_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> Benzyl 5,6-Dihydro-4<i>H</i>-pyrrolo[1,2-<i>b</i>]pyrazole-6-carboxylate (<b>55</b>)</h3><div class="NLM_p last">To a stirred solution of <b>54</b> (27.5g, 80.0 mmol) in THF (250 mL) cooled to −78 °C was added a 1.0 M solution of sodium bis(trimethylsilyl)amide in THF (88 mL, 88 mmol). The resulting dark-yellow solution was stirred for 1 h at −78 °C and then chlorotrimethylsilane (12 mL, 96 mmol) was added dropwise over 10 min, and the resulting mixture was stirred for 30 min. Solid <i>N</i>-bromosuccinimide (16g, 88 mmol) was then added in one portion, and the resulting mixture was stirred for 3 h at −78 °C followed by gradual warming to 0 °C over 1 h. The reaction was quenched with a saturated aqueous ammonium chloride solution and the aqueous phase extracted with ethyl acetate (3 × 200 mL). The combined organics were washed with brine, dried over MgSO<sub>4</sub>, and evaporated to dryness in vacuo. To a stirred solution of the crude residue of in dichloromethane (50 mL) was added trifluoroacetic acid (50 mL), and the resulting mixture was stirred for 2 h at ambient temperature. All volatiles were then evaporated in vacuo, and the residue was diluted with toluene (50 mL) and evaporated again in vacuo to remove all residual trifluoroacetic acid. The crude material was then dissolved in acetone (125 mL), and solid potassium carbonate (14.0 g, 100 mmol) was slowly added over 15 min, followed by sodium iodide (1.2 g, 8.0 mmol), and the resulting mixture was heated at reflux for 16 h. The mixture was cooled to room temperature and evaporated to dryness in vacuo. The residue was diluted with a saturated aqueous ammonium chloride solution (100 mL) and then extracted with EtOAc (3 × 100 mL). The combined organics layers were washed with brine, dried over MgSO<sub>4</sub>, and evaporated in vacuo. The residue was purified by flash column chromatography on a Biotage Horizon system (silica gel, 10% EtOAc in hexanes to 80% EtOAc in hexanes gradient) to afford the desired compound as clear gum (6.2 g, 64%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 2.63–2.70 (m, 1H), 2.85–3.01 (m, 3H), 4.99 (d, <i>J</i> = 9.4 Hz, 1H), 5.21 (s, 2H), 5.99 (d, <i>J</i> = 1.6 Hz, 1H), 7.31–7.38 (m, 5H), 7.58 (d, <i>J</i> = 1.6 Hz, 1H).</div></div><div id="sec5_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> 5,6-Dihydro-4<i>H</i>-pyrrolo[1,2-<i>b</i>]pyrazole-6-carboxylic Acid (<b>56</b>)</h3><div class="NLM_p last">A 100 mL round-bottom flask under an atmosphere of nitrogen and charged with 10 wt % palladium on activated carbon (6 mg, 0.560 mmol), which was subsequently wet with ethanol (10 mL). A solution of <b>55</b> (6.0 g, 0.025 mol) in ethanol (40 mL) was then added and the mixture placed under a balloon of hydrogen for 4 h. The reaction was filtered through a pad of Celite, the pad was washed with ethanol (20 mL), and the filtrate evaporated in vacuo to afford the title compound as a colorless solid (3.7 g, 100%). LC-MS: <i>m</i>/<i>z</i> (ES) 153 (MH)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 2.55 (m, 1H), 2.88 (m, 3H), 4.87 (dd, <i>J</i> = 8.9, 3.7 Hz, 1H), 5.98 (s, 1H), 7.44 (s, 1H), 11.90 (br s, 1H).</div></div><div id="sec5_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> β<sub>3</sub> cAMP Assay</h3><div class="NLM_p last">CHO cells, stably transfected with the cloned β<sub>3</sub>-adrenergic receptor were harvested after 3 days of subculturing. Harvesting of cells is done with Enzyme-Free Dissociation Media (Specialty Media). Cells are then counted and resuspended in assay buffer (Hank’s Balanced Salt Solution supplemented with 5 mM HEPES, 0.1%BSA) containing a phosphodiesterase inhibitor (IBMX, 0.6 mM). The reaction was initiated by mixing 6000 cells in with 6 μL of Alexa Fluor labeled cAMP antibody (LANCE kit), which was then added to an assay well containing 12 μL of compound (diluted in assay buffer to 2× final concentration). The reaction proceeded for 30 min at room temperature and was terminated by the addition of 24 μL of detection buffer (LANCE kit). The assay plate was then incubated for 1 h at room temperature and time-resolved fluorescence measured on a Perkin-Elmer Envision reader. The unknown cAMP level was determined by comparing fluorescence levels to a cAMP standard curve. The nonselective, full agonist β-adrenergic ligand isoproterenol was used to determine maximal stimulation. The human β<sub>3</sub>-adrenergic receptor selective ligand (<i>S</i>)-<i>N</i>-[4-[2[[2-hydroxy-3-(4-hydroxyphenoxy)propyl]amino]ethyl]-phenyl]-4-iodobenzenesulfonamide was used as a control. Isoproterenol was titrated at a final concentration in the assay of 10<sup>–10</sup> to 10<sup>–5</sup> M, and the selective ligand (<i>S</i>)-<i>N</i>-[4-[2[[2-hydroxy-3-(4-hydroxyphenoxy)propyl]amino]ethyl]-phenyl]-4-iodobenzenesulfonamide was titrated at the β<sub>3</sub> receptor at concentration of 10<sup>–10</sup> to 10<sup>–5</sup> M. Unknown ligands were titrated at the β<sub>3</sub>-adrenergic receptor at a final concentration in the assay of 10<sup>–10</sup> to 10<sup>–5</sup> M to determine the EC<sub>50</sub>. The EC<sub>50</sub> is defined as the concentration of compound that gives 50% activation of its own maximum. Data were analyzed using Microsoft Excel and Graphpad Prism, v4.</div></div><div id="sec5_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i86" class="anchor-spacer"></div><h3 class="article-section__title" id="_i86"> β<sub>1</sub> and β<sub>2</sub> Binding Assays</h3><div class="NLM_p last">CHO cells recombinantly expressing β<sub>1</sub> and β<sub>2</sub> receptors were grown for 3–4 days post splitting; the attached cells were washed with PBS and then lysed in 1 mM Tris, pH 7.2 for 10 min on ice. The flasks are scraped to remove the cells then homogenized using a Teflon/glass homogenizer. Membranes were collected by centrifuging at 38000<i>g</i> for 15 min at 4 °C. The pelleted membranes were resuspended in TME buffer (50 mM Tris, pH 7.4, 5 mM MgCl<sub>2</sub>, 2 mM EDTA) at a concentration of 1 mg protein/mL. The binding assay was performed by incubating together membranes (2–5 μg of protein), the radiolabeled tracer <sup>125</sup>I-cyanopindolol (<sup>125</sup>I-CYP, 45 pM), 200 μg of WGA-PVT SPA beads (GE Healthcare), and the test compounds at final concentrations from 10<sup>–10</sup> to 10<sup>–5</sup> M in a final volume of 200 μL of TME buffer containing 0.1% BSA. The assay plate is incubated for 1 h with shaking at room temperature and then placed in a Perkin-Elmer Trilux scintillation counter. The plates were allowed to rest in the Trilux counter for approximately 10 h in the dark prior to counting. Data were analyzed using a standard four-parameter nonlinear regression analysis using Graphpad Prism software, v4. The IC<sub>50</sub> is defined as the concentration of the title compound capable of inhibiting 50% of the binding of the radiolabeled tracer (<sup>125</sup>I-CYP).</div></div><div id="sec5_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i87" class="anchor-spacer"></div><h3 class="article-section__title" id="_i87"> Serotonin Transporter Assay</h3><div class="NLM_p last">HEK293 cells stably expressing the human serotonin transporter (SERT) were plated at a density of 20000 cells/well in a 384-well plate (BD Biocoat no. 35663) and incubated overnight at 37 °C. The following day, growth media was removed and replaced with assay buffer (HBSS containing 20 mM HEPES and 0.1% BSA; Sigma). Compounds (serially diluted in DMSO at 100× final concentration) were added to appropriate assay wells and the plate incubated for 30 min at 37 °C. Fluorescent transporter substrate was prepared following the manufacturer’s instructions (Neurotransmitter Uptake Kit, no. R8173, Molecular Probes) and added to the assay plate. The plate was then incubated for an additional 30 min at 37 °C. Uptake of the fluorescent dye was then determined by measuring fluorescence in a bottom read mode fluorescence plate reader (440 nm excitation, 520 nm emission wavelengths). Each plate included 0% inhibition (DMSO only) and 100% inhibition (10 μM fluoxetine) control wells which were used to normalize the fluorescence data. Normalized data was then fit to a standard four-parameter curve and IC<sub>50</sub> determined.</div></div><div id="sec6" class="NLM_sec NLM_sec_level_2"><div id="ac_i88" class="anchor-spacer"></div><h3 class="article-section__title" id="_i88"> Rat Bladder Hyperactivity Model</h3><div class="NLM_p last">Adult female Sprague–Dawley rats weighing 170–250 g (Charles River, Wilmington, MA) were used. All procedures were approved by the Institutional Animal Care and Use Committee at Merck and Co., Inc., Rahway, N.J. Cystometry was performed as described previously.<a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(26, 27)</a> In brief, animals were anesthetized with urethane (1.1 g/kg ip). A lower abdominal midline incision was made to expose the bladder, and two polyethylene tubes (PE-50) were inserted into the bladder dome, secured with a 4–0 silk suture and connected to both a syringe pump (555920; Harvard Apparatus, Holliston, MA) and a pressure transducer via a three way stopcock. Physiological saline solution was intravesically infused at a rate of 0.05 mL/min. The intravesical pressure signal was recorded using a Powerlab unit (16/30; AD Instruments) at a sampling rate of 10 Hz. An intravenous catheter (PE-100) was implanted into a femoral vein, and the drug solutions were infused at a rate of 0.01 mL/min using an infusion pump (BS-9000-8, Braintree Scientific, Braintree, MA). After a stable micturition cycle was observed, a 0.5% acetic acid was intravesically infused for 2 h. The drug solution was continuously infused from 1 to 2 h after beginning the intravesical acetic acid infusion. Peak micturition pressures were measured pre- and postdose. Data are presented as the mean ± SEM. The mean values were compared with one-way ANOVA with Bonferoni posthoc test. A probability value less than or equal to 0.05 was considered significant.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-5"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i89"><a href="/doi/suppl/10.1021/jm4017224">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13243" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13243" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Conditions for the separation of the isomers of <b>38a</b> and X-ray data collection on the isomer leading to more potent B<sub>3</sub>-AR agonists, and procedures and characterization for compounds <b>31a</b>–<b>g</b>, <b>32a</b>–<b>g</b>, <b>33a</b>, <b>37a</b>–<b>d</b>, <b>38a</b>, <b>41a</b>–<b>e</b>, <b>42a</b>–<b>e</b>, <b>43a</b>–<b>e</b>, <b>44a</b>–<b>e</b>, <b>45a</b>–<b>e</b>, <b>46a</b>–<b>e</b>, <b>47a</b>–<b>e</b>, <b>48a</b>–<b>e</b>, <b>49a</b>–<b>d</b>, <b>50a</b>. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm4017224/suppl_file/jm4017224_si_001.pdf">jm4017224_si_001.pdf (436.98 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm4017224" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16314" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16314" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher R. Moyes</span> - <span class="hlFld-Affiliation affiliation">Early
Development and Discovery Sciences, Merck
and Co., Inc., 2000 Galloping
Hill Road, Kenilworth, New
Jersey 07033, United
States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#2c4f445e455f58435c44495e73414355495f6c41495e4f47024f4341"><span class="__cf_email__" data-cfemail="7a19120813090e150a121f08251715031f093a171f08191154191517">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Richard Berger</span> - <span class="hlFld-Affiliation affiliation">Early
Development and Discovery Sciences, Merck
and Co., Inc., 770 Sumneytown
Pike, West Point, Pennsylvania 19486, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephen D. Goble</span> - <span class="hlFld-Affiliation affiliation">Early
Development and Discovery Sciences, Merck
and Co., Inc., 126 East
Lincoln Avenue, Rahway, New
Jersey 07065, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bart Harper</span> - <span class="hlFld-Affiliation affiliation">Early
Development and Discovery Sciences, Merck
and Co., Inc., 126 East
Lincoln Avenue, Rahway, New
Jersey 07065, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dong-Ming Shen</span> - <span class="hlFld-Affiliation affiliation">Early
Development and Discovery Sciences, Merck
and Co., Inc., 126 East
Lincoln Avenue, Rahway, New
Jersey 07065, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Liping Wang</span> - <span class="hlFld-Affiliation affiliation">Early
Development and Discovery Sciences, Merck
and Co., Inc., 126 East
Lincoln Avenue, Rahway, New
Jersey 07065, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alka Bansal</span> - <span class="hlFld-Affiliation affiliation">Early
Development and Discovery Sciences, Merck
and Co., Inc., 126 East
Lincoln Avenue, Rahway, New
Jersey 07065, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Patricia N. Brown</span> - <span class="hlFld-Affiliation affiliation">Early
Development and Discovery Sciences, Merck
and Co., Inc., 2000 Galloping
Hill Road, Kenilworth, New
Jersey 07033, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Airu S. Chen</span> - <span class="hlFld-Affiliation affiliation">Early
Development and Discovery Sciences, Merck
and Co., Inc., 126 East
Lincoln Avenue, Rahway, New
Jersey 07065, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Karen H. Dingley</span> - <span class="hlFld-Affiliation affiliation">Early
Development and Discovery Sciences, Merck
and Co., Inc., 2000 Galloping
Hill Road, Kenilworth, New
Jersey 07033, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jerry Di Salvo</span> - <span class="hlFld-Affiliation affiliation">Early
Development and Discovery Sciences, Merck
and Co., Inc., 2000 Galloping
Hill Road, Kenilworth, New
Jersey 07033, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Aileen Fitzmaurice</span> - <span class="hlFld-Affiliation affiliation">Early
Development and Discovery Sciences, Merck
and Co., Inc., 2000 Galloping
Hill Road, Kenilworth, New
Jersey 07033, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Loise N. Gichuru</span> - <span class="hlFld-Affiliation affiliation">Early
Development and Discovery Sciences, Merck
and Co., Inc., 2000 Galloping
Hill Road, Kenilworth, New
Jersey 07033, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Amanda L. Hurley</span> - <span class="hlFld-Affiliation affiliation">Early
Development and Discovery Sciences, Merck
and Co., Inc., 126 East
Lincoln Avenue, Rahway, New
Jersey 07065, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nina Jochnowitz</span> - <span class="hlFld-Affiliation affiliation">Early
Development and Discovery Sciences, Merck
and Co., Inc., 2000 Galloping
Hill Road, Kenilworth, New
Jersey 07033, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Randall R. Miller</span> - <span class="hlFld-Affiliation affiliation">Early
Development and Discovery Sciences, Merck
and Co., Inc., 2000 Galloping
Hill Road, Kenilworth, New
Jersey 07033, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shruty Mistry</span> - <span class="hlFld-Affiliation affiliation">Early
Development and Discovery Sciences, Merck
and Co., Inc., 126 East
Lincoln Avenue, Rahway, New
Jersey 07065, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hiroshi Nagabukuro</span> - <span class="hlFld-Affiliation affiliation">Early
Development and Discovery Sciences, Merck
and Co., Inc., 126 East
Lincoln Avenue, Rahway, New
Jersey 07065, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gino M. Salituro</span> - <span class="hlFld-Affiliation affiliation">Early
Development and Discovery Sciences, Merck
and Co., Inc., 126 East
Lincoln Avenue, Rahway, New
Jersey 07065, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anthony Sanfiz</span> - <span class="hlFld-Affiliation affiliation">Early
Development and Discovery Sciences, Merck
and Co., Inc., 126 East
Lincoln Avenue, Rahway, New
Jersey 07065, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andra S. Stevenson</span> - <span class="hlFld-Affiliation affiliation">Early
Development and Discovery Sciences, Merck
and Co., Inc., 2000 Galloping
Hill Road, Kenilworth, New
Jersey 07033, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Katherine Villa</span> - <span class="hlFld-Affiliation affiliation">Early
Development and Discovery Sciences, Merck
and Co., Inc., 126 East
Lincoln Avenue, Rahway, New
Jersey 07065, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Beata Zamlynny</span> - <span class="hlFld-Affiliation affiliation">Early
Development and Discovery Sciences, Merck
and Co., Inc., 2000 Galloping
Hill Road, Kenilworth, New
Jersey 07033, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mary Struthers</span> - <span class="hlFld-Affiliation affiliation">Early
Development and Discovery Sciences, Merck
and Co., Inc., 2000 Galloping
Hill Road, Kenilworth, New
Jersey 07033, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ann E. Weber</span> - <span class="hlFld-Affiliation affiliation">Early
Development and Discovery Sciences, Merck
and Co., Inc., 2000 Galloping
Hill Road, Kenilworth, New
Jersey 07033, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Scott D. Edmondson</span> - <span class="hlFld-Affiliation affiliation">Early
Development and Discovery Sciences, Merck
and Co., Inc., 2000 Galloping
Hill Road, Kenilworth, New
Jersey 07033, United
States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d3342e7175-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i94">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33240" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33240" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Judy Morris, Regina Black, and Lisa Frey for assistance with compound purification, Arlene McKeown and Richard Ball for collecting diffraction data, and Donna Hrenuik for in vitro assay support.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i95" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i95"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i96" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i96"> Abbreviations Used</h2><tr><td class="NLM_term">AcOH</td><td class="NLM_def"><p class="first last">acetic acid</p></td></tr><tr><td class="NLM_term">β-AR</td><td class="NLM_def"><p class="first last">β-adrenergic receptor</p></td></tr><tr><td class="NLM_term">AUC</td><td class="NLM_def"><p class="first last">area under the pharmacokinetic exposure curve</p></td></tr><tr><td class="NLM_term">b</td><td class="NLM_def"><p class="first last">broad</p></td></tr><tr><td class="NLM_term">Boc</td><td class="NLM_def"><p class="first last"><i>t</i>-butyl carbamate</p></td></tr><tr><td class="NLM_term">CHO cells</td><td class="NLM_def"><p class="first last">Chinese hamster ovary</p></td></tr><tr><td class="NLM_term">CYP</td><td class="NLM_def"><p class="first last">cytochrome P450</p></td></tr><tr><td class="NLM_term">d</td><td class="NLM_def"><p class="first last">doublet</p></td></tr><tr><td class="NLM_term">DMAP</td><td class="NLM_def"><p class="first last">4-dimethylaminopyridine</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethylformamide</p></td></tr><tr><td class="NLM_term">EDC</td><td class="NLM_def"><p class="first last"><i>N</i>-(3-dimethylaminopropyl)-<i>N</i>′-ethylcabodiimide hydrochloride</p></td></tr><tr><td class="NLM_term">EtOH</td><td class="NLM_def"><p class="first last">ethanol</p></td></tr><tr><td class="NLM_term">hERG</td><td class="NLM_def"><p class="first last">human Ether-à-go-go Related Gene potassium channel</p></td></tr><tr><td class="NLM_term">HOAt</td><td class="NLM_def"><p class="first last">1-hydroxy-7-azabenzotriazole</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high performance liquid chromatography</p></td></tr><tr><td class="NLM_term">IPA</td><td class="NLM_def"><p class="first last">propan-2-ol</p></td></tr><tr><td class="NLM_term">LC/MS</td><td class="NLM_def"><p class="first last">liquid chromatography–mass spectroscopy</p></td></tr><tr><td class="NLM_term">LHS</td><td class="NLM_def"><p class="first last">left-hand side</p></td></tr><tr><td class="NLM_term">m</td><td class="NLM_def"><p class="first last">multiplet</p></td></tr><tr><td class="NLM_term">MeOH</td><td class="NLM_def"><p class="first last">methanol</p></td></tr><tr><td class="NLM_term">Moz</td><td class="NLM_def"><p class="first last"><i>p</i>-methoxybenzyl carbamate</p></td></tr><tr><td class="NLM_term">NMR</td><td class="NLM_def"><p class="first last">nuclear magnetic resonance</p></td></tr><tr><td class="NLM_term">OAB</td><td class="NLM_def"><p class="first last">overactive bladder</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetic</p></td></tr><tr><td class="NLM_term">q</td><td class="NLM_def"><p class="first last">quartet</p></td></tr><tr><td class="NLM_term">quin</td><td class="NLM_def"><p class="first last">quintet</p></td></tr><tr><td class="NLM_term">RHS</td><td class="NLM_def"><p class="first last">right-hand side</p></td></tr><tr><td class="NLM_term">s</td><td class="NLM_def"><p class="first last">singlet</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">SFC</td><td class="NLM_def"><p class="first last">supercritical fluid chromatography</p></td></tr><tr><td class="NLM_term">SSRI</td><td class="NLM_def"><p class="first last">selective serotonin receptor uptake</p></td></tr><tr><td class="NLM_term">t</td><td class="NLM_def"><p class="first last">triplet</p></td></tr><tr><td class="NLM_term">TBS</td><td class="NLM_def"><p class="first last"><i>t</i>-butyldimethylsilyl</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">TMS</td><td class="NLM_def"><p class="first last">trimethylsilyl</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i97">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00408" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00408" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 28 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Arch, J. R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ainsworth, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cawthorne, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piercy, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sennitt, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thody, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, S.</span><span> </span><span class="NLM_article-title">Atypical β-adrenoceptor on brown adipocytes as target for anti-obesity drugs</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">309</span><span class="NLM_x">, </span> <span class="NLM_fpage">163</span><span class="NLM_x">–</span> <span class="NLM_lpage">165</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=309&publication_year=1984&pages=163-165&author=J.+R.+S.+Archauthor=A.+T.+Ainsworthauthor=M.+A.+Cawthorneauthor=V.+Piercyauthor=M.+V.+Sennittauthor=V.+E.+Thodyauthor=S.+Wilson&title=Atypical+%CE%B2-adrenoceptor+on+brown+adipocytes+as+target+for+anti-obesity+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArch%26aufirst%3DJ.%2BR.%2BS.%26aulast%3DAinsworth%26aufirst%3DA.%2BT.%26aulast%3DCawthorne%26aufirst%3DM.%2BA.%26aulast%3DPiercy%26aufirst%3DV.%26aulast%3DSennitt%26aufirst%3DM.%2BV.%26aulast%3DThody%26aufirst%3DV.%2BE.%26aulast%3DWilson%26aufirst%3DS.%26atitle%3DAtypical%2520%25CE%25B2-adrenoceptor%2520on%2520brown%2520adipocytes%2520as%2520target%2520for%2520anti-obesity%2520drugs%26jtitle%3DNature%26date%3D1984%26volume%3D309%26spage%3D163%26epage%3D165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Arch, J. R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ainsworth, A. T.</span><span> </span><span class="NLM_article-title">Thermogenic and antiobesity activity of a novel β-adrenoceptor agonist (BRL 26830A) in mice and rats</span> <span class="citation_source-journal">Am. J. Clin. Nutr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">549</span><span class="NLM_x">–</span> <span class="NLM_lpage">558</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm4017224&amp;key=6137948" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm4017224&amp;key=1%3ACAS%3A528%3ADyaL3sXmtVGqtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1983&pages=549-558&author=J.+R.+S.+Archauthor=A.+T.+Ainsworth&title=Thermogenic+and+antiobesity+activity+of+a+novel+%CE%B2-adrenoceptor+agonist+%28BRL+26830A%29+in+mice+and+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Thermogenic and antiobesity activity of a novel β-adrenoceptor agonist (BRL 26830A) in mice and rats</span></div><div class="casAuthors">Arch, Jonathan R. S.; Ainsworth, Anthony T.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Clinical Nutrition</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">549-58</span>CODEN:
                <span class="NLM_cas:coden">AJCNAC</span>;
        ISSN:<span class="NLM_cas:issn">0002-9165</span>.
    </div><div class="casAbstract">The effects of BRL 26830A (I)  [87857-42-9] on energy balance in normal and obese mice and obese rats were investigated.  I reduced body wt. or wt. gain in genetically (ob/ob), gold thioglucose-, and cafeteria diet-obese mice and in genetically obese (fa/fa) Zucker rats.  Wt. redn. was due to reduced body lipid content.  I caused little or no redn. in food intake in these animals, but it increased metabolic rate and in genetically obese mice this thermic effect was increased by repeat dosing.  I did not reduce body wt. gain in the lean counterparts of the genetically obese animals.  Its thermic effect was smaller in the lean than the genetically obese mice, and it increased food intake in the lean mice.  The thermic effect of I was inhibited by dl-propranolol, but not by the d-isomer.  I largely overcame the depression in metabolic rate caused by fasting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIs2dmv3mTqbVg90H21EOLACvtfcHk0ljFna46tUbuqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXmtVGqtr0%253D&md5=a7cba5deb318fe7ebebb3f82e8084043</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArch%26aufirst%3DJ.%2BR.%2BS.%26aulast%3DAinsworth%26aufirst%3DA.%2BT.%26atitle%3DThermogenic%2520and%2520antiobesity%2520activity%2520of%2520a%2520novel%2520%25CE%25B2-adrenoceptor%2520agonist%2520%2528BRL%252026830A%2529%2520in%2520mice%2520and%2520rats%26jtitle%3DAm.%2520J.%2520Clin.%2520Nutr.%26date%3D1983%26volume%3D38%26spage%3D549%26epage%3D558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Sennitt, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arch, J. R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levy, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simson, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cawthorne, M. A.</span><span> </span><span class="NLM_article-title">Anti-hyperglcaemic action of BRL 26830, a novel β-adrenoceptor agonist, in mice and rats</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1279</span><span class="NLM_x">–</span> <span class="NLM_lpage">1285</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1985&pages=1279-1285&author=M.+V.+Sennittauthor=J.+R.+S.+Archauthor=A.+L.+Levyauthor=D.+L.+Simsonauthor=S.+A.+Smithauthor=M.+A.+Cawthorne&title=Anti-hyperglcaemic+action+of+BRL+26830%2C+a+novel+%CE%B2-adrenoceptor+agonist%2C+in+mice+and+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSennitt%26aufirst%3DM.%2BV.%26aulast%3DArch%26aufirst%3DJ.%2BR.%2BS.%26aulast%3DLevy%26aufirst%3DA.%2BL.%26aulast%3DSimson%26aufirst%3DD.%2BL.%26aulast%3DSmith%26aufirst%3DS.%2BA.%26aulast%3DCawthorne%26aufirst%3DM.%2BA.%26atitle%3DAnti-hyperglcaemic%2520action%2520of%2520BRL%252026830%252C%2520a%2520novel%2520%25CE%25B2-adrenoceptor%2520agonist%252C%2520in%2520mice%2520and%2520rats%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1985%26volume%3D34%26spage%3D1279%26epage%3D1285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Weber, A. E.</span><span> </span><span class="NLM_article-title">β<sub>3</sub>-Adrenergic receptor agonists for the treatment of obesity</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">193</span><span class="NLM_x">–</span> <span class="NLM_lpage">202</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1998&pages=193-202&author=A.+E.+Weber&title=%CE%B23-Adrenergic+receptor+agonists+for+the+treatment+of+obesity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWeber%26aufirst%3DA.%2BE.%26atitle%3D%25CE%25B23-Adrenergic%2520receptor%2520agonists%2520for%2520the%2520treatment%2520of%2520obesity%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D1998%26volume%3D33%26spage%3D193%26epage%3D202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Irwin, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milsom, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunskaar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reilly, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopp, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herschorn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coyne, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelleher, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hampel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Artibani, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrams, P.</span><span> </span><span class="NLM_article-title">Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study</span> <span class="citation_source-journal">Eur. Urol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1306</span><span class="NLM_x">–</span> <span class="NLM_lpage">1315</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm4017224&amp;key=10.1016%2Fj.eururo.2006.09.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm4017224&amp;key=17049716" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm4017224&amp;key=1%3ACAS%3A280%3ADC%252BD28nmt1Kmsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2006&pages=1306-1315&author=D.+E.+Irwinauthor=I.+Milsomauthor=S.+Hunskaarauthor=K.+Reillyauthor=Z.+Koppauthor=S.+Herschornauthor=K.+Coyneauthor=C.+Kelleherauthor=C.+Hampelauthor=W.+Artibaniauthor=P.+Abrams&title=Population-based+survey+of+urinary+incontinence%2C+overactive+bladder%2C+and+other+lower+urinary+tract+symptoms+in+five+countries%3A+results+of+the+EPIC+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study</span></div><div class="casAuthors">Irwin Debra E; Milsom Ian; Hunskaar Steinar; Reilly Kate; Kopp Zoe; Herschorn Sender; Coyne Karin; Kelleher Con; Hampel Christian; Artibani Walter; Abrams Paul</div><div class="citationInfo"><span class="NLM_cas:title">European urology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1306-14; discussion 1314-5</span>
        ISSN:<span class="NLM_cas:issn">0302-2838</span>.
    </div><div class="casAbstract">OBJECTIVE:  Estimate the prevalence of urinary incontinence (UI), overactive bladder (OAB), and other lower urinary tract symptoms (LUTS) among men and women in five countries using the 2002 International Continence Society (ICS) definitions.  METHODS:  This population-based, cross-sectional survey was conducted between April and December 2005 in Canada, Germany, Italy, Sweden, and the United Kingdom using computer-assisted telephone interviews.  A random sample of men and women aged >/= 18 yr residing in the five countries and who were representative of the general populations in these countries was selected.  Using 2002 ICS definitions, the prevalence estimates of storage, voiding, and postmicturition LUTS were calculated.  Data were stratified by country, age cohort, and gender.  RESULTS:  A total of 19,165 individuals agreed to participate; 64.3% reported at least one LUTS.  Nocturia was the most prevalent LUTS (men, 48.6%; women, 54.5%).  The prevalence of storage LUTS (men, 51.3%; women, 59.2%) was greater than that for voiding (men, 25.7%; women, 19.5%) and postmicturition (men, 16.9%; women, 14.2%) symptoms combined.  The overall prevalence of OAB was 11.8%; rates were similar in men and women and increased with age.  OAB was more prevalent than all types of UI combined (9.4%).  CONCLUSIONS:  The EPIC study is the largest population-based survey to assess prevalence rates of OAB, UI, and other LUTS in five countries.  To date, this is the first study to evaluate these symptoms simultaneously using the 2002 ICS definitions.  The results indicate that these symptoms are highly prevalent in the countries surveyed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTDX7KjsEQJ0vSAs_PE1QvifW6udTcc2eYtAQItc2vjabntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28nmt1Kmsw%253D%253D&md5=8a24630cb261f6888e72b9dbd25ac55d</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.eururo.2006.09.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.eururo.2006.09.019%26sid%3Dliteratum%253Aachs%26aulast%3DIrwin%26aufirst%3DD.%2BE.%26aulast%3DMilsom%26aufirst%3DI.%26aulast%3DHunskaar%26aufirst%3DS.%26aulast%3DReilly%26aufirst%3DK.%26aulast%3DKopp%26aufirst%3DZ.%26aulast%3DHerschorn%26aufirst%3DS.%26aulast%3DCoyne%26aufirst%3DK.%26aulast%3DKelleher%26aufirst%3DC.%26aulast%3DHampel%26aufirst%3DC.%26aulast%3DArtibani%26aufirst%3DW.%26aulast%3DAbrams%26aufirst%3DP.%26atitle%3DPopulation-based%2520survey%2520of%2520urinary%2520incontinence%252C%2520overactive%2520bladder%252C%2520and%2520other%2520lower%2520urinary%2520tract%2520symptoms%2520in%2520five%2520countries%253A%2520results%2520of%2520the%2520EPIC%2520study%26jtitle%3DEur.%2520Urol.%26date%3D2006%26volume%3D50%26spage%3D1306%26epage%3D1315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Abrams, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersson, K. E.</span><span> </span><span class="NLM_article-title">Muscarinic receptor antagonists for overactive bladder</span> <span class="citation_source-journal">BJU Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">987</span><span class="NLM_x">–</span> <span class="NLM_lpage">1006</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm4017224&amp;key=10.1111%2Fj.1464-410X.2007.07205.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm4017224&amp;key=17922784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm4017224&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlGgur7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2007&pages=987-1006&author=P.+Abramsauthor=K.+E.+Andersson&title=Muscarinic+receptor+antagonists+for+overactive+bladder"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Muscarinic receptor antagonists for overactive bladder</span></div><div class="casAuthors">Abrams, Paul; Andersson, Karl-Erik</div><div class="citationInfo"><span class="NLM_cas:title">BJU International</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">987-1006</span>CODEN:
                <span class="NLM_cas:coden">BJINFO</span>;
        ISSN:<span class="NLM_cas:issn">1464-4096</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Overactive bladder (OAB) is a syndrome characterized by urinary urgency, with or without urgency urinary incontinence, usually with frequency and nocturia.  OAB symptoms are often assocd. with detrusor overactivity (DO).  Like OAB symptoms, the prevalence of DO increases with age and can have a neurogenic and/or myogenic etiol.  Bladder outlet obstruction can be a contributing factor in DO, possibly through cholinergic denervation of the detrusor and supersensitivity of muscarinic receptors to acetylcholine, although the prevalence of OAB is similar in men and women across age groups.  Acetylcholine is the primary contractile neurotransmitter in the human detrusor, and antimuscarinics exert their effects on OAB/DO by inhibiting the binding of acetylcholine at muscarinic receptors M2 and M3 on detrusor smooth muscle cells and other structures within the bladder wall.  Worldwide, there are six antimuscarinic drugs currently marketed for the treatment of OAB: oxybutynin, tolterodine, propiverine, trospium, darifenacin, and solifenacin.  Each has demonstrated efficacy for the treatment of OAB symptoms, but their pharmacokinetic and adverse event profiles differ somewhat due to structural differences (tertiary vs quaternary amines), muscarinic receptor subtype selectivities, and organ selectivities.  Antimuscarinics are generally well tolerated, even in special populations (e.g. men with bladder outlet obstruction, elderly patients, children).  The most frequently reported adverse events in clin. studies of antimuscarinics are dry mouth, constipation, headache, and blurred vision; few patients withdraw from clin. trials because of adverse events.  Development of an antimuscarinic with functional selectivity for the bladder would reduce the occurrence of antimuscarinic adverse events.  The therapeutic potential of several other agents, such as α3-adrenoceptor agonists, purinergic receptor antagonists, phosphodiesterase inhibitors, neurokinin-1 receptor antagonists, opioids, and Rho-kinase inhibitors, is also under investigation for the treatment of OAB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo46uZDo-vaI7Vg90H21EOLACvtfcHk0lhsBK8GRfszQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlGgur7M&md5=ae74f99443663035095e793c43358bfa</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1111%2Fj.1464-410X.2007.07205.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1464-410X.2007.07205.x%26sid%3Dliteratum%253Aachs%26aulast%3DAbrams%26aufirst%3DP.%26aulast%3DAndersson%26aufirst%3DK.%2BE.%26atitle%3DMuscarinic%2520receptor%2520antagonists%2520for%2520overactive%2520bladder%26jtitle%3DBJU%2520Int.%26date%3D2007%26volume%3D100%26spage%3D987%26epage%3D1006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Dmochowski, R.</span><span> </span><span class="NLM_article-title">Improving the tolerability of anticholinergic agents in the treatment of overactive bladder</span> <span class="citation_source-journal">Drug Safety</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">583</span><span class="NLM_x">–</span> <span class="NLM_lpage">600</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2005&pages=583-600&author=R.+Dmochowski&title=Improving+the+tolerability+of+anticholinergic+agents+in+the+treatment+of+overactive+bladder"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDmochowski%26aufirst%3DR.%26atitle%3DImproving%2520the%2520tolerability%2520of%2520anticholinergic%2520agents%2520in%2520the%2520treatment%2520of%2520overactive%2520bladder%26jtitle%3DDrug%2520Safety%26date%3D2005%26volume%3D28%26spage%3D583%26epage%3D600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Fujimura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsutsumi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koibuchi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, O.</span><span> </span><span class="NLM_article-title">Expression and possible functional role for the β<sub>3</sub>-adrenoreceptor in human and rat detrusor muscle</span> <span class="citation_source-journal">J. Urol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">680</span><span class="NLM_x">–</span> <span class="NLM_lpage">685</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm4017224&amp;key=10.1016%2FS0022-5347%2801%2961994-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1999&pages=680-685&author=T.+Fujimuraauthor=K.+Tamuraauthor=T.+Tsutsumiauthor=T.+Yamamotoauthor=K.+Nakamuraauthor=Y.+Koibuchiauthor=M.+Kobayashiauthor=O.+Yamaguchi&title=Expression+and+possible+functional+role+for+the+%CE%B23-adrenoreceptor+in+human+and+rat+detrusor+muscle"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2FS0022-5347%2801%2961994-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0022-5347%252801%252961994-3%26sid%3Dliteratum%253Aachs%26aulast%3DFujimura%26aufirst%3DT.%26aulast%3DTamura%26aufirst%3DK.%26aulast%3DTsutsumi%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DNakamura%26aufirst%3DK.%26aulast%3DKoibuchi%26aufirst%3DY.%26aulast%3DKobayashi%26aufirst%3DM.%26aulast%3DYamaguchi%26aufirst%3DO.%26atitle%3DExpression%2520and%2520possible%2520functional%2520role%2520for%2520the%2520%25CE%25B23-adrenoreceptor%2520in%2520human%2520and%2520rat%2520detrusor%2520muscle%26jtitle%3DJ.%2520Urol.%26date%3D1999%26volume%3D16%26spage%3D680%26epage%3D685" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Yamanishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitahara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ilzuka, H.</span><span> </span><span class="NLM_article-title">Effect of 138–355, a β<sub>3</sub>-adrenoreceptor selective agonist, on relaxation of the human detrusor muscle in vitro</span> <span class="citation_source-journal">Neurourol. Urodyn.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">815</span><span class="NLM_x">–</span> <span class="NLM_lpage">819</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Fjm4017224&amp;key=10.1002%2Fnau.20231" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=8&amp;doi=10.1021%2Fjm4017224&amp;key=16998863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Fjm4017224&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht12qsrvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2006&pages=815-819&author=T.+Yamanishiauthor=K.+Yasudaauthor=S.+Kitaharaauthor=H.+Nakaiauthor=K.+Yoshidaauthor=H.+Ilzuka&title=Effect+of+138%E2%80%93355%2C+a+%CE%B23-adrenoreceptor+selective+agonist%2C+on+relaxation+of+the+human+detrusor+muscle+in+vitro"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9a</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of 138-355, a β3-adrenoceptor selective agonist, on relaxation of the human detrusor muscle in vitro</span></div><div class="casAuthors">Yamanishi, Tomonori; Yasuda, Kosaku; Kitahara, Satoshi; Nakai, Hideo; Yoshida, Ken-Ichiro; Iizuka, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">Neurourology and Urodynamics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">815-819</span>CODEN:
                <span class="NLM_cas:coden">NEUREM</span>;
        ISSN:<span class="NLM_cas:issn">0733-2467</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Aims: β-adrenoceptors are the predominant β-adrenoceptor subtype present in the bladder and urethra.  This study investigates the effects of 138-355, an active-metabolite of TT-138 and β3-adrenoceptor agonist, on relaxation of the human detrusor in vitro.  Methods: Tumor-free tissue samples of human bladder muscle from 39 patients undergoing total cystectomy due to bladder cancer were obtained, and the mucosa and serosa were removed.  Tissues were mounted in 5 or 10 mL organ baths contg. Krebs soln., which was gassed with 95% O2 and 5% CO2.  Resting tension of 1 g was obtained.  When the contraction had stabilized, increasing concns. of β adrenoceptor agonists (non-selective, isoprenaline; β2-selective, clenbuterol; β3-selective, 138-355 and BRL37344) and propiverine (a non-selective anti-muscarinic antagonist) were added cumulatively and concn.-relaxation curves (CRCs) were obtained.  CRCs to 138-355 were obtained in the absence and presence of SR59230A, a β3-selective antagonist, and antagonist affinity values (pA2) were calcd. from the Schild plot.  Results: Isoproterenol, clenbuterol, 138-355 and BRL37344 concn.-dependently relaxed isolated human urinary bladder strips with pEC50 value being 6.76 ± 0.17, 5.23 ± 0.22, 5.80 ± 0.26 and 5.90 ± 0.28, resp.  Following antagonist assay, it was obsd. that concn.-relaxation curves to 138-355 was competitively antagonized by β3-adrenoceptor antagonist, SR59230A, with a pA2 value of 7.01 ± 0.45 and with a Schild slope of 0.72 ± 0.07.  Conclusions: Involvement of the β3-adrenoceptor appears to be greater than that of the β3-adrenoceptor for relaxations of the human bladder.  The relaxation response of 138-355 appears to be mediated via the β3-adrenoceptor stimulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWzVhhOAy15bVg90H21EOLACvtfcHk0lhsBK8GRfszQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht12qsrvI&md5=ddf6c9485e27030a5e9e121660eb3d02</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1002%2Fnau.20231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fnau.20231%26sid%3Dliteratum%253Aachs%26aulast%3DYamanishi%26aufirst%3DT.%26aulast%3DYasuda%26aufirst%3DK.%26aulast%3DKitahara%26aufirst%3DS.%26aulast%3DNakai%26aufirst%3DH.%26aulast%3DYoshida%26aufirst%3DK.%26aulast%3DIlzuka%26aufirst%3DH.%26atitle%3DEffect%2520of%2520138%25E2%2580%2593355%252C%2520a%2520%25CE%25B23-adrenoreceptor%2520selective%2520agonist%252C%2520on%2520relaxation%2520of%2520the%2520human%2520detrusor%2520muscle%2520in%2520vitro%26jtitle%3DNeurourol.%2520Urodyn.%26date%3D2006%26volume%3D25%26spage%3D815%26epage%3D819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Woods, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carson, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norton, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheldon, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Argentieri, T. M.</span><span> </span><span class="NLM_article-title">Efficacy of the β<sub>3</sub>-adrenergic receptor agonist CL-316234 on experimental bladder hyperreflexia and detrusor instability in the rat</span> <span class="citation_source-journal">J. Urol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">166</span><span class="NLM_x">, </span> <span class="NLM_fpage">1142</span><span class="NLM_x">–</span> <span class="NLM_lpage">1147</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=16&amp;doi=10.1021%2Fjm4017224&amp;key=10.1016%2FS0022-5347%2805%2965936-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=8&amp;doi=10.1021%2Fjm4017224&amp;key=11490313" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Fjm4017224&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmsF2gtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=166&publication_year=2001&pages=1142-1147&author=M.+Woodsauthor=N.+Carsonauthor=N.+W.+Nortonauthor=J.+H.+Sheldonauthor=T.+M.+Argentieri&title=Efficacy+of+the+%CE%B23-adrenergic+receptor+agonist+CL-316234+on+experimental+bladder+hyperreflexia+and+detrusor+instability+in+the+rat"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy of the β3-adrenergic receptor agonist CL-316243 on experimental bladder hyperreflexia and detrusor instability in the rat</span></div><div class="casAuthors">Woods, Morgan; Carson, Nancyleigh; Norton, N. Wesley; Sheldon, Jeffrey H.; Argentieri, Thomas M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Urology (Hagerstown, MD, United States)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">166</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1142-1147</span>CODEN:
                <span class="NLM_cas:coden">JOURAA</span>;
        ISSN:<span class="NLM_cas:issn">0022-5347</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Recent evidence indicates that in a no. of species detrusor relaxation is mediated through activation of the β3-adrenergic receptor.  We detd. whether activation of the β3-adrenergic receptor would be a useful therapeutic approach for bladder instability.  We profiled in vitro activity of the β3-adrenergic receptor agonist CL-616243 and the efficacy of this compd. in exptl. models of detrusor instability and bladder hyperreflexia.  Isolated rat detrusor strips were contracted by depolarizing the prepns. with 20 mM. KCl.  CL-316423 was added to the tissue bath in increasing concns. and contraction inhibition was assessed.  Efficacy against bladder instability was evaluated using the obstructed hypertrophied bladder model in the rat.  The acetic acid bladder cystometry model was used to assess the efficacy of CL-316423 in bladder hyperreflexia.  Isovolumetric contractions were evoked by elec. stimulation using a silver bipolar electrode.  Data are expressed as the mean plus or minus std. error of mean.  CL-316243 inhibited spontaneously contracting, isolated rat detrusor strips in a concn. dependent manner with a mean concn. inhibiting 50% of maximal response of 2.65±0.36 nM.  Intrinsic activity relative to forskolin was 1.  In vivo CL-316243 administered i.v. or orally significantly increased the voiding interval and bladder compliance.  In addn., there was a decrease in the no. of spontaneous contractions during the filling phase in a model of neurogenic and obstruction induced bladder instability.  The amplitude of elec. evoked isovolumetric contractions was significantly smaller after CL-316243 exposure.  These data suggest that activating the β3-adrenergic receptor in rat bladder using CL-316243 may directly inhibit smooth muscle contractility, exptl. hyperreflexia and detrusor instability, and be useful for urge urinary incontinence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZlXr82ZfbtLVg90H21EOLACvtfcHk0lhsBK8GRfszQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmsF2gtLg%253D&md5=db51e7a7c23855df5ce096f457aa16fb</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1016%2FS0022-5347%2805%2965936-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0022-5347%252805%252965936-8%26sid%3Dliteratum%253Aachs%26aulast%3DWoods%26aufirst%3DM.%26aulast%3DCarson%26aufirst%3DN.%26aulast%3DNorton%26aufirst%3DN.%2BW.%26aulast%3DSheldon%26aufirst%3DJ.%2BH.%26aulast%3DArgentieri%26aufirst%3DT.%2BM.%26atitle%3DEfficacy%2520of%2520the%2520%25CE%25B23-adrenergic%2520receptor%2520agonist%2520CL-316234%2520on%2520experimental%2520bladder%2520hyperreflexia%2520and%2520detrusor%2520instability%2520in%2520the%2520rat%26jtitle%3DJ.%2520Urol.%26date%3D2001%26volume%3D166%26spage%3D1142%26epage%3D1147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="note"><p class="first last">For recently published examples, see</p></div><div class="NLM_citation" id="cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hattori, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imanishi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itou, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakajima, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Washizuka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Araki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamashima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomishima, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakurai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsui, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imamura, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueshima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unami, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamada, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takamura, F.</span><span> </span><span class="NLM_article-title">Discovery of highly potent and selective biphenylacylsulfonamide-based β<sub>3</sub>-adrenergic receptor agonists and evaluation of physical properties as potential overactive bladder therapies: Part 5</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">3063</span><span class="NLM_x">–</span> <span class="NLM_lpage">3072</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9000709" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=3063-3072&author=K.+Hattoriauthor=S.+Todaauthor=M.+Imanishiauthor=S.+Itouauthor=Y.+Nakajimaauthor=K.+Washizukaauthor=T.+Arakiauthor=H.+Hamashimaauthor=Y.+Tomishimaauthor=M.+Sakuraiauthor=S.+Matsuiauthor=E.+Imamuraauthor=K.+Ueshimaauthor=T.+Yamamotoauthor=N.+Yamamotoauthor=H.+Ishikawaauthor=K.+Nakanoauthor=N.+Unamiauthor=K.+Hamadaauthor=Y.+Matsumuraauthor=F.+Takamura&title=Discovery+of+highly+potent+and+selective+biphenylacylsulfonamide-based+%CE%B23-adrenergic+receptor+agonists+and+evaluation+of+physical+properties+as+potential+overactive+bladder+therapies%3A+Part+5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1021%2Fjm9000709&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9000709%26sid%3Dliteratum%253Aachs%26aulast%3DHattori%26aufirst%3DK.%26aulast%3DToda%26aufirst%3DS.%26aulast%3DImanishi%26aufirst%3DM.%26aulast%3DItou%26aufirst%3DS.%26aulast%3DNakajima%26aufirst%3DY.%26aulast%3DWashizuka%26aufirst%3DK.%26aulast%3DAraki%26aufirst%3DT.%26aulast%3DHamashima%26aufirst%3DH.%26aulast%3DTomishima%26aufirst%3DY.%26aulast%3DSakurai%26aufirst%3DM.%26aulast%3DMatsui%26aufirst%3DS.%26aulast%3DImamura%26aufirst%3DE.%26aulast%3DUeshima%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DN.%26aulast%3DIshikawa%26aufirst%3DH.%26aulast%3DNakano%26aufirst%3DK.%26aulast%3DUnami%26aufirst%3DN.%26aulast%3DHamada%26aufirst%3DK.%26aulast%3DMatsumura%26aufirst%3DY.%26aulast%3DTakamura%26aufirst%3DF.%26atitle%3DDiscovery%2520of%2520highly%2520potent%2520and%2520selective%2520biphenylacylsulfonamide-based%2520%25CE%25B23-adrenergic%2520receptor%2520agonists%2520and%2520evaluation%2520of%2520physical%2520properties%2520as%2520potential%2520overactive%2520bladder%2520therapies%253A%2520Part%25205%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D3063%26epage%3D3072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Uehling, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shearer, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donaldson, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chao, E. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deaton, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adkinson, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cariello, N. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faison, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lancaster, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milliken, T. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paulik, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherman, B. W</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugg, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowan, C.</span><span> </span><span class="NLM_article-title">Biarylamine phenethanolamines as potent and selective β<sub>3</sub>-adrenergic receptor agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">2758</span><span class="NLM_x">–</span> <span class="NLM_lpage">2771</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0509445" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=2758-2771&author=D.+E.+Uehlingauthor=B.+G.+Shearerauthor=K.+H.+Donaldsonauthor=E.+Y.+Chaoauthor=D.+N.+Deatonauthor=K.+K.+Adkinsonauthor=K.+K.+Brownauthor=N.+F.+Carielloauthor=W.+L.+Faisonauthor=M.+E.+Lancasterauthor=J.+Linauthor=R.+Hartauthor=T.+O.+Millikenauthor=M.+A.+Paulikauthor=B.+W+Shermanauthor=E.+E.+Suggauthor=C.+Cowan&title=Biarylamine+phenethanolamines+as+potent+and+selective+%CE%B23-adrenergic+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.1021%2Fjm0509445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0509445%26sid%3Dliteratum%253Aachs%26aulast%3DUehling%26aufirst%3DD.%2BE.%26aulast%3DShearer%26aufirst%3DB.%2BG.%26aulast%3DDonaldson%26aufirst%3DK.%2BH.%26aulast%3DChao%26aufirst%3DE.%2BY.%26aulast%3DDeaton%26aufirst%3DD.%2BN.%26aulast%3DAdkinson%26aufirst%3DK.%2BK.%26aulast%3DBrown%26aufirst%3DK.%2BK.%26aulast%3DCariello%26aufirst%3DN.%2BF.%26aulast%3DFaison%26aufirst%3DW.%2BL.%26aulast%3DLancaster%26aufirst%3DM.%2BE.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DHart%26aufirst%3DR.%26aulast%3DMilliken%26aufirst%3DT.%2BO.%26aulast%3DPaulik%26aufirst%3DM.%2BA.%26aulast%3DSherman%26aufirst%3DB.%2BW%26aulast%3DSugg%26aufirst%3DE.%2BE.%26aulast%3DCowan%26aufirst%3DC.%26atitle%3DBiarylamine%2520phenethanolamines%2520as%2520potent%2520and%2520selective%2520%25CE%25B23-adrenergic%2520receptor%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D2758%26epage%3D2771" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Stevens, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bloomquist, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borel, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Droste, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heiman, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kriauciunas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sall, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tinsley, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jesudason, C. D.</span><span> </span><span class="NLM_article-title">Potent oxindole based β<sub>3</sub>-adrenergic receptor agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">6270</span><span class="NLM_x">–</span> <span class="NLM_lpage">6273</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=6270-6273&author=F.+C.+Stevensauthor=W.+E.+Bloomquistauthor=A.+G.+Borelauthor=M.+L.+Cohenauthor=C.+A.+Drosteauthor=M.+L.+Heimanauthor=A.+Kriauciunasauthor=D.+Sallauthor=F.+C.+Tinsleyauthor=C.+D.+Jesudason&title=Potent+oxindole+based+%CE%B23-adrenergic+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStevens%26aufirst%3DF.%2BC.%26aulast%3DBloomquist%26aufirst%3DW.%2BE.%26aulast%3DBorel%26aufirst%3DA.%2BG.%26aulast%3DCohen%26aufirst%3DM.%2BL.%26aulast%3DDroste%26aufirst%3DC.%2BA.%26aulast%3DHeiman%26aufirst%3DM.%2BL.%26aulast%3DKriauciunas%26aufirst%3DA.%26aulast%3DSall%26aufirst%3DD.%26aulast%3DTinsley%26aufirst%3DF.%2BC.%26aulast%3DJesudason%26aufirst%3DC.%2BD.%26atitle%3DPotent%2520oxindole%2520based%2520%25CE%25B23-adrenergic%2520receptor%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D6270%26epage%3D6273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Harada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirokawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiyama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawashima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furutani, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, S.</span><span> </span><span class="NLM_article-title">Novel and potent human and rat β<sub>3</sub>-adrenergic receptor agonists containing substituted 3-indolylalkylamines</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1301</span><span class="NLM_x">–</span> <span class="NLM_lpage">1305</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10d&amp;dbid=16&amp;doi=10.1021%2Fjm4017224&amp;key=10.1016%2FS0960-894X%2803%2900073-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10d&amp;dbid=8&amp;doi=10.1021%2Fjm4017224&amp;key=12657269" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10d&amp;dbid=32&amp;doi=10.1021%2Fjm4017224&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitlKjsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=1301-1305&author=H.+Haradaauthor=Y.+Hirokawaauthor=K.+Suzukiauthor=Y.+Hiyamaauthor=M.+Oueauthor=H.+Kawashimaauthor=N.+Yoshidaauthor=Y.+Furutaniauthor=S.+Kato&title=Novel+and+potent+human+and+rat+%CE%B23-adrenergic+receptor+agonists+containing+substituted+3-indolylalkylamines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10dR"><div class="casContent"><span class="casTitleNuber">10d</span><div class="casTitle"><span class="NLM_cas:atitle">Novel and potent human and rat β3-adrenergic receptor agonists containing substituted 3-indolylalkylamines</span></div><div class="casAuthors">Harada, Hiroshi; Hirokawa, Yoshimi; Suzuki, Kenji; Hiyama, Yoichi; Oue, Mayumi; Kawashima, Hitoshi; Yoshida, Naoyuki; Furutani, Yasuji; Kato, Shiro</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1301-1305</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A novel series of 2-(3-indolyl)alkylamino-1-(3-chlorophenyl)ethanols was prepd. and evaluated for in vitro ability to stimulate cAMP prodn. in Chinese hamster ovary cells expressing cloned human β3-adrenergic receptor (AR).  The optically active I was found to be the most potent and selective human β3-AR agonist in this series with an EC50 value of 0.062 nM.  In addn., the selectivity of I for human β3-AR was 210-fold and 103-fold that for human β2-AR and β1-AR, resp.  Furthermore, I showed potent agonistic activity at rat β3-AR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpb82yaU63CvLVg90H21EOLACvtfcHk0lg87Ulv6XOiPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitlKjsLY%253D&md5=bcde23d92df0ac550f818744ce0ba613</span></div><a href="/servlet/linkout?suffix=cit10d&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2803%2900073-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252803%252900073-8%26sid%3Dliteratum%253Aachs%26aulast%3DHarada%26aufirst%3DH.%26aulast%3DHirokawa%26aufirst%3DY.%26aulast%3DSuzuki%26aufirst%3DK.%26aulast%3DHiyama%26aufirst%3DY.%26aulast%3DOue%26aufirst%3DM.%26aulast%3DKawashima%26aufirst%3DH.%26aulast%3DYoshida%26aufirst%3DN.%26aulast%3DFurutani%26aufirst%3DY.%26aulast%3DKato%26aufirst%3DS.%26atitle%3DNovel%2520and%2520potent%2520human%2520and%2520rat%2520%25CE%25B23-adrenergic%2520receptor%2520agonists%2520containing%2520substituted%25203-indolylalkylamines%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D1301%26epage%3D1305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Sum, F.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Largis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulvey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tillet, J.</span><span> </span><span class="NLM_article-title">Cyclic amine sulfonamides as linkers in the design and synthesis of β<sub>3</sub>-adrenergic receptor agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">2191</span><span class="NLM_x">–</span> <span class="NLM_lpage">2194</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=2191-2194&author=F.-W.+Sumauthor=V.+Wongauthor=S.+Hanauthor=E.+Largisauthor=R.+Mulveyauthor=J.+Tillet&title=Cyclic+amine+sulfonamides+as+linkers+in+the+design+and+synthesis+of+%CE%B23-adrenergic+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSum%26aufirst%3DF.-W.%26aulast%3DWong%26aufirst%3DV.%26aulast%3DHan%26aufirst%3DS.%26aulast%3DLargis%26aufirst%3DE.%26aulast%3DMulvey%26aufirst%3DR.%26aulast%3DTillet%26aufirst%3DJ.%26atitle%3DCyclic%2520amine%2520sulfonamides%2520as%2520linkers%2520in%2520the%2520design%2520and%2520synthesis%2520of%2520%25CE%25B23-adrenergic%2520receptor%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D2191%26epage%3D2194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Maruyama, T.; Suzuki, T.; Onda, K.; Hayakawa, M.; Morimoto, H.; Kimizuka, T.; Matsui, T.</span><span> </span><span class="NLM_article-title">Preparation of amides as antidiabetics</span>. WO 199920607,<span class="NLM_x"> </span><span class="NLM_year">1999</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1999&author=T.+Maruyama&author=T.+Suzuki&author=K.+Onda&author=M.+Hayakawa&author=H.+Morimoto&author=T.+Kimizuka&author=T.+Matsui&title=Preparation+of+amides+as+antidiabetics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMaruyama%26aufirst%3DT.%26atitle%3DPreparation%2520of%2520amides%2520as%2520antidiabetics%26date%3D1999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Donaldson, K. H.; Shearer, B. G.; Uehling, D. E.</span><span> </span><span class="NLM_article-title">Therapeutic biayrl derivatives useful as beta-3 adrenoreceptor agonists</span>. WO 199965877,<span class="NLM_x"> </span><span class="NLM_year">1999</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1999&author=K.+H.+Donaldson&author=B.+G.+Shearer&author=D.+E.+Uehling&title=Therapeutic+biayrl+derivatives+useful+as+beta-3+adrenoreceptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDonaldson%26aufirst%3DK.%2BH.%26atitle%3DTherapeutic%2520biayrl%2520derivatives%2520useful%2520as%2520beta-3%2520adrenoreceptor%2520agonists%26date%3D1999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Mathvink, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolman, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chitty, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Candelore, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cascieri, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colwell, L. F.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feeny, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forrest, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hom, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacIntyre, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stearns, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tota, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyvratt, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, A. E.</span><span> </span><span class="NLM_article-title">Discovery of a potent, orally bioavailable β<sub>3</sub> adrenergic receptor agonist, (<i>R</i>)-<i>N</i>-[4-[2-[[2-hydroxy-2-(3-pyridinyl)ethyl]amino]ethyl]phenyl]-4-[4-[4-(trifluoromethyl)phenyl]thiazol-2-yl]benzenesulfonamide</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">3832</span><span class="NLM_x">–</span> <span class="NLM_lpage">3836</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm000286i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=3832-3836&author=R.+J.+Mathvinkauthor=J.+S.+Tolmanauthor=D.+Chittyauthor=M.+R.+Candeloreauthor=M.+A.+Cascieriauthor=L.+F.+Colwellauthor=L.+Dengauthor=W.+P.+Feenyauthor=M.+J.+Forrestauthor=G.+J.+Homauthor=D.+E.+MacIntyreauthor=R.+R.+Millerauthor=R.+A.+Stearnsauthor=L.+Totaauthor=M.+J.+Wyvrattauthor=M.+H.+Fisherauthor=A.+E.+Weber&title=Discovery+of+a+potent%2C+orally+bioavailable+%CE%B23+adrenergic+receptor+agonist%2C+%28R%29-N-%5B4-%5B2-%5B%5B2-hydroxy-2-%283-pyridinyl%29ethyl%5Damino%5Dethyl%5Dphenyl%5D-4-%5B4-%5B4-%28trifluoromethyl%29phenyl%5Dthiazol-2-yl%5Dbenzenesulfonamide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm000286i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000286i%26sid%3Dliteratum%253Aachs%26aulast%3DMathvink%26aufirst%3DR.%2BJ.%26aulast%3DTolman%26aufirst%3DJ.%2BS.%26aulast%3DChitty%26aufirst%3DD.%26aulast%3DCandelore%26aufirst%3DM.%2BR.%26aulast%3DCascieri%26aufirst%3DM.%2BA.%26aulast%3DColwell%26aufirst%3DL.%2BF.%26aulast%3DDeng%26aufirst%3DL.%26aulast%3DFeeny%26aufirst%3DW.%2BP.%26aulast%3DForrest%26aufirst%3DM.%2BJ.%26aulast%3DHom%26aufirst%3DG.%2BJ.%26aulast%3DMacIntyre%26aufirst%3DD.%2BE.%26aulast%3DMiller%26aufirst%3DR.%2BR.%26aulast%3DStearns%26aufirst%3DR.%2BA.%26aulast%3DTota%26aufirst%3DL.%26aulast%3DWyvratt%26aufirst%3DM.%2BJ.%26aulast%3DFisher%26aufirst%3DM.%2BH.%26aulast%3DWeber%26aufirst%3DA.%2BE.%26atitle%3DDiscovery%2520of%2520a%2520potent%252C%2520orally%2520bioavailable%2520%25CE%25B23%2520adrenergic%2520receptor%2520agonist%252C%2520%2528R%2529-N-%255B4-%255B2-%255B%255B2-hydroxy-2-%25283-pyridinyl%2529ethyl%255Damino%255Dethyl%255Dphenyl%255D-4-%255B4-%255B4-%2528trifluoromethyl%2529phenyl%255Dthiazol-2-yl%255Dbenzenesulfonamide%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D3832%26epage%3D3836" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Tang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stearns, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ngui, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathvink, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwei, G. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strauss, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doss, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiu, S-H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baillie, T. A.</span><span> </span><span class="NLM_article-title">Metabolism of a thiazole benzenesulfonamide derivative, a potent and selective agonist of the human β<sub>3</sub>-adrenergic receptor, in rats: identification of a novel isethionic acid conjugate</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">778</span><span class="NLM_x">–</span> <span class="NLM_lpage">787</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2002&pages=778-787&author=W.+Tangauthor=R.+A.+Stearnsauthor=R.+R.+Millerauthor=J.+S.+Nguiauthor=R.+J.+Mathvinkauthor=A.+E.+Weberauthor=G.+Y.+Kweiauthor=J.+R.+Straussauthor=C.+A.+Keohaneauthor=G.+A.+Dossauthor=S-H.+L.+Chiuauthor=T.+A.+Baillie&title=Metabolism+of+a+thiazole+benzenesulfonamide+derivative%2C+a+potent+and+selective+agonist+of+the+human+%CE%B23-adrenergic+receptor%2C+in+rats%3A+identification+of+a+novel+isethionic+acid+conjugate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DW.%26aulast%3DStearns%26aufirst%3DR.%2BA.%26aulast%3DMiller%26aufirst%3DR.%2BR.%26aulast%3DNgui%26aufirst%3DJ.%2BS.%26aulast%3DMathvink%26aufirst%3DR.%2BJ.%26aulast%3DWeber%26aufirst%3DA.%2BE.%26aulast%3DKwei%26aufirst%3DG.%2BY.%26aulast%3DStrauss%26aufirst%3DJ.%2BR.%26aulast%3DKeohane%26aufirst%3DC.%2BA.%26aulast%3DDoss%26aufirst%3DG.%2BA.%26aulast%3DChiu%26aufirst%3DS-H.%2BL.%26aulast%3DBaillie%26aufirst%3DT.%2BA.%26atitle%3DMetabolism%2520of%2520a%2520thiazole%2520benzenesulfonamide%2520derivative%252C%2520a%2520potent%2520and%2520selective%2520agonist%2520of%2520the%2520human%2520%25CE%25B23-adrenergic%2520receptor%252C%2520in%2520rats%253A%2520identification%2520of%2520a%2520novel%2520isethionic%2520acid%2520conjugate%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2002%26volume%3D30%26spage%3D778%26epage%3D787" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Morriello, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wendt, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bansel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Salvo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feighner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurley, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hreniuk, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salituro, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galloway, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGettigan, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laws, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKnight, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doss, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsou, N. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ball, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanfiz, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Streckfuss, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Struthers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edmondson, S. D.</span><span> </span><span class="NLM_article-title">Design of a novel pyrrolidine scaffold utilized in the discovery of potent and selective human β<sub>3</sub> adrenergic receptor agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1865</span><span class="NLM_x">–</span> <span class="NLM_lpage">1870</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=1865-1870&author=G.+J.+Morrielloauthor=H.+R.+Wendtauthor=A.+Banselauthor=J.+Di+Salvoauthor=S.+Feighnerauthor=J.+Heauthor=A.+L.+Hurleyauthor=D.+L.+Hreniukauthor=G.+M.+Salituroauthor=M.+V.+Reddyauthor=S.+M.+Gallowayauthor=K.+K.+McGettiganauthor=G.+Lawsauthor=C.+McKnightauthor=G.+A.+Dossauthor=N.+N.+Tsouauthor=R.+M.+Blackauthor=J.+Morrisauthor=R.+G.+Ballauthor=A.+T.+Sanfizauthor=E.+Streckfussauthor=M.+Struthersauthor=S.+D.+Edmondson&title=Design+of+a+novel+pyrrolidine+scaffold+utilized+in+the+discovery+of+potent+and+selective+human+%CE%B23+adrenergic+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMorriello%26aufirst%3DG.%2BJ.%26aulast%3DWendt%26aufirst%3DH.%2BR.%26aulast%3DBansel%26aufirst%3DA.%26aulast%3DDi%2BSalvo%26aufirst%3DJ.%26aulast%3DFeighner%26aufirst%3DS.%26aulast%3DHe%26aufirst%3DJ.%26aulast%3DHurley%26aufirst%3DA.%2BL.%26aulast%3DHreniuk%26aufirst%3DD.%2BL.%26aulast%3DSalituro%26aufirst%3DG.%2BM.%26aulast%3DReddy%26aufirst%3DM.%2BV.%26aulast%3DGalloway%26aufirst%3DS.%2BM.%26aulast%3DMcGettigan%26aufirst%3DK.%2BK.%26aulast%3DLaws%26aufirst%3DG.%26aulast%3DMcKnight%26aufirst%3DC.%26aulast%3DDoss%26aufirst%3DG.%2BA.%26aulast%3DTsou%26aufirst%3DN.%2BN.%26aulast%3DBlack%26aufirst%3DR.%2BM.%26aulast%3DMorris%26aufirst%3DJ.%26aulast%3DBall%26aufirst%3DR.%2BG.%26aulast%3DSanfiz%26aufirst%3DA.%2BT.%26aulast%3DStreckfuss%26aufirst%3DE.%26aulast%3DStruthers%26aufirst%3DM.%26aulast%3DEdmondson%26aufirst%3DS.%2BD.%26atitle%3DDesign%2520of%2520a%2520novel%2520pyrrolidine%2520scaffold%2520utilized%2520in%2520the%2520discovery%2520of%2520potent%2520and%2520selective%2520human%2520%25CE%25B23%2520adrenergic%2520receptor%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D1865%26epage%3D1870" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Goble, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howell, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bansal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger., R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brockunier, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiSalvo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feighner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harper, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurley, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hreniuk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parmee, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robbins, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salituro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanfiz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Streckfuss, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watkins, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Struthers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edmondson, S. D.</span><span> </span><span class="NLM_article-title">Heterocyclic acetamide and benzamide derivatives as potent and selective β<sub>3</sub>-adrenergic receptor agonists with improved rodent pharmacokinetic profiles</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1895</span><span class="NLM_x">–</span> <span class="NLM_lpage">1899</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1895-1899&author=S.+D.+Gobleauthor=L.+Wangauthor=K.+L.+Howellauthor=A.+Bansalauthor=R.+Berger.author=L.+Brockunierauthor=J.+DiSalvoauthor=S.+Feighnerauthor=B.+Harperauthor=J.+Heauthor=A.+Hurleyauthor=D.+Hreniukauthor=E.+Parmeeauthor=M.+Robbinsauthor=G.+Salituroauthor=A.+Sanfizauthor=E.+Streckfussauthor=E.+Watkinsauthor=A.+E.+Weberauthor=M.+Struthersauthor=S.+D.+Edmondson&title=Heterocyclic+acetamide+and+benzamide+derivatives+as+potent+and+selective+%CE%B23-adrenergic+receptor+agonists+with+improved+rodent+pharmacokinetic+profiles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGoble%26aufirst%3DS.%2BD.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DHowell%26aufirst%3DK.%2BL.%26aulast%3DBansal%26aufirst%3DA.%26aulast%3DBerger.%26aufirst%3DR.%26aulast%3DBrockunier%26aufirst%3DL.%26aulast%3DDiSalvo%26aufirst%3DJ.%26aulast%3DFeighner%26aufirst%3DS.%26aulast%3DHarper%26aufirst%3DB.%26aulast%3DHe%26aufirst%3DJ.%26aulast%3DHurley%26aufirst%3DA.%26aulast%3DHreniuk%26aufirst%3DD.%26aulast%3DParmee%26aufirst%3DE.%26aulast%3DRobbins%26aufirst%3DM.%26aulast%3DSalituro%26aufirst%3DG.%26aulast%3DSanfiz%26aufirst%3DA.%26aulast%3DStreckfuss%26aufirst%3DE.%26aulast%3DWatkins%26aufirst%3DE.%26aulast%3DWeber%26aufirst%3DA.%2BE.%26aulast%3DStruthers%26aufirst%3DM.%26aulast%3DEdmondson%26aufirst%3DS.%2BD.%26atitle%3DHeterocyclic%2520acetamide%2520and%2520benzamide%2520derivatives%2520as%2520potent%2520and%2520selective%2520%25CE%25B23-adrenergic%2520receptor%2520agonists%2520with%2520improved%2520rodent%2520pharmacokinetic%2520profiles%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D1895%26epage%3D1899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Svendson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boll, P. M.</span><span> </span><span class="NLM_article-title">Naturally occurring lactones and lactames-V</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">4251</span><span class="NLM_x">–</span> <span class="NLM_lpage">4258</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1973&pages=4251-4258&author=A.+Svendsonauthor=P.+M.+Boll&title=Naturally+occurring+lactones+and+lactames-V"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSvendson%26aufirst%3DA.%26aulast%3DBoll%26aufirst%3DP.%2BM.%26atitle%3DNaturally%2520occurring%2520lactones%2520and%2520lactames-V%26jtitle%3DTetrahedron%26date%3D1973%26volume%3D29%26spage%3D4251%26epage%3D4258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Evans, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tedrow, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Downey, C. W.</span><span> </span><span class="NLM_article-title">Diastereoselective magnesium halide-catalyzed anti-aldol reactions of chiral <i>N</i>-acyloxazolidinones</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">124</span><span class="NLM_x">, </span> <span class="NLM_fpage">392</span><span class="NLM_x">–</span> <span class="NLM_lpage">393</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja0119548" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2002&pages=392-393&author=D.+A.+Evansauthor=J.+S.+Tedrowauthor=J.+T.+Shawauthor=C.+W.+Downey&title=Diastereoselective+magnesium+halide-catalyzed+anti-aldol+reactions+of+chiral+N-acyloxazolidinones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fja0119548&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0119548%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DD.%2BA.%26aulast%3DTedrow%26aufirst%3DJ.%2BS.%26aulast%3DShaw%26aufirst%3DJ.%2BT.%26aulast%3DDowney%26aufirst%3DC.%2BW.%26atitle%3DDiastereoselective%2520magnesium%2520halide-catalyzed%2520anti-aldol%2520reactions%2520of%2520chiral%2520N-acyloxazolidinones%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2002%26volume%3D124%26spage%3D392%26epage%3D393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Suzuki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kambe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokuyama, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuyama, T.</span><span> </span><span class="NLM_article-title">Enantioselective total synthesis of FR900482</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">2831</span><span class="NLM_x">–</span> <span class="NLM_lpage">2843</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo049862z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2004&pages=2831-2843&author=M.+Suzukiauthor=M.+Kambeauthor=H.+Tokuyamaauthor=T.+Fukuyama&title=Enantioselective+total+synthesis+of+FR900482"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjo049862z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo049862z%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DM.%26aulast%3DKambe%26aufirst%3DM.%26aulast%3DTokuyama%26aufirst%3DH.%26aulast%3DFukuyama%26aufirst%3DT.%26atitle%3DEnantioselective%2520total%2520synthesis%2520of%2520FR900482%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2004%26volume%3D69%26spage%3D2831%26epage%3D2843" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><div class="note"><p class="first last">The reason for comparing β<sub>3</sub>-AR EC<sub>50</sub>s and β<sub>1</sub>-AR and β<sub>2</sub>-AR IC<sub>50</sub>s as an assessment of selectivity is described in</p></div><span class="NLM_contrib-group">Mathvink, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolman, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chitty, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Candelore, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cascieri, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colwell, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feeney, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forrest, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hom, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacIntyre, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tota, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyvratt, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber., A. E.</span><span> </span><span class="NLM_article-title">Potent, selective 3-pyridylethanoloamine β<sub>3</sub> adrenergic receptor agonists possessing a thiazole benzenesulfonamide pharmacophore</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1971</span><span class="NLM_x">–</span> <span class="NLM_lpage">1973</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2000&pages=1971-1973&author=R.+J.+Mathvinkauthor=J.+S.+Tolmanauthor=D.+Chittyauthor=M.+R.+Candeloreauthor=M.+A.+Cascieriauthor=L.+F.+Colwellauthor=L.+Dengauthor=W.+P.+Feeneyauthor=M.+J.+Forrestauthor=G.+J.+Homauthor=E.+MacIntyreauthor=L.+Totaauthor=M.+J.+Wyvrattauthor=M.+H.+Fisherauthor=A.+E.+Weber.&title=Potent%2C+selective+3-pyridylethanoloamine+%CE%B23+adrenergic+receptor+agonists+possessing+a+thiazole+benzenesulfonamide+pharmacophore"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMathvink%26aufirst%3DR.%2BJ.%26aulast%3DTolman%26aufirst%3DJ.%2BS.%26aulast%3DChitty%26aufirst%3DD.%26aulast%3DCandelore%26aufirst%3DM.%2BR.%26aulast%3DCascieri%26aufirst%3DM.%2BA.%26aulast%3DColwell%26aufirst%3DL.%2BF.%26aulast%3DDeng%26aufirst%3DL.%26aulast%3DFeeney%26aufirst%3DW.%2BP.%26aulast%3DForrest%26aufirst%3DM.%2BJ.%26aulast%3DHom%26aufirst%3DG.%2BJ.%26aulast%3DMacIntyre%26aufirst%3DE.%26aulast%3DTota%26aufirst%3DL.%26aulast%3DWyvratt%26aufirst%3DM.%2BJ.%26aulast%3DFisher%26aufirst%3DM.%2BH.%26aulast%3DWeber.%26aufirst%3DA.%2BE.%26atitle%3DPotent%252C%2520selective%25203-pyridylethanoloamine%2520%25CE%25B23%2520adrenergic%2520receptor%2520agonists%2520possessing%2520a%2520thiazole%2520benzenesulfonamide%2520pharmacophore%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2000%26volume%3D10%26spage%3D1971%26epage%3D1973" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Driscoll, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shepard, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soglia, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atherton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mutlib, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munchhof, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiter, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doty, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trevena, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ripp, S. L.</span><span> </span><span class="NLM_article-title">A rational chemical intervention strategy to circumvent bioactivation liabilities associated with a nonpeptidyl thrombopoietin receptor agonist containing a 2-amino-4-arylthiazole motif</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1954</span><span class="NLM_x">–</span> <span class="NLM_lpage">1965</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx700270r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm4017224&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFKhtbfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2007&pages=1954-1965&author=A.+S.+Kalgutkarauthor=J.+Driscollauthor=S.+X.+Zhaoauthor=G.+S.+Walkerauthor=R.+M.+Shepardauthor=J.+R.+Sogliaauthor=J.+Athertonauthor=L.+Yuauthor=A.+E.+Mutlibauthor=M.+J.+Munchhofauthor=L.+A.+Reiterauthor=C.+S.+Jonesauthor=J.+L.+Dotyauthor=K.+A.+Trevenaauthor=C.+L.+Shafferauthor=S.+L.+Ripp&title=A+rational+chemical+intervention+strategy+to+circumvent+bioactivation+liabilities+associated+with+a+nonpeptidyl+thrombopoietin+receptor+agonist+containing+a+2-amino-4-arylthiazole+motif"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">A rational chemical intervention strategy to circumvent bioactivation liabilities associated with a nonpeptidyl thrombopoietin receptor agonist containing a 2-amino-4-arylthiazole motif</span></div><div class="casAuthors">Kalgutkar, Amit S.; Driscoll, James; Zhao, Sabrina X.; Walker, Gregory S.; Shepard, Richard M.; Soglia, John R.; Atherton, James; Yu, Linning; Mutlib, Abdul E.; Munchhof, Michael J.; Reiter, Lawrence A.; Jones, Christopher S.; Doty, Johnathan L.; Trevena, Kristen A.; Shaffer, Christopher L.; Ripp, Sharon L.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1954-1965</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The current study examd. the bioactivation potential of a nonpeptidyl thrombopoietin receptor agonist, 1-(3-chloro-5-((4-(4-fluoro-3-(trifluoromethyl)phenyl)thiazol-2-yl)carbamoyl)pyridine-2-yl)piperidine-4-carboxylic acid (1), contg. a 2-carboxamido-4-arylthiazole moiety in the core structure.  Toxicol. risks arising from P 450-catalyzed C4-C5 thiazole ring opening in 1 via the epoxidn. diol sequence were alleviated, since mass spectrometric anal. of human liver microsome and/or hepatocyte incubations of 1 did not reveal the formation of reactive acylthiourea and/or glyoxal metabolites, which are prototypic products derived from thiazole ring scission.  However, 4-(4-fluoro-3-(trifluoromethyl)phenyl)thiazol-2-amine (2), the product of hydrolysis of 1 in human liver microsomes, hepatocytes, and plasma, underwent oxidative bioactivation in human liver microsomes, since trapping studies with glutathione led to the formation of two conjugates derived from the addn. of the thiol nucleophile to 2 and a thiazole-S-oxide metabolite of 2.  Mass spectral fragmentation and NMR anal. indicated that the site of attachment of the glutathionyl moiety in both conjugates was the C5 position in the thiazole ring.  Based on the structures of the glutathione conjugates, two bioactivation pathways are proposed, one involving β-elimination of an initially formed hydroxylamine metabolite and the other involving direct two-electron oxidn. of the electron-rich 2-aminothiazole system to electrophilic intermediates.  This mechanistic insight into the bioactivation process allowed the development of a rational chem. intervention strategy that involved blocking the C5 position with a fluorine atom or replacing the thiazole ring with a 1,2,4-thiadiazole group.  These structural changes not only abrogated the bioactivation liability assocd. with 1 but also resulted in compds. that retained the attractive pharmacol. and pharmacokinetic attributes of the prototype agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxi1Bp9ve-TLVg90H21EOLACvtfcHk0ljhL0in061mRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFKhtbfM&md5=97c144c6d3c621dcef18a76b63f1806e</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Ftx700270r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx700270r%26sid%3Dliteratum%253Aachs%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DDriscoll%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DS.%2BX.%26aulast%3DWalker%26aufirst%3DG.%2BS.%26aulast%3DShepard%26aufirst%3DR.%2BM.%26aulast%3DSoglia%26aufirst%3DJ.%2BR.%26aulast%3DAtherton%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DL.%26aulast%3DMutlib%26aufirst%3DA.%2BE.%26aulast%3DMunchhof%26aufirst%3DM.%2BJ.%26aulast%3DReiter%26aufirst%3DL.%2BA.%26aulast%3DJones%26aufirst%3DC.%2BS.%26aulast%3DDoty%26aufirst%3DJ.%2BL.%26aulast%3DTrevena%26aufirst%3DK.%2BA.%26aulast%3DShaffer%26aufirst%3DC.%2BL.%26aulast%3DRipp%26aufirst%3DS.%2BL.%26atitle%3DA%2520rational%2520chemical%2520intervention%2520strategy%2520to%2520circumvent%2520bioactivation%2520liabilities%2520associated%2520with%2520a%2520nonpeptidyl%2520thrombopoietin%2520receptor%2520agonist%2520containing%2520a%25202-amino-4-arylthiazole%2520motif%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2007%26volume%3D20%26spage%3D1954%26epage%3D1965" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lynch, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stupienski, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baskin, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beare, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appleby, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salata, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jurkiewicz, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanguinetti, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stein, R. B.</span><span> </span><span class="NLM_article-title">Cardiac electrophysiologic and antiarrhythmic actions of two long-acting spirobenzopyran piperidine class III agents, L-702,958 and L-706,000 [MK-499]</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">269</span><span class="NLM_x">, </span> <span class="NLM_fpage">541</span><span class="NLM_x">–</span> <span class="NLM_lpage">554</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=8&amp;doi=10.1021%2Fjm4017224&amp;key=7802864" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=32&amp;doi=10.1021%2Fjm4017224&amp;key=1%3ACAS%3A528%3ADyaK2cXkt1KmtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=269&publication_year=1994&pages=541-554&author=J.+J.+Lynchauthor=A.+A.+Wallaceauthor=R.+F.+Stupienskiauthor=E.+P.+Baskinauthor=C.+M.+Beareauthor=S.+D.+Applebyauthor=J.+J.+Salataauthor=N.+K.+Jurkiewiczauthor=M.+C.+Sanguinettiauthor=R.+B.+Stein&title=Cardiac+electrophysiologic+and+antiarrhythmic+actions+of+two+long-acting+spirobenzopyran+piperidine+class+III+agents%2C+L-702%2C958+and+L-706%2C000+%5BMK-499%5D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22aR"><div class="casContent"><span class="casTitleNuber">22a</span><div class="casTitle"><span class="NLM_cas:atitle">Cardiac electrophysiologic and antiarrhythmic actions of two long-acting spirobenzopyran piperidine class III agents, L-702,958 and L-706,000 [MK-499]</span></div><div class="casAuthors">Lynch, Joseph J., Jr.; Wallace, Audrey A.; Stupienski, Raymond F., III; Baskin, Elizabeth P.; Beare, Carolann M.; Appleby, Sandra D.; Salata, Joseph J.; Jurkiewicz, Nancy K.; Sanguinetti, Michael; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">269</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">541-54</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">The cardiac electrophysiol. and antiarrhythmic actions of two Class III ketone- and alc.-contg. spirobenzopyran piperidine analogs, L-702,958 and L-706,000 [MK-499], resp., were assessed in vitro and in vivo.  L-702,958 and L-706,000 [MK-499] selectively blocked the rapidly activating component of the delayed rectifier K+ current in guinea pig isolated ventricular myocytes (IC50 values, 14.6 and 43.9 nM, resp.), and prolonged effective refractory period in ferret isolated papillary muscles (EC25 values, 10.5 and 53.8 nM, resp.).  In anesthetized dogs, L-702,958 and L-706,000 [MK-499] increased ventricular refractory periods (ED20 values, 3.3 and 9.2 μg/kg i.v., resp.) and concomitantly increased ECG QT interval and left ventricular + dP/dt.  Cumulative i.v. administrations of ≤100 μg/kg of L-702,958 and 300 μg/kg L-706,000 [MK-499] in anesthetized dogs increased atrial and ventricular refractoriness and prolonged the ECG QT interval, but did not alter atrial, atrioventricular nodal, His-Purkinje or ventricular conduction indexes.  In anesthetized dogs studied chronically (9.2 days) after anterior myocardial infarction, the cumulative i.v. administrations of 100 μg/kg of L-702,958 and 300 μg/kg L-706,000 [MK-499] suppressed the induction of ventricular tachyarrhythmia by programmed ventricular stimulation (suppression rates: 8 of 10, 80% and 9 of 11, 82%, resp.) and reduced the incidence of lethal ventricular arrhythmias (incidences of lethal ischemic arrhythmias: 4 of 10, 40% and 1 of 11 9%, resp., compared to 34 of 40, 85%, in vehicle controls).  L-702,958 and L-706,000 [MK-499] (cumulative 100 and 300 μg/kg i.v., resp.) did not facilitate the induction of arrhythmias by programmed ventricular stimulation in postinfarction dogs.  After equivalently effective p.o. doses in conscious dogs, L-702,958 (10 μg/kg) and L-706,000 [MK-499] (30 μg/kg) increased ECG QT interval with long durations of action of approx. 9 and 14 h, resp.  L-706,000 [MK-499] elicited a more consistent and sustained prolongation of the QT interval than L-702,958.  These findings show that both L-702,958 and L-706,000 [MK-499] are potentially useful agents for the prevention of malignant ventricular arrhythmias in the setting of myocardial ischemic injury.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoodlHaDa4-FrVg90H21EOLACvtfcHk0lhX3JkG-I9TFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXkt1KmtLY%253D&md5=b13505c41ffd30d723860c4b9e13dfb8</span></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLynch%26aufirst%3DJ.%2BJ.%26aulast%3DWallace%26aufirst%3DA.%2BA.%26aulast%3DStupienski%26aufirst%3DR.%2BF.%26aulast%3DBaskin%26aufirst%3DE.%2BP.%26aulast%3DBeare%26aufirst%3DC.%2BM.%26aulast%3DAppleby%26aufirst%3DS.%2BD.%26aulast%3DSalata%26aufirst%3DJ.%2BJ.%26aulast%3DJurkiewicz%26aufirst%3DN.%2BK.%26aulast%3DSanguinetti%26aufirst%3DM.%2BC.%26aulast%3DStein%26aufirst%3DR.%2BB.%26atitle%3DCardiac%2520electrophysiologic%2520and%2520antiarrhythmic%2520actions%2520of%2520two%2520long-acting%2520spirobenzopyran%2520piperidine%2520class%2520III%2520agents%252C%2520L-702%252C958%2520and%2520L-706%252C000%2520%255BMK-499%255D%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1994%26volume%3D269%26spage%3D541%26epage%3D554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit22b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Schoemaker, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hicks, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langer, S.</span><span> </span><span class="NLM_article-title">Calcium Channel Receptor Binding Studies for Diltiazem and Its Major Metabolites: Functional Correlation to Inhibition of Portal Vein Myogenic Activity</span> <span class="citation_source-journal">J. Cardiovasc. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">173</span><span class="NLM_x">–</span> <span class="NLM_lpage">180</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1987&pages=173-180&author=H.+Schoemakerauthor=P.+Hicksauthor=S.+Langer&title=Calcium+Channel+Receptor+Binding+Studies+for+Diltiazem+and+Its+Major+Metabolites%3A+Functional+Correlation+to+Inhibition+of+Portal+Vein+Myogenic+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchoemaker%26aufirst%3DH.%26aulast%3DHicks%26aufirst%3DP.%26aulast%3DLanger%26aufirst%3DS.%26atitle%3DCalcium%2520Channel%2520Receptor%2520Binding%2520Studies%2520for%2520Diltiazem%2520and%2520Its%2520Major%2520Metabolites%253A%2520Functional%2520Correlation%2520to%2520Inhibition%2520of%2520Portal%2520Vein%2520Myogenic%2520Activity%26jtitle%3DJ.%2520Cardiovasc.%2520Pharmacol.%26date%3D1987%26volume%3D9%26spage%3D173%26epage%3D180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit22c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Hartmann, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiedeman, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirsh, G. E.</span><span> </span><span class="NLM_article-title">Effects of III–IV Linker Mutations on Human Heart Na<sup>+</sup> Channel Inactivation Gating</span> <span class="citation_source-journal">Circ. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">114</span><span class="NLM_x">–</span> <span class="NLM_lpage">122</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=1994&pages=114-122&author=H.+A.+Hartmannauthor=A.+A.+Tiedemanauthor=S.+F.+Chenauthor=A.+M.+Brownauthor=G.+E.+Kirsh&title=Effects+of+III%E2%80%93IV+Linker+Mutations+on+Human+Heart+Na%2B+Channel+Inactivation+Gating"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHartmann%26aufirst%3DH.%2BA.%26aulast%3DTiedeman%26aufirst%3DA.%2BA.%26aulast%3DChen%26aufirst%3DS.%2BF.%26aulast%3DBrown%26aufirst%3DA.%2BM.%26aulast%3DKirsh%26aufirst%3DG.%2BE.%26atitle%3DEffects%2520of%2520III%25E2%2580%2593IV%2520Linker%2520Mutations%2520on%2520Human%2520Heart%2520Na%252B%2520Channel%2520Inactivation%2520Gating%26jtitle%3DCirc.%2520Res.%26date%3D1994%26volume%3D75%26spage%3D114%26epage%3D122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Takusagawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ushigome, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerbusch, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyashita, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwatsubo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Usui, T.</span><span> </span><span class="NLM_article-title">Intestinal Absorption Mechanism of Mirabegron, a Potent and Selective β<sub>3</sub>-Adrenoreceptor Agonist: Involvement of Human Efflux and/or Influx Transport Systems</span> <span class="citation_source-journal">Mol. Pharmaceutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1783</span><span class="NLM_x">–</span> <span class="NLM_lpage">1794</span></span><div class="citationLinks">[<a href="/doi/10.1021/mp300582s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm4017224&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlsVeqs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2013&pages=1783-1794&author=S.+Takusagawaauthor=F.+Ushigomeauthor=H.+Nemotoauthor=Y.+Takahashiauthor=Q.+Liauthor=V.+Kerbuschauthor=A.+Miyashitaauthor=T.+Iwatsuboauthor=T.+Usui&title=Intestinal+Absorption+Mechanism+of+Mirabegron%2C+a+Potent+and+Selective+%CE%B23-Adrenoreceptor+Agonist%3A+Involvement+of+Human+Efflux+and%2For+Influx+Transport+Systems"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Intestinal Absorption Mechanism of Mirabegron, a Potent and Selective β3-Adrenoceptor Agonist: Involvement of Human Efflux and/or Influx Transport Systems</span></div><div class="casAuthors">Takusagawa, Shin; Ushigome, Fumihiko; Nemoto, Hiroyuki; Takahashi, Yutaka; Li, Qun; Kerbusch, Virginie; Miyashita, Aiji; Iwatsubo, Takafumi; Usui, Takashi</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1783-1794</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mirabegron, a weak-basic compd., is a potent and selective β3-adrenoceptor agonist for the treatment of overactive bladder.  Mirabegron extended release formulation shows dose-dependent oral bioavailability in humans, which is likely attributable to satn. of intestinal efflux abilities leading to higher absorption with higher doses.  This study evaluated the membrane permeability of mirabegron and investigated the involvement of human intestinal transport proteins in the membrane permeation of mirabegron.  Transcellular transport and cellular/vesicular uptake assays were performed using Caco-2 cells and/or human intestinal efflux (P-glycoprotein [P-gp], breast cancer resistance protein [BCRP], and multidrug resistance assocd. protein 2 [MRP2]) and influx (peptide transporter 1 [PEPT1], OATP1A2, and OATP2B1) transporter-expressing cells, vesicles, or Xenopus laevis oocytes.  The absorptive permeability coeffs. of mirabegron in Caco-2 cells (1.68-1.83 × 10-6 cm/s) at the apical and basal pH of 6.5 and 7.4, resp., were slightly higher than those of nadolol (0.97-1.41 × 10-6 cm/s), a low permeability ref. std., but lower than those of metoprolol and propranolol (both ranged from 8.49 to 11.6 × 10-6 cm/s), low/high permeability boundary ref. stds.  Increasing buffer pH at the apical side from 5.5 to 8.0 gradually increased the absorptive permeation of mirabegron from 0.226 to 1.66 × 10-6 cm/s, but was still less than the value in the opposite direction (11.0-14.2 × 10-6 cm/s).  The time- and concn.-dependent transport of mirabegron was obsd. in P-gp-expressing cells and OATP1A2-expressing oocytes with apparent Km values of 294 and 8.59 μM, resp.  In contrast, no clear BCRP-, MRP2-, PEPT1-, or OATP2B1-mediated uptake of mirabegron was obsd. in their expressing vesicles or cells.  These findings suggest that mirabegron has low-to-moderate membrane permeability and P-gp is likely to be involved in its efflux into the lumen in the intestinal absorption process.  The results also suggest that mirabegron could possibly be transported by intestinal influx transporters as well as simple diffusion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3wX4ewFwIjLVg90H21EOLACvtfcHk0lhX3JkG-I9TFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlsVeqs7w%253D&md5=6ad3db6d889826db00eb7296a4b3d22b</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fmp300582s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp300582s%26sid%3Dliteratum%253Aachs%26aulast%3DTakusagawa%26aufirst%3DS.%26aulast%3DUshigome%26aufirst%3DF.%26aulast%3DNemoto%26aufirst%3DH.%26aulast%3DTakahashi%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DKerbusch%26aufirst%3DV.%26aulast%3DMiyashita%26aufirst%3DA.%26aulast%3DIwatsubo%26aufirst%3DT.%26aulast%3DUsui%26aufirst%3DT.%26atitle%3DIntestinal%2520Absorption%2520Mechanism%2520of%2520Mirabegron%252C%2520a%2520Potent%2520and%2520Selective%2520%25CE%25B23-Adrenoreceptor%2520Agonist%253A%2520Involvement%2520of%2520Human%2520Efflux%2520and%252For%2520Influx%2520Transport%2520Systems%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2013%26volume%3D10%26spage%3D1783%26epage%3D1794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Stearns, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwei, G. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathvink, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naylor, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chitty, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colandrea, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webber, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colletti, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strauss, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feeney, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iliff, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiu, S-H. L.</span><span> </span><span class="NLM_article-title">The Pharmacokinetics of a thiazole benzenesulfonomide β<sub>3</sub>-adrenergic receptor agonist and its analogys in rats, dogs and monkeys: improving oral bioavailbility</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">771</span><span class="NLM_x">–</span> <span class="NLM_lpage">777</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2002&pages=771-777&author=R.+A.+Stearnsauthor=R.+R.+Millerauthor=W.+Tangauthor=G.+Y.+Kweiauthor=F.+S.+Tangauthor=R.+J.+Mathvinkauthor=E.+M.+Naylorauthor=D.+Chittyauthor=V.+J.+Colandreaauthor=A.+E.+Webberauthor=A.+E.+Collettiauthor=J.+R.+Straussauthor=C.+A.+Keohaneauthor=W.+P.+Feeneyauthor=S.+A.+Iliffauthor=S-H.+L.+Chiu&title=The+Pharmacokinetics+of+a+thiazole+benzenesulfonomide+%CE%B23-adrenergic+receptor+agonist+and+its+analogys+in+rats%2C+dogs+and+monkeys%3A+improving+oral+bioavailbility"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStearns%26aufirst%3DR.%2BA.%26aulast%3DMiller%26aufirst%3DR.%2BR.%26aulast%3DTang%26aufirst%3DW.%26aulast%3DKwei%26aufirst%3DG.%2BY.%26aulast%3DTang%26aufirst%3DF.%2BS.%26aulast%3DMathvink%26aufirst%3DR.%2BJ.%26aulast%3DNaylor%26aufirst%3DE.%2BM.%26aulast%3DChitty%26aufirst%3DD.%26aulast%3DColandrea%26aufirst%3DV.%2BJ.%26aulast%3DWebber%26aufirst%3DA.%2BE.%26aulast%3DColletti%26aufirst%3DA.%2BE.%26aulast%3DStrauss%26aufirst%3DJ.%2BR.%26aulast%3DKeohane%26aufirst%3DC.%2BA.%26aulast%3DFeeney%26aufirst%3DW.%2BP.%26aulast%3DIliff%26aufirst%3DS.%2BA.%26aulast%3DChiu%26aufirst%3DS-H.%2BL.%26atitle%3DThe%2520Pharmacokinetics%2520of%2520a%2520thiazole%2520benzenesulfonomide%2520%25CE%25B23-adrenergic%2520receptor%2520agonist%2520and%2520its%2520analogys%2520in%2520rats%252C%2520dogs%2520and%2520monkeys%253A%2520improving%2520oral%2520bioavailbility%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2002%26volume%3D30%26spage%3D771%26epage%3D777" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Birder, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Groat, W. C.</span><span> </span><span class="NLM_article-title">Increased c-fos expression in spinal neurons after irritation of the lower urinary tract in the rat</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">4878</span><span class="NLM_x">–</span> <span class="NLM_lpage">4889</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm4017224&amp;key=1464772" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm4017224&amp;key=1%3ACAS%3A528%3ADyaK3sXht1aht7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1992&pages=4878-4889&author=L.+A.+Birderauthor=W.+C.+de+Groat&title=Increased+c-fos+expression+in+spinal+neurons+after+irritation+of+the+lower+urinary+tract+in+the+rat"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Increased c-fos expression in spinal neurons after irritation of the lower urinary tract in the rat</span></div><div class="casAuthors">Birder, Lori A.; De Groat, William C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4878-89</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    </div><div class="casAbstract">This study utilized neuronal c-fos expression to examine the spinal pathways involved in processing nociceptive and non-nociceptive afferent input from the lower urinary tract (LUT) of the urethane-anesthetized rat.  C-fos protein was detected immunocytochem. in only a small no. of cells (<2 cells/L6 section) in control animals.  However, chem. irritation with 1% acetic acid or mech. stimulation of the LUT markedly increased the no. of c-fos-pos. neurons (56-180 cells/L6 section) in four regions of the caudal lumbosacral (L6-S1) spinal cord: medial dorsal horn (MDH), lateral dorsal horn, dorsal commissure (DCM), and sacral parasympathetic nucleus (SPN).  Only small nos. of c-fos-pos. cells were detected in rostral lumbar segments, a region that is though to receive nociceptive input from the LUT via afferent pathways in sympathetic nerves.  The distribution of c-fos-pos. cells in the L6 spinal cord varied according to the stimulus (i.e., urethral catheter, bladder distension, or chem. irritation).  Distension of the urinary bladder increased the no. of c-fos-pos. cells mainly in DCM and SPN regions of the cord.  In contrast, irritation of the LUT increased c-fos expression largely in DCM and MDH areas.  Spinal cord transection (T8 level) did not alter the c-fos expression induced by a catheter or chem. irritation, indicating that gene expression was mediated by spinal pathways.  Denervation expts. showed that c-fos expression was induced by activation of afferent pathways in the pelvic and pudendal nerves.  These results suggest that neurons in several regions of the spinal cord are involved in processing afferent input from different parts of the LUT.  Neurons in the DCM appear to have an important role since they respond to both nociceptive and non-nociceptive inputs and to visceral (pelvic nerve) and somatic (pudendal nerve) afferent pathways.  Thus, these neurons may be involved in the mechanisms of visceral-somatic referred pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp23_bMKp_6CbVg90H21EOLACvtfcHk0ljVzsZUPpiz7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXht1aht7o%253D&md5=89d69a06b5be4eff23c8e3b34d8e8804</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBirder%26aufirst%3DL.%2BA.%26aulast%3Dde%2BGroat%26aufirst%3DW.%2BC.%26atitle%3DIncreased%2520c-fos%2520expression%2520in%2520spinal%2520neurons%2520after%2520irritation%2520of%2520the%2520lower%2520urinary%2520tract%2520in%2520the%2520rat%26jtitle%3DJ.%2520Neurosci.%26date%3D1992%26volume%3D12%26spage%3D4878%26epage%3D4889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Nagabukuro, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Degenhardt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villa, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mistry, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gichuru, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jochnowitz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbadie, C.</span> <span class="citation_source-journal">Auton. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">156</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm4017224&amp;key=10.1016%2Fj.autneu.2010.02.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm4017224&amp;key=20335078" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm4017224&amp;key=1%3ACAS%3A528%3ADC%252BC3cXps1aqsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Nagabukuro%2C+H.%3B+Degenhardt%2C+A.%3B+Villa%2C+K.+L.%3B+Mistry%2C+S.+L.%3B+Gichuru%2C+L.%3B+Jochnowitz%2C+N.%3B+Abbadie%2C+C.Auton.+Neurosci.+2010%2C+156%2C+19%E2%80%9326"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Correlation between pharmacologically-induced changes in cystometric parameters and spinal c-Fos expression in rats</span></div><div class="casAuthors">Nagabukuro, Hiroshi; Degenhardt, Amanda; Villa, Katherine L.; Mistry, Shruti L.; Gichuru, Loise; Jochnowitz, Nina; Abbadie, Catherine</div><div class="citationInfo"><span class="NLM_cas:title">Autonomic Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">156</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">19-26</span>CODEN:
                <span class="NLM_cas:coden">ANUEB2</span>;
        ISSN:<span class="NLM_cas:issn">1566-0702</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The inhibition of bladder sensory transmission is crit. for the pharmacotherapy of urine storage symptoms.  The purpose of this study is to examine the correlation between pharmacol.-induced changes in cystometric parameters and spinal c-Fos expression in anesthetized rats with bladder hyperactivity induced by the intravesical infusion of acetic acid.  Animals were i.v. infused with either oxybutynin (OXY), a muscarinic receptor antagonist, tamsulosin (TAM), an α1-adrenoceptor antagonist, CL316243 (CL), a β3-adrenoceptor agonist, or saline.  Morphine (MOR) treatment served as a pos. control to inhibit bladder afferent activity.  Intermicturition intervals, micturition pressure and pressure threshold were measured after intravesical acetic acid infusion.  Animals were then perfused and spinal cords were removed.  Sections from the L6 spinal cord were immunostained with an anti-c-Fos antibody, and c-Fos pos. cells in the dorsal region were counted.  CL and MOR significantly increased intermicturition intervals, whereas OXY and TAM had no significant effect on intermicturition intervals.  While TAM and MOR did not affect the micturition pressure, OXY and CL caused a significant decrease.  Pressure threshold was significantly decreased by CL and increased by MOR.  All drugs significantly decreased the no. of c-Fos pos. cells with the following order of efficacy: MOR > CL > OXT > TAM.  The no. of c-Fos pos. cells in each animal from all treatment groups was neg. correlated with its av. intermicturition interval and pressure threshold, but not with its micturition pressure.  Bladder afferent activity is suppressed by several clin. proven mechanisms as measured by c-Fos expression, despite the varied effects on cystometric parameters of each pharmacol. treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2OrWBZy2DaLVg90H21EOLACvtfcHk0ljjrKn_NnEfVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXps1aqsrc%253D&md5=ba706884210b87c5c212b4b44335023a</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.autneu.2010.02.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.autneu.2010.02.006%26sid%3Dliteratum%253Aachs%26aulast%3DNagabukuro%26aufirst%3DH.%26aulast%3DDegenhardt%26aufirst%3DA.%26aulast%3DVilla%26aufirst%3DK.%2BL.%26aulast%3DMistry%26aufirst%3DS.%2BL.%26aulast%3DGichuru%26aufirst%3DL.%26aulast%3DJochnowitz%26aufirst%3DN.%26aulast%3DAbbadie%26aufirst%3DC.%26jtitle%3DAuton.%2520Neurosci.%26date%3D2010%26volume%3D156%26spage%3D19%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Strosberg, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietri-Rouxel, F.</span><span> </span><span class="NLM_article-title">Function and regulation of the β<sub>3</sub>-adrenoreceptor</span> <span class="citation_source-journal">Trends. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">373</span><span class="NLM_x">–</span> <span class="NLM_lpage">381</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm4017224&amp;key=10.1016%2FS0165-6147%2896%2980011-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm4017224&amp;key=8979772" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm4017224&amp;key=1%3ACAS%3A528%3ADyaK28Xnt1Khsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1996&pages=373-381&author=A.+D.+Strosbergauthor=F.+Pietri-Rouxel&title=Function+and+regulation+of+the+%CE%B23-adrenoreceptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Function and regulation of the β3-adrenoceptor</span></div><div class="casAuthors">Strosberg, A. Donny; Pietri-Rouxel, France</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">373-381</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review, with 64 refs., on functional and pharmacol. characterization, structure-function relationships, expression regulation, and role in obesity for β3-adrenoceptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcc8LGEACaNrVg90H21EOLACvtfcHk0ljjrKn_NnEfVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xnt1Khsro%253D&md5=c27ae9affbcbd8679bc6dad944d0da04</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2FS0165-6147%2896%2980011-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0165-6147%252896%252980011-3%26sid%3Dliteratum%253Aachs%26aulast%3DStrosberg%26aufirst%3DA.%2BD.%26aulast%3DPietri-Rouxel%26aufirst%3DF.%26atitle%3DFunction%2520and%2520regulation%2520of%2520the%2520%25CE%25B23-adrenoreceptor%26jtitle%3DTrends.%2520Pharm.%2520Sci.%26date%3D1996%26volume%3D17%26spage%3D373%26epage%3D381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="note"><p class="first last">Mass Spectrometer: Micromass ZQ single quadrupole, electrospray positive ionization, full scan mode (150–750 amu in 0.5 s). HPLC: Agilent 1100, binary pump. DAD UV detector: hardware/software Waters/Micromass MassLynx 4.0. Column: Waters Xterra, 2.1 mm width, 20 mm length, 3.5 μm packing material. Runtime: 4 min. Flow rate: 1.0 mL/min. Mobile phase A = water + 0.05% TFA, B = acetonitrile + 0.05% TFA. Gradient: time/%A/%B: 0.00/95/5, 3.00/2/98, 3.25/2/98, 3.26/95/5, 4.00/95/5.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9a','cit9b'],'ref10':['cit10a','cit10b','cit10c','cit10d','cit10e'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22a','cit22b','cit22c'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':[]}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 16 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shivakrishna  Kallepu</span>, <span class="hlFld-ContribAuthor ">Minnapuram  Kavitha</span>, <span class="hlFld-ContribAuthor ">Ragini  Yeeravalli</span>, <span class="hlFld-ContribAuthor ">Kanakaraju  Manupati</span>, <span class="hlFld-ContribAuthor ">Surender Singh  Jadav</span>, <span class="hlFld-ContribAuthor ">Amitava  Das</span>, <span class="hlFld-ContribAuthor ">Prathama S.  Mainkar</span>, and <span class="hlFld-ContribAuthor ">Srivari  Chandrasekhar</span>  . </span><span class="cited-content_cbyCitation_article-title">Total Synthesis of Desmethyl Jahanyne and Its Lipo-Tetrapeptide Conjugates Derived from Parent Skeleton as BCL-2-Mediated Apoptosis-Inducing Agents. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2018,</strong> <em>3 </em>
                                    (1)
                                     , 63-75. <a href="https://doi.org/10.1021/acsomega.7b01634" title="DOI URL">https://doi.org/10.1021/acsomega.7b01634</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.7b01634&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.7b01634%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DTotal%252BSynthesis%252Bof%252BDesmethyl%252BJahanyne%252Band%252BIts%252BLipo-Tetrapeptide%252BConjugates%252BDerived%252Bfrom%252BParent%252BSkeleton%252Bas%252BBCL-2-Mediated%252BApoptosis-Inducing%252BAgents%26aulast%3DKallepu%26aufirst%3DShivakrishna%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D2017%26date%3D25102017%26date%3D21122017%26date%3D31012018%26volume%3D3%26issue%3D1%26spage%3D63%26epage%3D75" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Scott D.  Edmondson</span>, <span class="hlFld-ContribAuthor ">Cheng  Zhu</span>, <span class="hlFld-ContribAuthor ">Nam Fung  Kar</span>, <span class="hlFld-ContribAuthor ">Jerry  Di Salvo</span>, <span class="hlFld-ContribAuthor ">Hiroshi  Nagabukuro</span>, <span class="hlFld-ContribAuthor ">Beatrice  Sacre-Salem</span>, <span class="hlFld-ContribAuthor ">Karen  Dingley</span>, <span class="hlFld-ContribAuthor ">Richard  Berger</span>, <span class="hlFld-ContribAuthor ">Stephen D.  Goble</span>, <span class="hlFld-ContribAuthor ">Gregori  Morriello</span>, <span class="hlFld-ContribAuthor ">Bart  Harper</span>, <span class="hlFld-ContribAuthor ">Christopher R.  Moyes</span>, <span class="hlFld-ContribAuthor ">Dong-Ming  Shen</span>, <span class="hlFld-ContribAuthor ">Liping  Wang</span>, <span class="hlFld-ContribAuthor ">Richard  Ball</span>, <span class="hlFld-ContribAuthor ">Aileen  Fitzmaurice</span>, <span class="hlFld-ContribAuthor ">Tara  Frenkl</span>, <span class="hlFld-ContribAuthor ">Loise N.  Gichuru</span>, <span class="hlFld-ContribAuthor ">Sookhee  Ha</span>, <span class="hlFld-ContribAuthor ">Amanda L.  Hurley</span>, <span class="hlFld-ContribAuthor ">Nina  Jochnowitz</span>, <span class="hlFld-ContribAuthor ">Dorothy  Levorse</span>, <span class="hlFld-ContribAuthor ">Shruty  Mistry</span>, <span class="hlFld-ContribAuthor ">Randy R.  Miller</span>, <span class="hlFld-ContribAuthor ">James  Ormes</span>, <span class="hlFld-ContribAuthor ">Gino M.  Salituro</span>, <span class="hlFld-ContribAuthor ">Anthony  Sanfiz</span>, <span class="hlFld-ContribAuthor ">Andra S.  Stevenson</span>, <span class="hlFld-ContribAuthor ">Katherine  Villa</span>, <span class="hlFld-ContribAuthor ">Beata  Zamlynny</span>, <span class="hlFld-ContribAuthor ">Stuart  Green</span>, <span class="hlFld-ContribAuthor ">Mary  Struthers</span>, and <span class="hlFld-ContribAuthor ">Ann E.  Weber</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Vibegron: A Potent and Selective β3 Adrenergic Receptor Agonist for the Treatment of Overactive Bladder. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (2)
                                     , 609-623. <a href="https://doi.org/10.1021/acs.jmedchem.5b01372" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01372</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01372&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01372%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BVibegron%25253A%252BA%252BPotent%252Band%252BSelective%252B%2525CE%2525B23%252BAdrenergic%252BReceptor%252BAgonist%252Bfor%252Bthe%252BTreatment%252Bof%252BOveractive%252BBladder%26aulast%3DEdmondson%26aufirst%3DScott%2BD.%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D04092015%26date%3D08012016%26date%3D28012016%26date%3D27122015%26volume%3D59%26issue%3D2%26spage%3D609%26epage%3D623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yasuhiro  Wada</span>, <span class="hlFld-ContribAuthor ">Hiromitsu  Shirahashi</span>, <span class="hlFld-ContribAuthor ">Taisuke  Iwanami</span>, <span class="hlFld-ContribAuthor ">Masami  Ogawa</span>, <span class="hlFld-ContribAuthor ">Seiji  Nakano</span>, <span class="hlFld-ContribAuthor ">Akifumi  Morimoto</span>, <span class="hlFld-ContribAuthor ">Ken-ichi  Kasahara</span>, <span class="hlFld-ContribAuthor ">Eiichi  Tanaka</span>, <span class="hlFld-ContribAuthor ">Yoshio  Takada</span>, <span class="hlFld-ContribAuthor ">Shigeki  Ohashi</span>, <span class="hlFld-ContribAuthor ">Mutsuhiro  Mori</span>, and <span class="hlFld-ContribAuthor ">Satoshi  Shuto</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel Indazole Derivatives as Highly Potent and Selective Human β3-Adrenergic Receptor Agonists with the Possibility of Having No Cardiovascular Side Effects. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (15)
                                     , 6048-6057. <a href="https://doi.org/10.1021/acs.jmedchem.5b00638" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00638</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00638&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00638%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BNovel%252BIndazole%252BDerivatives%252Bas%252BHighly%252BPotent%252Band%252BSelective%252BHuman%252B%2525CE%2525B23-Adrenergic%252BReceptor%252BAgonists%252Bwith%252Bthe%252BPossibility%252Bof%252BHaving%252BNo%252BCardiovascular%252BSide%252BEffects%26aulast%3DWada%26aufirst%3DYasuhiro%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D26042015%26date%3D15072015%26date%3D13082015%26date%3D30062015%26volume%3D58%26issue%3D15%26spage%3D6048%26epage%3D6057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shuo  Yuan</span>, <span class="hlFld-ContribAuthor ">Yong-Qiang  Luo</span>, <span class="hlFld-ContribAuthor ">Jia-Hui  Zuo</span>, <span class="hlFld-ContribAuthor ">Hui  Liu</span>, <span class="hlFld-ContribAuthor ">Fang  Li</span>, <span class="hlFld-ContribAuthor ">Bin  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">New drug approvals for 2020: Synthesis and clinical applications. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>215 </em>, 113284. <a href="https://doi.org/10.1016/j.ejmech.2021.113284" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113284</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113284&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113284%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNew%252Bdrug%252Bapprovals%252Bfor%252B2020%25253A%252BSynthesis%252Band%252Bclinical%252Bapplications%26aulast%3DYuan%26aufirst%3DShuo%26date%3D2021%26volume%3D215%26spage%3D113284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">E.  González-Zamora</span>, <span class="hlFld-ContribAuthor ">A.  Islas-Jácome</span>. </span><span class="cited-content_cbyCitation_article-title">Bicyclic 5–5 Systems With One Bridgehead (Ring Junction) Nitrogen Atom: One Extra Heteroatom 1:0. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,<a href="https://doi.org/10.1016/B978-0-12-818655-8.00029-9" title="DOI URL">https://doi.org/10.1016/B978-0-12-818655-8.00029-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-818655-8.00029-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-818655-8.00029-9%26sid%3Dliteratum%253Aachs%26atitle%3DBicyclic%252B5%2525E2%252580%2525935%252BSystems%252BWith%252BOne%252BBridgehead%252B%252528Ring%252BJunction%252529%252BNitrogen%252BAtom%25253A%252BOne%252BExtra%252BHeteroatom%252B1%25253A0%26aulast%3DGonz%25C3%25A1lez-Zamora%26aufirst%3DE.%26date%3D2020%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2020%26volume%3D76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ana L.  Ocampo-Néstor</span>, <span class="hlFld-ContribAuthor ">Ruth M.  López-Mayorga</span>, <span class="hlFld-ContribAuthor ">Enrique F.  Castillo-Henkel</span>, <span class="hlFld-ContribAuthor ">Itzia I.  Padilla-Martínez</span>, <span class="hlFld-ContribAuthor ">José G.  Trujillo-Ferrara</span>, <span class="hlFld-ContribAuthor ">Marvin A.  Soriano-Ursúa</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and in vitro evaluation of a Dopa-organoboron compound that acts as a bladder relaxant through non-catecholamine receptors. </span><span class="cited-content_cbyCitation_journal-name">Molecular Diversity</span><span> <strong>2019,</strong> <em>23 </em>
                                    (2)
                                     , 361-370. <a href="https://doi.org/10.1007/s11030-018-9883-7" title="DOI URL">https://doi.org/10.1007/s11030-018-9883-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11030-018-9883-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11030-018-9883-7%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Diversity%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bin%252Bvitro%252Bevaluation%252Bof%252Ba%252BDopa-organoboron%252Bcompound%252Bthat%252Bacts%252Bas%252Ba%252Bbladder%252Brelaxant%252Bthrough%252Bnon-catecholamine%252Breceptors%26aulast%3DOcampo-N%25C3%25A9stor%26aufirst%3DAna%2BL.%26date%3D2019%26date%3D2018%26volume%3D23%26issue%3D2%26spage%3D361%26epage%3D370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marcos  Lorca</span>, <span class="hlFld-ContribAuthor ">Cesar  Morales-Verdejo</span>, <span class="hlFld-ContribAuthor ">David  Vásquez-Velásquez</span>, <span class="hlFld-ContribAuthor ">Juan  Andrades-Lagos</span>, <span class="hlFld-ContribAuthor ">Javier  Campanini-Salinas</span>, <span class="hlFld-ContribAuthor ">Jorge  Soto-Delgado</span>, <span class="hlFld-ContribAuthor ">Gonzalo  Recabarren-Gajardo</span>, <span class="hlFld-ContribAuthor ">Jaime  Mella</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Activity Relationships Based on 3D-QSAR CoMFA/CoMSIA and Design of Aryloxypropanol-Amine Agonists with Selectivity for the Human β3-Adrenergic Receptor and Anti-Obesity and Anti-Diabetic Profiles. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2018,</strong> <em>23 </em>
                                    (5)
                                     , 1191. <a href="https://doi.org/10.3390/molecules23051191" title="DOI URL">https://doi.org/10.3390/molecules23051191</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules23051191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules23051191%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DStructure-Activity%252BRelationships%252BBased%252Bon%252B3D-QSAR%252BCoMFA%25252FCoMSIA%252Band%252BDesign%252Bof%252BAryloxypropanol-Amine%252BAgonists%252Bwith%252BSelectivity%252Bfor%252Bthe%252BHuman%252B%2525CE%2525B23-Adrenergic%252BReceptor%252Band%252BAnti-Obesity%252Band%252BAnti-Diabetic%252BProfiles%26aulast%3DLorca%26aufirst%3DMarcos%26date%3D2018%26date%3D2018%26volume%3D23%26issue%3D5%26spage%3D1191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Martin C.  Michel</span>, <span class="hlFld-ContribAuthor ">Steven J.  Charlton</span>. </span><span class="cited-content_cbyCitation_article-title">Biased Agonism in Drug Discovery—Is It Too Soon to Choose a Path?. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmacology</span><span> <strong>2018,</strong> <em>93 </em>
                                    (4)
                                     , 259-265. <a href="https://doi.org/10.1124/mol.117.110890" title="DOI URL">https://doi.org/10.1124/mol.117.110890</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/mol.117.110890&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fmol.117.110890%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmacology%26atitle%3DBiased%252BAgonism%252Bin%252BDrug%252BDiscovery%2525E2%252580%252594Is%252BIt%252BToo%252BSoon%252Bto%252BChoose%252Ba%252BPath%25253F%26aulast%3DMichel%26aufirst%3DMartin%2BC.%26date%3D2018%26date%3D2018%26volume%3D93%26issue%3D4%26spage%3D259%26epage%3D265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Angela F.  Ku</span>, <span class="hlFld-ContribAuthor ">Gregory D.  Cuny</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 7-hydroxyaporphines as conformationally restricted ligands for beta-1 and beta-2 adrenergic receptors. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2018,</strong> <em>9 </em>
                                    (2)
                                     , 353-356. <a href="https://doi.org/10.1039/C7MD00656J" title="DOI URL">https://doi.org/10.1039/C7MD00656J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7MD00656J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7MD00656J%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DDiscovery%252Bof%252B7-hydroxyaporphines%252Bas%252Bconformationally%252Brestricted%252Bligands%252Bfor%252Bbeta-1%252Band%252Bbeta-2%252Badrenergic%252Breceptors%26aulast%3DKu%26aufirst%3DAngela%2BF.%26date%3D2018%26date%3D2018%26volume%3D9%26issue%3D2%26spage%3D353%26epage%3D356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mikhail I.  Yagofarov</span>, <span class="hlFld-ContribAuthor ">Ruslan N.  Nagrimanov</span>, <span class="hlFld-ContribAuthor ">Boris N.  Solomonov</span>. </span><span class="cited-content_cbyCitation_article-title">Sublimation enthalpies of 9 substituted acetanilides at 298 K estimated by solution calorimetry approach. </span><span class="cited-content_cbyCitation_journal-name">Thermochimica Acta</span><span> <strong>2017,</strong> <em>656 </em>, 85-89. <a href="https://doi.org/10.1016/j.tca.2017.08.011" title="DOI URL">https://doi.org/10.1016/j.tca.2017.08.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tca.2017.08.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tca.2017.08.011%26sid%3Dliteratum%253Aachs%26jtitle%3DThermochimica%2520Acta%26atitle%3DSublimation%252Benthalpies%252Bof%252B9%252Bsubstituted%252Bacetanilides%252Bat%252B298%252BK%252Bestimated%252Bby%252Bsolution%252Bcalorimetry%252Bapproach%26aulast%3DYagofarov%26aufirst%3DMikhail%2BI.%26date%3D2017%26volume%3D656%26spage%3D85%26epage%3D89" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bart H.  Harper</span>, <span class="hlFld-ContribAuthor ">Liping  Wang</span>, <span class="hlFld-ContribAuthor ">Cheng  Zhu</span>, <span class="hlFld-ContribAuthor ">Nam F.  Kar</span>, <span class="hlFld-ContribAuthor ">Bing  Li</span>, <span class="hlFld-ContribAuthor ">Christopher R.  Moyes</span>, <span class="hlFld-ContribAuthor ">Stephen D.  Goble</span>, <span class="hlFld-ContribAuthor ">Melissa  Costa</span>, <span class="hlFld-ContribAuthor ">Karen  Dingley</span>, <span class="hlFld-ContribAuthor ">Jerry  Di Salvo</span>, <span class="hlFld-ContribAuthor ">Sookhee N.  Ha</span>, <span class="hlFld-ContribAuthor ">Amanda  Hurley</span>, <span class="hlFld-ContribAuthor ">Xiaofang  Li</span>, <span class="hlFld-ContribAuthor ">Randy R.  Miller</span>, <span class="hlFld-ContribAuthor ">Hiroshi  Nagabukuro</span>, <span class="hlFld-ContribAuthor ">Gino M.  Salituro</span>, <span class="hlFld-ContribAuthor ">Sean  Smith</span>, <span class="hlFld-ContribAuthor ">Mary  Struthers</span>, <span class="hlFld-ContribAuthor ">Jeffrey J.  Hale</span>, <span class="hlFld-ContribAuthor ">Scott D.  Edmondson</span>, <span class="hlFld-ContribAuthor ">Richard  Berger</span>. </span><span class="cited-content_cbyCitation_article-title">Investigation of piperazine benzamides as human β 3 adrenergic receptor agonists for the treatment of overactive bladder. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (4)
                                     , 1094-1098. <a href="https://doi.org/10.1016/j.bmcl.2016.12.033" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.12.033</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.12.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.12.033%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DInvestigation%252Bof%252Bpiperazine%252Bbenzamides%252Bas%252Bhuman%252B%2525CE%2525B2%252B3%252Badrenergic%252Breceptor%252Bagonists%252Bfor%252Bthe%252Btreatment%252Bof%252Boveractive%252Bbladder%26aulast%3DHarper%26aufirst%3DBart%2BH.%26date%3D2017%26volume%3D27%26issue%3D4%26spage%3D1094%26epage%3D1098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">J.  Di Salvo</span>, <span class="hlFld-ContribAuthor ">H.  Nagabukuro</span>, <span class="hlFld-ContribAuthor ">L. A.  Wickham</span>, <span class="hlFld-ContribAuthor ">C.  Abbadie</span>, <span class="hlFld-ContribAuthor ">J. A.  DeMartino</span>, <span class="hlFld-ContribAuthor ">A.  Fitzmaurice</span>, <span class="hlFld-ContribAuthor ">L.  Gichuru</span>, <span class="hlFld-ContribAuthor ">A.  Kulick</span>, <span class="hlFld-ContribAuthor ">M. J.  Donnelly</span>, <span class="hlFld-ContribAuthor ">N.  Jochnowitz</span>, <span class="hlFld-ContribAuthor ">A. L.  Hurley</span>, <span class="hlFld-ContribAuthor ">A.  Pereira</span>, <span class="hlFld-ContribAuthor ">A.  Sanfiz</span>, <span class="hlFld-ContribAuthor ">G.  Veronin</span>, <span class="hlFld-ContribAuthor ">K.  Villa</span>, <span class="hlFld-ContribAuthor ">J.  Woods</span>, <span class="hlFld-ContribAuthor ">B.  Zamlynny</span>, <span class="hlFld-ContribAuthor ">E.  Zycband</span>, <span class="hlFld-ContribAuthor ">G.M.  Salituro</span>, <span class="hlFld-ContribAuthor ">T.  Frenkl</span>, <span class="hlFld-ContribAuthor ">A. E.  Weber</span>, <span class="hlFld-ContribAuthor ">S. D.  Edmondson</span>, <span class="hlFld-ContribAuthor ">M.  Struthers</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacological Characterization of a Novel Beta 3 Adrenergic Agonist, Vibegron: Evaluation of Antimuscarinic Receptor Selectivity for Combination Therapy for Overactive Bladder. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmacology and Experimental Therapeutics</span><span> <strong>2017,</strong> <em>360 </em>
                                    (2)
                                     , 346-355. <a href="https://doi.org/10.1124/jpet.116.237313" title="DOI URL">https://doi.org/10.1124/jpet.116.237313</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/jpet.116.237313&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fjpet.116.237313%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmacology%2520and%2520Experimental%2520Therapeutics%26atitle%3DPharmacological%252BCharacterization%252Bof%252Ba%252BNovel%252BBeta%252B3%252BAdrenergic%252BAgonist%25252C%252BVibegron%25253A%252BEvaluation%252Bof%252BAntimuscarinic%252BReceptor%252BSelectivity%252Bfor%252BCombination%252BTherapy%252Bfor%252BOveractive%252BBladder%26aulast%3DDi%2BSalvo%26aufirst%3DJ.%26date%3D2017%26date%3D2016%26volume%3D360%26issue%3D2%26spage%3D346%26epage%3D355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">S.D.  Edmondson</span>. </span><span class="cited-content_cbyCitation_article-title">β 3 -AR Agonists for the Treatment of Overactive Bladder. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 714-737. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12788-X" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12788-X</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12788-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12788-X%26sid%3Dliteratum%253Aachs%26atitle%3D%2525CE%2525B2%252B3%252B-AR%252BAgonists%252Bfor%252Bthe%252BTreatment%252Bof%252BOveractive%252BBladder%26aulast%3DEdmondson%26aufirst%3DS.D.%26date%3D2017%26spage%3D714%26epage%3D737%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cheng  Zhu</span>, <span class="hlFld-ContribAuthor ">Nam F.  Kar</span>, <span class="hlFld-ContribAuthor ">Bing  Li</span>, <span class="hlFld-ContribAuthor ">Melissa  Costa</span>, <span class="hlFld-ContribAuthor ">Karen H.  Dingley</span>, <span class="hlFld-ContribAuthor ">Jerry  Di Salvo</span>, <span class="hlFld-ContribAuthor ">Sookhee N.  Ha</span>, <span class="hlFld-ContribAuthor ">Amanda L.  Hurley</span>, <span class="hlFld-ContribAuthor ">Xiaofang  Li</span>, <span class="hlFld-ContribAuthor ">Randy R.  Miller</span>, <span class="hlFld-ContribAuthor ">Gino M.  Salituro</span>, <span class="hlFld-ContribAuthor ">Mary  Struthers</span>, <span class="hlFld-ContribAuthor ">Ann E.  Weber</span>, <span class="hlFld-ContribAuthor ">Jeffrey J.  Hale</span>, <span class="hlFld-ContribAuthor ">Scott D.  Edmondson</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of benzamides as potent human β3 adrenergic receptor agonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (1)
                                     , 55-59. <a href="https://doi.org/10.1016/j.bmcl.2015.11.030" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.11.030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.11.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.11.030%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bbenzamides%252Bas%252Bpotent%252Bhuman%252B%2525CE%2525B23%252Badrenergic%252Breceptor%252Bagonists%26aulast%3DZhu%26aufirst%3DCheng%26date%3D2016%26volume%3D26%26issue%3D1%26spage%3D55%26epage%3D59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M. A.  Soriano-Ursúa</span>, <span class="hlFld-ContribAuthor ">J. G.  Trujillo-Ferrara</span>, <span class="hlFld-ContribAuthor ">J. A.  Arias-Montaño</span>, <span class="hlFld-ContribAuthor ">R.  Villalobos-Molina</span>. </span><span class="cited-content_cbyCitation_article-title">Insights into a defined secondary binding region on β-adrenoceptors and putative roles in ligand binding and drug design. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2015,</strong> <em>6 </em>
                                    (6)
                                     , 991-1002. <a href="https://doi.org/10.1039/C5MD00011D" title="DOI URL">https://doi.org/10.1039/C5MD00011D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5MD00011D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5MD00011D%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DInsights%252Binto%252Ba%252Bdefined%252Bsecondary%252Bbinding%252Bregion%252Bon%252B%2525CE%2525B2-adrenoceptors%252Band%252Bputative%252Broles%252Bin%252Bligand%252Bbinding%252Band%252Bdrug%252Bdesign%26aulast%3DSoriano-Urs%25C3%25BAa%26aufirst%3DM.%2BA.%26date%3D2015%26date%3D2015%26volume%3D6%26issue%3D6%26spage%3D991%26epage%3D1002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Karl-Erik  Andersson</span>. </span><span class="cited-content_cbyCitation_article-title">Drug therapy of overactive bladder - What is coming next?. </span><span class="cited-content_cbyCitation_journal-name">Korean Journal of Urology</span><span> <strong>2015,</strong> <em>56 </em>
                                    (10)
                                     , 673. <a href="https://doi.org/10.4111/kju.2015.56.10.673" title="DOI URL">https://doi.org/10.4111/kju.2015.56.10.673</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4111/kju.2015.56.10.673&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4111%2Fkju.2015.56.10.673%26sid%3Dliteratum%253Aachs%26jtitle%3DKorean%2520Journal%2520of%2520Urology%26atitle%3DDrug%252Btherapy%252Bof%252Boveractive%252Bbladder%252B-%252BWhat%252Bis%252Bcoming%252Bnext%25253F%26aulast%3DAndersson%26aufirst%3DKarl-Erik%26date%3D2015%26volume%3D56%26issue%3D10%26spage%3D673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm4017224/production/images/medium/jm-2013-017224_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm4017224/production/images/large/jm-2013-017224_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4017224&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm4017224/production/images/medium/jm-2013-017224_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm4017224/production/images/large/jm-2013-017224_0002.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of some of the β<sub>3</sub>-AR agonists to have entered the clinic.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm4017224/production/images/large/jm-2013-017224_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4017224&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm4017224/production/images/medium/jm-2013-017224_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm4017224/production/images/large/jm-2013-017224_0003.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures of second-generation pyrrolidine based β<sub>3</sub>-AR agonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm4017224/production/images/large/jm-2013-017224_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4017224&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm4017224/production/images/medium/jm-2013-017224_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm4017224/production/images/large/jm-2013-017224_0005.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Preparation of RHS-Thiazole Intermediates<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm4017224/production/images/large/jm-2013-017224_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4017224&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) Br<sub>2</sub>, CHCl<sub>3</sub>, 0 °C; (b) thiourea, EtOH, reflux; (c) (Boc)<sub>2</sub>O, Et<sub>3</sub>N, DMAP, CH<sub>2</sub>Cl<sub>2</sub>; (d) LiOH, THF, MeOH, H<sub>2</sub>O; (e) <i>tert</i>-butylnitrite, DMF, 50 °C; (f) R<sup>3</sup>-thioamide <b>36a</b>–<b>e</b>, EtOH, reflux.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm4017224/production/images/medium/jm-2013-017224_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm4017224/production/images/large/jm-2013-017224_0006.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Preparation of LHS-Aromatic Intermediates<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm4017224/production/images/large/jm-2013-017224_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4017224&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) Trimethylacetyl chloride, Et<sub>3</sub>N, THF; (b) (<i>S</i>)-4-benzyl-2-oxazolidinone, LiCl, THF; (c) ArCHO, MgCl<sub>2</sub>, TMS-Cl, Et<sub>3</sub>N, EtOAc; (d) TFA, MeOH; (e) TBS-triflate, 2,6-lutidine, CH<sub>2</sub>Cl<sub>2</sub>; (f) H<sub>2</sub>O<sub>2</sub>, LiOH, THF, H<sub>2</sub>O; (g) DPPA, Et<sub>3</sub>N, 4-methoxybenzyl alcohol, toluene, 80 °C; (h) 4-iodonitrobenzene, PdCl<sub>2</sub>(dppf), CuI, Et<sub>3</sub>N, DMF; (i) pyrrolidine, DMF, 85 °C; (j) AcOH, H<sub>2</sub>O; (k) TFA, CH<sub>2</sub>Cl<sub>2</sub>; (l) NaCNBH<sub>3</sub>, MeOH; (m) (Boc)<sub>2</sub>O, i-Pr<sub>2</sub>NEt, CH<sub>2</sub>Cl<sub>2</sub>; (n) H<sub>2</sub>, 10% Pd/C, MeOH or Zinc, AcOH, EtOH 80 °C; (o) TBAF, THF; (p) H<sub>2</sub> 50 psi, 10% Pd/C, KOAc MeOH.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm4017224/production/images/medium/jm-2013-017224_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm4017224/production/images/large/jm-2013-017224_0007.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. General Synthesis Route to Targets <b>7</b>–<b>26</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm4017224/production/images/large/jm-2013-017224_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4017224&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) EDC, HOAt, i-Pr<sub>2</sub>NEt, DMF; (b) chiral HPLC separation, (<i>R</i>,<i>R</i>)-Whelk-O column, eluent IPA/heptanes; (c) TFA, CH<sub>2</sub>Cl<sub>2</sub>.</p></p></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm4017224/production/images/medium/jm-2013-017224_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm4017224/production/images/large/jm-2013-017224_0008.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis Route to Pyrazole Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm4017224/production/images/large/jm-2013-017224_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4017224&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) Bis(trimethylsilyl)acetylene, AlCl<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>; (b) Boc-hydrazine, i-PrOH; (c) TBAF, THF; (d) benzyl bromide, K<sub>2</sub>CO<sub>3</sub>, DMF; (e) (i) LiHMDS, TMS-Cl, THF, (ii) NBS, (iii) TFA, CH<sub>2</sub>Cl<sub>2</sub>, (iv) K<sub>2</sub>CO<sub>3</sub>, NaI, acetone 58 °C; (f) H<sub>2</sub>, Pd(C), EtOH; (g) EDC, HOAt, Hunig’s base, DMF; (h) chiral HPLC separation, (<i>R</i>,<i>R</i>)-Whelk-O column, eluent IPA/heptanes; (i) TFA, DCM.</p></p></figure><figure data-id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm4017224/production/images/medium/jm-2013-017224_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm4017224/production/images/large/jm-2013-017224_0004.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Reduction in micturation pressure produced by increasing doses of <b>19</b> and <b>29</b> in acetic acid induced bladder hyperactivity model with unbound plasma levels. *, <i>P</i> < 0.05, and **, <i>P</i> < 0.01, versus vehicle group. Each bar represents mean ± SEM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm4017224/production/images/large/jm-2013-017224_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4017224&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i97">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80857" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80857" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 28 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Arch, J. R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ainsworth, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cawthorne, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piercy, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sennitt, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thody, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, S.</span><span> </span><span class="NLM_article-title">Atypical β-adrenoceptor on brown adipocytes as target for anti-obesity drugs</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">309</span><span class="NLM_x">, </span> <span class="NLM_fpage">163</span><span class="NLM_x">–</span> <span class="NLM_lpage">165</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=309&publication_year=1984&pages=163-165&author=J.+R.+S.+Archauthor=A.+T.+Ainsworthauthor=M.+A.+Cawthorneauthor=V.+Piercyauthor=M.+V.+Sennittauthor=V.+E.+Thodyauthor=S.+Wilson&title=Atypical+%CE%B2-adrenoceptor+on+brown+adipocytes+as+target+for+anti-obesity+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArch%26aufirst%3DJ.%2BR.%2BS.%26aulast%3DAinsworth%26aufirst%3DA.%2BT.%26aulast%3DCawthorne%26aufirst%3DM.%2BA.%26aulast%3DPiercy%26aufirst%3DV.%26aulast%3DSennitt%26aufirst%3DM.%2BV.%26aulast%3DThody%26aufirst%3DV.%2BE.%26aulast%3DWilson%26aufirst%3DS.%26atitle%3DAtypical%2520%25CE%25B2-adrenoceptor%2520on%2520brown%2520adipocytes%2520as%2520target%2520for%2520anti-obesity%2520drugs%26jtitle%3DNature%26date%3D1984%26volume%3D309%26spage%3D163%26epage%3D165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Arch, J. R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ainsworth, A. T.</span><span> </span><span class="NLM_article-title">Thermogenic and antiobesity activity of a novel β-adrenoceptor agonist (BRL 26830A) in mice and rats</span> <span class="citation_source-journal">Am. J. Clin. Nutr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">549</span><span class="NLM_x">–</span> <span class="NLM_lpage">558</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm4017224&amp;key=6137948" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm4017224&amp;key=1%3ACAS%3A528%3ADyaL3sXmtVGqtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1983&pages=549-558&author=J.+R.+S.+Archauthor=A.+T.+Ainsworth&title=Thermogenic+and+antiobesity+activity+of+a+novel+%CE%B2-adrenoceptor+agonist+%28BRL+26830A%29+in+mice+and+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Thermogenic and antiobesity activity of a novel β-adrenoceptor agonist (BRL 26830A) in mice and rats</span></div><div class="casAuthors">Arch, Jonathan R. S.; Ainsworth, Anthony T.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Clinical Nutrition</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">549-58</span>CODEN:
                <span class="NLM_cas:coden">AJCNAC</span>;
        ISSN:<span class="NLM_cas:issn">0002-9165</span>.
    </div><div class="casAbstract">The effects of BRL 26830A (I)  [87857-42-9] on energy balance in normal and obese mice and obese rats were investigated.  I reduced body wt. or wt. gain in genetically (ob/ob), gold thioglucose-, and cafeteria diet-obese mice and in genetically obese (fa/fa) Zucker rats.  Wt. redn. was due to reduced body lipid content.  I caused little or no redn. in food intake in these animals, but it increased metabolic rate and in genetically obese mice this thermic effect was increased by repeat dosing.  I did not reduce body wt. gain in the lean counterparts of the genetically obese animals.  Its thermic effect was smaller in the lean than the genetically obese mice, and it increased food intake in the lean mice.  The thermic effect of I was inhibited by dl-propranolol, but not by the d-isomer.  I largely overcame the depression in metabolic rate caused by fasting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIs2dmv3mTqbVg90H21EOLACvtfcHk0ljwFGwOe4Kbww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXmtVGqtr0%253D&md5=a7cba5deb318fe7ebebb3f82e8084043</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArch%26aufirst%3DJ.%2BR.%2BS.%26aulast%3DAinsworth%26aufirst%3DA.%2BT.%26atitle%3DThermogenic%2520and%2520antiobesity%2520activity%2520of%2520a%2520novel%2520%25CE%25B2-adrenoceptor%2520agonist%2520%2528BRL%252026830A%2529%2520in%2520mice%2520and%2520rats%26jtitle%3DAm.%2520J.%2520Clin.%2520Nutr.%26date%3D1983%26volume%3D38%26spage%3D549%26epage%3D558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Sennitt, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arch, J. R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levy, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simson, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cawthorne, M. A.</span><span> </span><span class="NLM_article-title">Anti-hyperglcaemic action of BRL 26830, a novel β-adrenoceptor agonist, in mice and rats</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1279</span><span class="NLM_x">–</span> <span class="NLM_lpage">1285</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1985&pages=1279-1285&author=M.+V.+Sennittauthor=J.+R.+S.+Archauthor=A.+L.+Levyauthor=D.+L.+Simsonauthor=S.+A.+Smithauthor=M.+A.+Cawthorne&title=Anti-hyperglcaemic+action+of+BRL+26830%2C+a+novel+%CE%B2-adrenoceptor+agonist%2C+in+mice+and+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSennitt%26aufirst%3DM.%2BV.%26aulast%3DArch%26aufirst%3DJ.%2BR.%2BS.%26aulast%3DLevy%26aufirst%3DA.%2BL.%26aulast%3DSimson%26aufirst%3DD.%2BL.%26aulast%3DSmith%26aufirst%3DS.%2BA.%26aulast%3DCawthorne%26aufirst%3DM.%2BA.%26atitle%3DAnti-hyperglcaemic%2520action%2520of%2520BRL%252026830%252C%2520a%2520novel%2520%25CE%25B2-adrenoceptor%2520agonist%252C%2520in%2520mice%2520and%2520rats%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1985%26volume%3D34%26spage%3D1279%26epage%3D1285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Weber, A. E.</span><span> </span><span class="NLM_article-title">β<sub>3</sub>-Adrenergic receptor agonists for the treatment of obesity</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">193</span><span class="NLM_x">–</span> <span class="NLM_lpage">202</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1998&pages=193-202&author=A.+E.+Weber&title=%CE%B23-Adrenergic+receptor+agonists+for+the+treatment+of+obesity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWeber%26aufirst%3DA.%2BE.%26atitle%3D%25CE%25B23-Adrenergic%2520receptor%2520agonists%2520for%2520the%2520treatment%2520of%2520obesity%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D1998%26volume%3D33%26spage%3D193%26epage%3D202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Irwin, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milsom, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunskaar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reilly, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopp, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herschorn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coyne, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelleher, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hampel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Artibani, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrams, P.</span><span> </span><span class="NLM_article-title">Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study</span> <span class="citation_source-journal">Eur. Urol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1306</span><span class="NLM_x">–</span> <span class="NLM_lpage">1315</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm4017224&amp;key=10.1016%2Fj.eururo.2006.09.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm4017224&amp;key=17049716" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm4017224&amp;key=1%3ACAS%3A280%3ADC%252BD28nmt1Kmsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2006&pages=1306-1315&author=D.+E.+Irwinauthor=I.+Milsomauthor=S.+Hunskaarauthor=K.+Reillyauthor=Z.+Koppauthor=S.+Herschornauthor=K.+Coyneauthor=C.+Kelleherauthor=C.+Hampelauthor=W.+Artibaniauthor=P.+Abrams&title=Population-based+survey+of+urinary+incontinence%2C+overactive+bladder%2C+and+other+lower+urinary+tract+symptoms+in+five+countries%3A+results+of+the+EPIC+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study</span></div><div class="casAuthors">Irwin Debra E; Milsom Ian; Hunskaar Steinar; Reilly Kate; Kopp Zoe; Herschorn Sender; Coyne Karin; Kelleher Con; Hampel Christian; Artibani Walter; Abrams Paul</div><div class="citationInfo"><span class="NLM_cas:title">European urology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1306-14; discussion 1314-5</span>
        ISSN:<span class="NLM_cas:issn">0302-2838</span>.
    </div><div class="casAbstract">OBJECTIVE:  Estimate the prevalence of urinary incontinence (UI), overactive bladder (OAB), and other lower urinary tract symptoms (LUTS) among men and women in five countries using the 2002 International Continence Society (ICS) definitions.  METHODS:  This population-based, cross-sectional survey was conducted between April and December 2005 in Canada, Germany, Italy, Sweden, and the United Kingdom using computer-assisted telephone interviews.  A random sample of men and women aged >/= 18 yr residing in the five countries and who were representative of the general populations in these countries was selected.  Using 2002 ICS definitions, the prevalence estimates of storage, voiding, and postmicturition LUTS were calculated.  Data were stratified by country, age cohort, and gender.  RESULTS:  A total of 19,165 individuals agreed to participate; 64.3% reported at least one LUTS.  Nocturia was the most prevalent LUTS (men, 48.6%; women, 54.5%).  The prevalence of storage LUTS (men, 51.3%; women, 59.2%) was greater than that for voiding (men, 25.7%; women, 19.5%) and postmicturition (men, 16.9%; women, 14.2%) symptoms combined.  The overall prevalence of OAB was 11.8%; rates were similar in men and women and increased with age.  OAB was more prevalent than all types of UI combined (9.4%).  CONCLUSIONS:  The EPIC study is the largest population-based survey to assess prevalence rates of OAB, UI, and other LUTS in five countries.  To date, this is the first study to evaluate these symptoms simultaneously using the 2002 ICS definitions.  The results indicate that these symptoms are highly prevalent in the countries surveyed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTDX7KjsEQJ0vSAs_PE1QvifW6udTcc2eYw0peID9zrNLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28nmt1Kmsw%253D%253D&md5=8a24630cb261f6888e72b9dbd25ac55d</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.eururo.2006.09.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.eururo.2006.09.019%26sid%3Dliteratum%253Aachs%26aulast%3DIrwin%26aufirst%3DD.%2BE.%26aulast%3DMilsom%26aufirst%3DI.%26aulast%3DHunskaar%26aufirst%3DS.%26aulast%3DReilly%26aufirst%3DK.%26aulast%3DKopp%26aufirst%3DZ.%26aulast%3DHerschorn%26aufirst%3DS.%26aulast%3DCoyne%26aufirst%3DK.%26aulast%3DKelleher%26aufirst%3DC.%26aulast%3DHampel%26aufirst%3DC.%26aulast%3DArtibani%26aufirst%3DW.%26aulast%3DAbrams%26aufirst%3DP.%26atitle%3DPopulation-based%2520survey%2520of%2520urinary%2520incontinence%252C%2520overactive%2520bladder%252C%2520and%2520other%2520lower%2520urinary%2520tract%2520symptoms%2520in%2520five%2520countries%253A%2520results%2520of%2520the%2520EPIC%2520study%26jtitle%3DEur.%2520Urol.%26date%3D2006%26volume%3D50%26spage%3D1306%26epage%3D1315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Abrams, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersson, K. E.</span><span> </span><span class="NLM_article-title">Muscarinic receptor antagonists for overactive bladder</span> <span class="citation_source-journal">BJU Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">987</span><span class="NLM_x">–</span> <span class="NLM_lpage">1006</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm4017224&amp;key=10.1111%2Fj.1464-410X.2007.07205.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm4017224&amp;key=17922784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm4017224&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlGgur7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2007&pages=987-1006&author=P.+Abramsauthor=K.+E.+Andersson&title=Muscarinic+receptor+antagonists+for+overactive+bladder"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Muscarinic receptor antagonists for overactive bladder</span></div><div class="casAuthors">Abrams, Paul; Andersson, Karl-Erik</div><div class="citationInfo"><span class="NLM_cas:title">BJU International</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">987-1006</span>CODEN:
                <span class="NLM_cas:coden">BJINFO</span>;
        ISSN:<span class="NLM_cas:issn">1464-4096</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Overactive bladder (OAB) is a syndrome characterized by urinary urgency, with or without urgency urinary incontinence, usually with frequency and nocturia.  OAB symptoms are often assocd. with detrusor overactivity (DO).  Like OAB symptoms, the prevalence of DO increases with age and can have a neurogenic and/or myogenic etiol.  Bladder outlet obstruction can be a contributing factor in DO, possibly through cholinergic denervation of the detrusor and supersensitivity of muscarinic receptors to acetylcholine, although the prevalence of OAB is similar in men and women across age groups.  Acetylcholine is the primary contractile neurotransmitter in the human detrusor, and antimuscarinics exert their effects on OAB/DO by inhibiting the binding of acetylcholine at muscarinic receptors M2 and M3 on detrusor smooth muscle cells and other structures within the bladder wall.  Worldwide, there are six antimuscarinic drugs currently marketed for the treatment of OAB: oxybutynin, tolterodine, propiverine, trospium, darifenacin, and solifenacin.  Each has demonstrated efficacy for the treatment of OAB symptoms, but their pharmacokinetic and adverse event profiles differ somewhat due to structural differences (tertiary vs quaternary amines), muscarinic receptor subtype selectivities, and organ selectivities.  Antimuscarinics are generally well tolerated, even in special populations (e.g. men with bladder outlet obstruction, elderly patients, children).  The most frequently reported adverse events in clin. studies of antimuscarinics are dry mouth, constipation, headache, and blurred vision; few patients withdraw from clin. trials because of adverse events.  Development of an antimuscarinic with functional selectivity for the bladder would reduce the occurrence of antimuscarinic adverse events.  The therapeutic potential of several other agents, such as α3-adrenoceptor agonists, purinergic receptor antagonists, phosphodiesterase inhibitors, neurokinin-1 receptor antagonists, opioids, and Rho-kinase inhibitors, is also under investigation for the treatment of OAB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo46uZDo-vaI7Vg90H21EOLACvtfcHk0lgl9rKda6C6_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlGgur7M&md5=ae74f99443663035095e793c43358bfa</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1111%2Fj.1464-410X.2007.07205.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1464-410X.2007.07205.x%26sid%3Dliteratum%253Aachs%26aulast%3DAbrams%26aufirst%3DP.%26aulast%3DAndersson%26aufirst%3DK.%2BE.%26atitle%3DMuscarinic%2520receptor%2520antagonists%2520for%2520overactive%2520bladder%26jtitle%3DBJU%2520Int.%26date%3D2007%26volume%3D100%26spage%3D987%26epage%3D1006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Dmochowski, R.</span><span> </span><span class="NLM_article-title">Improving the tolerability of anticholinergic agents in the treatment of overactive bladder</span> <span class="citation_source-journal">Drug Safety</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">583</span><span class="NLM_x">–</span> <span class="NLM_lpage">600</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2005&pages=583-600&author=R.+Dmochowski&title=Improving+the+tolerability+of+anticholinergic+agents+in+the+treatment+of+overactive+bladder"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDmochowski%26aufirst%3DR.%26atitle%3DImproving%2520the%2520tolerability%2520of%2520anticholinergic%2520agents%2520in%2520the%2520treatment%2520of%2520overactive%2520bladder%26jtitle%3DDrug%2520Safety%26date%3D2005%26volume%3D28%26spage%3D583%26epage%3D600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Fujimura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsutsumi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koibuchi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, O.</span><span> </span><span class="NLM_article-title">Expression and possible functional role for the β<sub>3</sub>-adrenoreceptor in human and rat detrusor muscle</span> <span class="citation_source-journal">J. Urol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">680</span><span class="NLM_x">–</span> <span class="NLM_lpage">685</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm4017224&amp;key=10.1016%2FS0022-5347%2801%2961994-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1999&pages=680-685&author=T.+Fujimuraauthor=K.+Tamuraauthor=T.+Tsutsumiauthor=T.+Yamamotoauthor=K.+Nakamuraauthor=Y.+Koibuchiauthor=M.+Kobayashiauthor=O.+Yamaguchi&title=Expression+and+possible+functional+role+for+the+%CE%B23-adrenoreceptor+in+human+and+rat+detrusor+muscle"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2FS0022-5347%2801%2961994-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0022-5347%252801%252961994-3%26sid%3Dliteratum%253Aachs%26aulast%3DFujimura%26aufirst%3DT.%26aulast%3DTamura%26aufirst%3DK.%26aulast%3DTsutsumi%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DNakamura%26aufirst%3DK.%26aulast%3DKoibuchi%26aufirst%3DY.%26aulast%3DKobayashi%26aufirst%3DM.%26aulast%3DYamaguchi%26aufirst%3DO.%26atitle%3DExpression%2520and%2520possible%2520functional%2520role%2520for%2520the%2520%25CE%25B23-adrenoreceptor%2520in%2520human%2520and%2520rat%2520detrusor%2520muscle%26jtitle%3DJ.%2520Urol.%26date%3D1999%26volume%3D16%26spage%3D680%26epage%3D685" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Yamanishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitahara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ilzuka, H.</span><span> </span><span class="NLM_article-title">Effect of 138–355, a β<sub>3</sub>-adrenoreceptor selective agonist, on relaxation of the human detrusor muscle in vitro</span> <span class="citation_source-journal">Neurourol. Urodyn.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">815</span><span class="NLM_x">–</span> <span class="NLM_lpage">819</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Fjm4017224&amp;key=10.1002%2Fnau.20231" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=8&amp;doi=10.1021%2Fjm4017224&amp;key=16998863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Fjm4017224&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht12qsrvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2006&pages=815-819&author=T.+Yamanishiauthor=K.+Yasudaauthor=S.+Kitaharaauthor=H.+Nakaiauthor=K.+Yoshidaauthor=H.+Ilzuka&title=Effect+of+138%E2%80%93355%2C+a+%CE%B23-adrenoreceptor+selective+agonist%2C+on+relaxation+of+the+human+detrusor+muscle+in+vitro"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9a</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of 138-355, a β3-adrenoceptor selective agonist, on relaxation of the human detrusor muscle in vitro</span></div><div class="casAuthors">Yamanishi, Tomonori; Yasuda, Kosaku; Kitahara, Satoshi; Nakai, Hideo; Yoshida, Ken-Ichiro; Iizuka, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">Neurourology and Urodynamics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">815-819</span>CODEN:
                <span class="NLM_cas:coden">NEUREM</span>;
        ISSN:<span class="NLM_cas:issn">0733-2467</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Aims: β-adrenoceptors are the predominant β-adrenoceptor subtype present in the bladder and urethra.  This study investigates the effects of 138-355, an active-metabolite of TT-138 and β3-adrenoceptor agonist, on relaxation of the human detrusor in vitro.  Methods: Tumor-free tissue samples of human bladder muscle from 39 patients undergoing total cystectomy due to bladder cancer were obtained, and the mucosa and serosa were removed.  Tissues were mounted in 5 or 10 mL organ baths contg. Krebs soln., which was gassed with 95% O2 and 5% CO2.  Resting tension of 1 g was obtained.  When the contraction had stabilized, increasing concns. of β adrenoceptor agonists (non-selective, isoprenaline; β2-selective, clenbuterol; β3-selective, 138-355 and BRL37344) and propiverine (a non-selective anti-muscarinic antagonist) were added cumulatively and concn.-relaxation curves (CRCs) were obtained.  CRCs to 138-355 were obtained in the absence and presence of SR59230A, a β3-selective antagonist, and antagonist affinity values (pA2) were calcd. from the Schild plot.  Results: Isoproterenol, clenbuterol, 138-355 and BRL37344 concn.-dependently relaxed isolated human urinary bladder strips with pEC50 value being 6.76 ± 0.17, 5.23 ± 0.22, 5.80 ± 0.26 and 5.90 ± 0.28, resp.  Following antagonist assay, it was obsd. that concn.-relaxation curves to 138-355 was competitively antagonized by β3-adrenoceptor antagonist, SR59230A, with a pA2 value of 7.01 ± 0.45 and with a Schild slope of 0.72 ± 0.07.  Conclusions: Involvement of the β3-adrenoceptor appears to be greater than that of the β3-adrenoceptor for relaxations of the human bladder.  The relaxation response of 138-355 appears to be mediated via the β3-adrenoceptor stimulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWzVhhOAy15bVg90H21EOLACvtfcHk0liVFaqMSNlm3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht12qsrvI&md5=ddf6c9485e27030a5e9e121660eb3d02</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1002%2Fnau.20231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fnau.20231%26sid%3Dliteratum%253Aachs%26aulast%3DYamanishi%26aufirst%3DT.%26aulast%3DYasuda%26aufirst%3DK.%26aulast%3DKitahara%26aufirst%3DS.%26aulast%3DNakai%26aufirst%3DH.%26aulast%3DYoshida%26aufirst%3DK.%26aulast%3DIlzuka%26aufirst%3DH.%26atitle%3DEffect%2520of%2520138%25E2%2580%2593355%252C%2520a%2520%25CE%25B23-adrenoreceptor%2520selective%2520agonist%252C%2520on%2520relaxation%2520of%2520the%2520human%2520detrusor%2520muscle%2520in%2520vitro%26jtitle%3DNeurourol.%2520Urodyn.%26date%3D2006%26volume%3D25%26spage%3D815%26epage%3D819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Woods, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carson, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norton, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheldon, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Argentieri, T. M.</span><span> </span><span class="NLM_article-title">Efficacy of the β<sub>3</sub>-adrenergic receptor agonist CL-316234 on experimental bladder hyperreflexia and detrusor instability in the rat</span> <span class="citation_source-journal">J. Urol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">166</span><span class="NLM_x">, </span> <span class="NLM_fpage">1142</span><span class="NLM_x">–</span> <span class="NLM_lpage">1147</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=16&amp;doi=10.1021%2Fjm4017224&amp;key=10.1016%2FS0022-5347%2805%2965936-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=8&amp;doi=10.1021%2Fjm4017224&amp;key=11490313" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Fjm4017224&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmsF2gtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=166&publication_year=2001&pages=1142-1147&author=M.+Woodsauthor=N.+Carsonauthor=N.+W.+Nortonauthor=J.+H.+Sheldonauthor=T.+M.+Argentieri&title=Efficacy+of+the+%CE%B23-adrenergic+receptor+agonist+CL-316234+on+experimental+bladder+hyperreflexia+and+detrusor+instability+in+the+rat"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy of the β3-adrenergic receptor agonist CL-316243 on experimental bladder hyperreflexia and detrusor instability in the rat</span></div><div class="casAuthors">Woods, Morgan; Carson, Nancyleigh; Norton, N. Wesley; Sheldon, Jeffrey H.; Argentieri, Thomas M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Urology (Hagerstown, MD, United States)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">166</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1142-1147</span>CODEN:
                <span class="NLM_cas:coden">JOURAA</span>;
        ISSN:<span class="NLM_cas:issn">0022-5347</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Recent evidence indicates that in a no. of species detrusor relaxation is mediated through activation of the β3-adrenergic receptor.  We detd. whether activation of the β3-adrenergic receptor would be a useful therapeutic approach for bladder instability.  We profiled in vitro activity of the β3-adrenergic receptor agonist CL-616243 and the efficacy of this compd. in exptl. models of detrusor instability and bladder hyperreflexia.  Isolated rat detrusor strips were contracted by depolarizing the prepns. with 20 mM. KCl.  CL-316423 was added to the tissue bath in increasing concns. and contraction inhibition was assessed.  Efficacy against bladder instability was evaluated using the obstructed hypertrophied bladder model in the rat.  The acetic acid bladder cystometry model was used to assess the efficacy of CL-316423 in bladder hyperreflexia.  Isovolumetric contractions were evoked by elec. stimulation using a silver bipolar electrode.  Data are expressed as the mean plus or minus std. error of mean.  CL-316243 inhibited spontaneously contracting, isolated rat detrusor strips in a concn. dependent manner with a mean concn. inhibiting 50% of maximal response of 2.65±0.36 nM.  Intrinsic activity relative to forskolin was 1.  In vivo CL-316243 administered i.v. or orally significantly increased the voiding interval and bladder compliance.  In addn., there was a decrease in the no. of spontaneous contractions during the filling phase in a model of neurogenic and obstruction induced bladder instability.  The amplitude of elec. evoked isovolumetric contractions was significantly smaller after CL-316243 exposure.  These data suggest that activating the β3-adrenergic receptor in rat bladder using CL-316243 may directly inhibit smooth muscle contractility, exptl. hyperreflexia and detrusor instability, and be useful for urge urinary incontinence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZlXr82ZfbtLVg90H21EOLACvtfcHk0liVFaqMSNlm3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmsF2gtLg%253D&md5=db51e7a7c23855df5ce096f457aa16fb</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1016%2FS0022-5347%2805%2965936-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0022-5347%252805%252965936-8%26sid%3Dliteratum%253Aachs%26aulast%3DWoods%26aufirst%3DM.%26aulast%3DCarson%26aufirst%3DN.%26aulast%3DNorton%26aufirst%3DN.%2BW.%26aulast%3DSheldon%26aufirst%3DJ.%2BH.%26aulast%3DArgentieri%26aufirst%3DT.%2BM.%26atitle%3DEfficacy%2520of%2520the%2520%25CE%25B23-adrenergic%2520receptor%2520agonist%2520CL-316234%2520on%2520experimental%2520bladder%2520hyperreflexia%2520and%2520detrusor%2520instability%2520in%2520the%2520rat%26jtitle%3DJ.%2520Urol.%26date%3D2001%26volume%3D166%26spage%3D1142%26epage%3D1147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="note"><p class="first last">For recently published examples, see</p></div><div class="NLM_citation" id="rightTab-cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hattori, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imanishi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itou, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakajima, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Washizuka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Araki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamashima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomishima, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakurai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsui, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imamura, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueshima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unami, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamada, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takamura, F.</span><span> </span><span class="NLM_article-title">Discovery of highly potent and selective biphenylacylsulfonamide-based β<sub>3</sub>-adrenergic receptor agonists and evaluation of physical properties as potential overactive bladder therapies: Part 5</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">3063</span><span class="NLM_x">–</span> <span class="NLM_lpage">3072</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9000709" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=3063-3072&author=K.+Hattoriauthor=S.+Todaauthor=M.+Imanishiauthor=S.+Itouauthor=Y.+Nakajimaauthor=K.+Washizukaauthor=T.+Arakiauthor=H.+Hamashimaauthor=Y.+Tomishimaauthor=M.+Sakuraiauthor=S.+Matsuiauthor=E.+Imamuraauthor=K.+Ueshimaauthor=T.+Yamamotoauthor=N.+Yamamotoauthor=H.+Ishikawaauthor=K.+Nakanoauthor=N.+Unamiauthor=K.+Hamadaauthor=Y.+Matsumuraauthor=F.+Takamura&title=Discovery+of+highly+potent+and+selective+biphenylacylsulfonamide-based+%CE%B23-adrenergic+receptor+agonists+and+evaluation+of+physical+properties+as+potential+overactive+bladder+therapies%3A+Part+5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1021%2Fjm9000709&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9000709%26sid%3Dliteratum%253Aachs%26aulast%3DHattori%26aufirst%3DK.%26aulast%3DToda%26aufirst%3DS.%26aulast%3DImanishi%26aufirst%3DM.%26aulast%3DItou%26aufirst%3DS.%26aulast%3DNakajima%26aufirst%3DY.%26aulast%3DWashizuka%26aufirst%3DK.%26aulast%3DAraki%26aufirst%3DT.%26aulast%3DHamashima%26aufirst%3DH.%26aulast%3DTomishima%26aufirst%3DY.%26aulast%3DSakurai%26aufirst%3DM.%26aulast%3DMatsui%26aufirst%3DS.%26aulast%3DImamura%26aufirst%3DE.%26aulast%3DUeshima%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DN.%26aulast%3DIshikawa%26aufirst%3DH.%26aulast%3DNakano%26aufirst%3DK.%26aulast%3DUnami%26aufirst%3DN.%26aulast%3DHamada%26aufirst%3DK.%26aulast%3DMatsumura%26aufirst%3DY.%26aulast%3DTakamura%26aufirst%3DF.%26atitle%3DDiscovery%2520of%2520highly%2520potent%2520and%2520selective%2520biphenylacylsulfonamide-based%2520%25CE%25B23-adrenergic%2520receptor%2520agonists%2520and%2520evaluation%2520of%2520physical%2520properties%2520as%2520potential%2520overactive%2520bladder%2520therapies%253A%2520Part%25205%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D3063%26epage%3D3072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Uehling, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shearer, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donaldson, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chao, E. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deaton, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adkinson, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cariello, N. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faison, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lancaster, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milliken, T. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paulik, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherman, B. W</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugg, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowan, C.</span><span> </span><span class="NLM_article-title">Biarylamine phenethanolamines as potent and selective β<sub>3</sub>-adrenergic receptor agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">2758</span><span class="NLM_x">–</span> <span class="NLM_lpage">2771</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0509445" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=2758-2771&author=D.+E.+Uehlingauthor=B.+G.+Shearerauthor=K.+H.+Donaldsonauthor=E.+Y.+Chaoauthor=D.+N.+Deatonauthor=K.+K.+Adkinsonauthor=K.+K.+Brownauthor=N.+F.+Carielloauthor=W.+L.+Faisonauthor=M.+E.+Lancasterauthor=J.+Linauthor=R.+Hartauthor=T.+O.+Millikenauthor=M.+A.+Paulikauthor=B.+W+Shermanauthor=E.+E.+Suggauthor=C.+Cowan&title=Biarylamine+phenethanolamines+as+potent+and+selective+%CE%B23-adrenergic+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.1021%2Fjm0509445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0509445%26sid%3Dliteratum%253Aachs%26aulast%3DUehling%26aufirst%3DD.%2BE.%26aulast%3DShearer%26aufirst%3DB.%2BG.%26aulast%3DDonaldson%26aufirst%3DK.%2BH.%26aulast%3DChao%26aufirst%3DE.%2BY.%26aulast%3DDeaton%26aufirst%3DD.%2BN.%26aulast%3DAdkinson%26aufirst%3DK.%2BK.%26aulast%3DBrown%26aufirst%3DK.%2BK.%26aulast%3DCariello%26aufirst%3DN.%2BF.%26aulast%3DFaison%26aufirst%3DW.%2BL.%26aulast%3DLancaster%26aufirst%3DM.%2BE.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DHart%26aufirst%3DR.%26aulast%3DMilliken%26aufirst%3DT.%2BO.%26aulast%3DPaulik%26aufirst%3DM.%2BA.%26aulast%3DSherman%26aufirst%3DB.%2BW%26aulast%3DSugg%26aufirst%3DE.%2BE.%26aulast%3DCowan%26aufirst%3DC.%26atitle%3DBiarylamine%2520phenethanolamines%2520as%2520potent%2520and%2520selective%2520%25CE%25B23-adrenergic%2520receptor%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D2758%26epage%3D2771" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Stevens, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bloomquist, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borel, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Droste, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heiman, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kriauciunas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sall, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tinsley, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jesudason, C. D.</span><span> </span><span class="NLM_article-title">Potent oxindole based β<sub>3</sub>-adrenergic receptor agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">6270</span><span class="NLM_x">–</span> <span class="NLM_lpage">6273</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=6270-6273&author=F.+C.+Stevensauthor=W.+E.+Bloomquistauthor=A.+G.+Borelauthor=M.+L.+Cohenauthor=C.+A.+Drosteauthor=M.+L.+Heimanauthor=A.+Kriauciunasauthor=D.+Sallauthor=F.+C.+Tinsleyauthor=C.+D.+Jesudason&title=Potent+oxindole+based+%CE%B23-adrenergic+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStevens%26aufirst%3DF.%2BC.%26aulast%3DBloomquist%26aufirst%3DW.%2BE.%26aulast%3DBorel%26aufirst%3DA.%2BG.%26aulast%3DCohen%26aufirst%3DM.%2BL.%26aulast%3DDroste%26aufirst%3DC.%2BA.%26aulast%3DHeiman%26aufirst%3DM.%2BL.%26aulast%3DKriauciunas%26aufirst%3DA.%26aulast%3DSall%26aufirst%3DD.%26aulast%3DTinsley%26aufirst%3DF.%2BC.%26aulast%3DJesudason%26aufirst%3DC.%2BD.%26atitle%3DPotent%2520oxindole%2520based%2520%25CE%25B23-adrenergic%2520receptor%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D6270%26epage%3D6273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Harada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirokawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiyama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawashima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furutani, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, S.</span><span> </span><span class="NLM_article-title">Novel and potent human and rat β<sub>3</sub>-adrenergic receptor agonists containing substituted 3-indolylalkylamines</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1301</span><span class="NLM_x">–</span> <span class="NLM_lpage">1305</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10d&amp;dbid=16&amp;doi=10.1021%2Fjm4017224&amp;key=10.1016%2FS0960-894X%2803%2900073-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10d&amp;dbid=8&amp;doi=10.1021%2Fjm4017224&amp;key=12657269" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10d&amp;dbid=32&amp;doi=10.1021%2Fjm4017224&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitlKjsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=1301-1305&author=H.+Haradaauthor=Y.+Hirokawaauthor=K.+Suzukiauthor=Y.+Hiyamaauthor=M.+Oueauthor=H.+Kawashimaauthor=N.+Yoshidaauthor=Y.+Furutaniauthor=S.+Kato&title=Novel+and+potent+human+and+rat+%CE%B23-adrenergic+receptor+agonists+containing+substituted+3-indolylalkylamines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10dR"><div class="casContent"><span class="casTitleNuber">10d</span><div class="casTitle"><span class="NLM_cas:atitle">Novel and potent human and rat β3-adrenergic receptor agonists containing substituted 3-indolylalkylamines</span></div><div class="casAuthors">Harada, Hiroshi; Hirokawa, Yoshimi; Suzuki, Kenji; Hiyama, Yoichi; Oue, Mayumi; Kawashima, Hitoshi; Yoshida, Naoyuki; Furutani, Yasuji; Kato, Shiro</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1301-1305</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A novel series of 2-(3-indolyl)alkylamino-1-(3-chlorophenyl)ethanols was prepd. and evaluated for in vitro ability to stimulate cAMP prodn. in Chinese hamster ovary cells expressing cloned human β3-adrenergic receptor (AR).  The optically active I was found to be the most potent and selective human β3-AR agonist in this series with an EC50 value of 0.062 nM.  In addn., the selectivity of I for human β3-AR was 210-fold and 103-fold that for human β2-AR and β1-AR, resp.  Furthermore, I showed potent agonistic activity at rat β3-AR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpb82yaU63CvLVg90H21EOLACvtfcHk0ljnve352V1fYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitlKjsLY%253D&md5=bcde23d92df0ac550f818744ce0ba613</span></div><a href="/servlet/linkout?suffix=cit10d&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2803%2900073-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252803%252900073-8%26sid%3Dliteratum%253Aachs%26aulast%3DHarada%26aufirst%3DH.%26aulast%3DHirokawa%26aufirst%3DY.%26aulast%3DSuzuki%26aufirst%3DK.%26aulast%3DHiyama%26aufirst%3DY.%26aulast%3DOue%26aufirst%3DM.%26aulast%3DKawashima%26aufirst%3DH.%26aulast%3DYoshida%26aufirst%3DN.%26aulast%3DFurutani%26aufirst%3DY.%26aulast%3DKato%26aufirst%3DS.%26atitle%3DNovel%2520and%2520potent%2520human%2520and%2520rat%2520%25CE%25B23-adrenergic%2520receptor%2520agonists%2520containing%2520substituted%25203-indolylalkylamines%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D1301%26epage%3D1305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Sum, F.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Largis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulvey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tillet, J.</span><span> </span><span class="NLM_article-title">Cyclic amine sulfonamides as linkers in the design and synthesis of β<sub>3</sub>-adrenergic receptor agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">2191</span><span class="NLM_x">–</span> <span class="NLM_lpage">2194</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=2191-2194&author=F.-W.+Sumauthor=V.+Wongauthor=S.+Hanauthor=E.+Largisauthor=R.+Mulveyauthor=J.+Tillet&title=Cyclic+amine+sulfonamides+as+linkers+in+the+design+and+synthesis+of+%CE%B23-adrenergic+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSum%26aufirst%3DF.-W.%26aulast%3DWong%26aufirst%3DV.%26aulast%3DHan%26aufirst%3DS.%26aulast%3DLargis%26aufirst%3DE.%26aulast%3DMulvey%26aufirst%3DR.%26aulast%3DTillet%26aufirst%3DJ.%26atitle%3DCyclic%2520amine%2520sulfonamides%2520as%2520linkers%2520in%2520the%2520design%2520and%2520synthesis%2520of%2520%25CE%25B23-adrenergic%2520receptor%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D2191%26epage%3D2194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Maruyama, T.; Suzuki, T.; Onda, K.; Hayakawa, M.; Morimoto, H.; Kimizuka, T.; Matsui, T.</span><span> </span><span class="NLM_article-title">Preparation of amides as antidiabetics</span>. WO 199920607,<span class="NLM_x"> </span><span class="NLM_year">1999</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1999&author=T.+Maruyama&author=T.+Suzuki&author=K.+Onda&author=M.+Hayakawa&author=H.+Morimoto&author=T.+Kimizuka&author=T.+Matsui&title=Preparation+of+amides+as+antidiabetics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMaruyama%26aufirst%3DT.%26atitle%3DPreparation%2520of%2520amides%2520as%2520antidiabetics%26date%3D1999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Donaldson, K. H.; Shearer, B. G.; Uehling, D. E.</span><span> </span><span class="NLM_article-title">Therapeutic biayrl derivatives useful as beta-3 adrenoreceptor agonists</span>. WO 199965877,<span class="NLM_x"> </span><span class="NLM_year">1999</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1999&author=K.+H.+Donaldson&author=B.+G.+Shearer&author=D.+E.+Uehling&title=Therapeutic+biayrl+derivatives+useful+as+beta-3+adrenoreceptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDonaldson%26aufirst%3DK.%2BH.%26atitle%3DTherapeutic%2520biayrl%2520derivatives%2520useful%2520as%2520beta-3%2520adrenoreceptor%2520agonists%26date%3D1999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Mathvink, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolman, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chitty, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Candelore, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cascieri, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colwell, L. F.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feeny, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forrest, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hom, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacIntyre, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stearns, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tota, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyvratt, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, A. E.</span><span> </span><span class="NLM_article-title">Discovery of a potent, orally bioavailable β<sub>3</sub> adrenergic receptor agonist, (<i>R</i>)-<i>N</i>-[4-[2-[[2-hydroxy-2-(3-pyridinyl)ethyl]amino]ethyl]phenyl]-4-[4-[4-(trifluoromethyl)phenyl]thiazol-2-yl]benzenesulfonamide</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">3832</span><span class="NLM_x">–</span> <span class="NLM_lpage">3836</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm000286i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=3832-3836&author=R.+J.+Mathvinkauthor=J.+S.+Tolmanauthor=D.+Chittyauthor=M.+R.+Candeloreauthor=M.+A.+Cascieriauthor=L.+F.+Colwellauthor=L.+Dengauthor=W.+P.+Feenyauthor=M.+J.+Forrestauthor=G.+J.+Homauthor=D.+E.+MacIntyreauthor=R.+R.+Millerauthor=R.+A.+Stearnsauthor=L.+Totaauthor=M.+J.+Wyvrattauthor=M.+H.+Fisherauthor=A.+E.+Weber&title=Discovery+of+a+potent%2C+orally+bioavailable+%CE%B23+adrenergic+receptor+agonist%2C+%28R%29-N-%5B4-%5B2-%5B%5B2-hydroxy-2-%283-pyridinyl%29ethyl%5Damino%5Dethyl%5Dphenyl%5D-4-%5B4-%5B4-%28trifluoromethyl%29phenyl%5Dthiazol-2-yl%5Dbenzenesulfonamide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm000286i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000286i%26sid%3Dliteratum%253Aachs%26aulast%3DMathvink%26aufirst%3DR.%2BJ.%26aulast%3DTolman%26aufirst%3DJ.%2BS.%26aulast%3DChitty%26aufirst%3DD.%26aulast%3DCandelore%26aufirst%3DM.%2BR.%26aulast%3DCascieri%26aufirst%3DM.%2BA.%26aulast%3DColwell%26aufirst%3DL.%2BF.%26aulast%3DDeng%26aufirst%3DL.%26aulast%3DFeeny%26aufirst%3DW.%2BP.%26aulast%3DForrest%26aufirst%3DM.%2BJ.%26aulast%3DHom%26aufirst%3DG.%2BJ.%26aulast%3DMacIntyre%26aufirst%3DD.%2BE.%26aulast%3DMiller%26aufirst%3DR.%2BR.%26aulast%3DStearns%26aufirst%3DR.%2BA.%26aulast%3DTota%26aufirst%3DL.%26aulast%3DWyvratt%26aufirst%3DM.%2BJ.%26aulast%3DFisher%26aufirst%3DM.%2BH.%26aulast%3DWeber%26aufirst%3DA.%2BE.%26atitle%3DDiscovery%2520of%2520a%2520potent%252C%2520orally%2520bioavailable%2520%25CE%25B23%2520adrenergic%2520receptor%2520agonist%252C%2520%2528R%2529-N-%255B4-%255B2-%255B%255B2-hydroxy-2-%25283-pyridinyl%2529ethyl%255Damino%255Dethyl%255Dphenyl%255D-4-%255B4-%255B4-%2528trifluoromethyl%2529phenyl%255Dthiazol-2-yl%255Dbenzenesulfonamide%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D3832%26epage%3D3836" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Tang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stearns, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ngui, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathvink, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwei, G. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strauss, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doss, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiu, S-H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baillie, T. A.</span><span> </span><span class="NLM_article-title">Metabolism of a thiazole benzenesulfonamide derivative, a potent and selective agonist of the human β<sub>3</sub>-adrenergic receptor, in rats: identification of a novel isethionic acid conjugate</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">778</span><span class="NLM_x">–</span> <span class="NLM_lpage">787</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2002&pages=778-787&author=W.+Tangauthor=R.+A.+Stearnsauthor=R.+R.+Millerauthor=J.+S.+Nguiauthor=R.+J.+Mathvinkauthor=A.+E.+Weberauthor=G.+Y.+Kweiauthor=J.+R.+Straussauthor=C.+A.+Keohaneauthor=G.+A.+Dossauthor=S-H.+L.+Chiuauthor=T.+A.+Baillie&title=Metabolism+of+a+thiazole+benzenesulfonamide+derivative%2C+a+potent+and+selective+agonist+of+the+human+%CE%B23-adrenergic+receptor%2C+in+rats%3A+identification+of+a+novel+isethionic+acid+conjugate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DW.%26aulast%3DStearns%26aufirst%3DR.%2BA.%26aulast%3DMiller%26aufirst%3DR.%2BR.%26aulast%3DNgui%26aufirst%3DJ.%2BS.%26aulast%3DMathvink%26aufirst%3DR.%2BJ.%26aulast%3DWeber%26aufirst%3DA.%2BE.%26aulast%3DKwei%26aufirst%3DG.%2BY.%26aulast%3DStrauss%26aufirst%3DJ.%2BR.%26aulast%3DKeohane%26aufirst%3DC.%2BA.%26aulast%3DDoss%26aufirst%3DG.%2BA.%26aulast%3DChiu%26aufirst%3DS-H.%2BL.%26aulast%3DBaillie%26aufirst%3DT.%2BA.%26atitle%3DMetabolism%2520of%2520a%2520thiazole%2520benzenesulfonamide%2520derivative%252C%2520a%2520potent%2520and%2520selective%2520agonist%2520of%2520the%2520human%2520%25CE%25B23-adrenergic%2520receptor%252C%2520in%2520rats%253A%2520identification%2520of%2520a%2520novel%2520isethionic%2520acid%2520conjugate%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2002%26volume%3D30%26spage%3D778%26epage%3D787" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Morriello, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wendt, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bansel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Salvo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feighner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurley, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hreniuk, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salituro, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galloway, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGettigan, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laws, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKnight, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doss, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsou, N. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ball, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanfiz, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Streckfuss, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Struthers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edmondson, S. D.</span><span> </span><span class="NLM_article-title">Design of a novel pyrrolidine scaffold utilized in the discovery of potent and selective human β<sub>3</sub> adrenergic receptor agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1865</span><span class="NLM_x">–</span> <span class="NLM_lpage">1870</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=1865-1870&author=G.+J.+Morrielloauthor=H.+R.+Wendtauthor=A.+Banselauthor=J.+Di+Salvoauthor=S.+Feighnerauthor=J.+Heauthor=A.+L.+Hurleyauthor=D.+L.+Hreniukauthor=G.+M.+Salituroauthor=M.+V.+Reddyauthor=S.+M.+Gallowayauthor=K.+K.+McGettiganauthor=G.+Lawsauthor=C.+McKnightauthor=G.+A.+Dossauthor=N.+N.+Tsouauthor=R.+M.+Blackauthor=J.+Morrisauthor=R.+G.+Ballauthor=A.+T.+Sanfizauthor=E.+Streckfussauthor=M.+Struthersauthor=S.+D.+Edmondson&title=Design+of+a+novel+pyrrolidine+scaffold+utilized+in+the+discovery+of+potent+and+selective+human+%CE%B23+adrenergic+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMorriello%26aufirst%3DG.%2BJ.%26aulast%3DWendt%26aufirst%3DH.%2BR.%26aulast%3DBansel%26aufirst%3DA.%26aulast%3DDi%2BSalvo%26aufirst%3DJ.%26aulast%3DFeighner%26aufirst%3DS.%26aulast%3DHe%26aufirst%3DJ.%26aulast%3DHurley%26aufirst%3DA.%2BL.%26aulast%3DHreniuk%26aufirst%3DD.%2BL.%26aulast%3DSalituro%26aufirst%3DG.%2BM.%26aulast%3DReddy%26aufirst%3DM.%2BV.%26aulast%3DGalloway%26aufirst%3DS.%2BM.%26aulast%3DMcGettigan%26aufirst%3DK.%2BK.%26aulast%3DLaws%26aufirst%3DG.%26aulast%3DMcKnight%26aufirst%3DC.%26aulast%3DDoss%26aufirst%3DG.%2BA.%26aulast%3DTsou%26aufirst%3DN.%2BN.%26aulast%3DBlack%26aufirst%3DR.%2BM.%26aulast%3DMorris%26aufirst%3DJ.%26aulast%3DBall%26aufirst%3DR.%2BG.%26aulast%3DSanfiz%26aufirst%3DA.%2BT.%26aulast%3DStreckfuss%26aufirst%3DE.%26aulast%3DStruthers%26aufirst%3DM.%26aulast%3DEdmondson%26aufirst%3DS.%2BD.%26atitle%3DDesign%2520of%2520a%2520novel%2520pyrrolidine%2520scaffold%2520utilized%2520in%2520the%2520discovery%2520of%2520potent%2520and%2520selective%2520human%2520%25CE%25B23%2520adrenergic%2520receptor%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D1865%26epage%3D1870" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Goble, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howell, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bansal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger., R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brockunier, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiSalvo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feighner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harper, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurley, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hreniuk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parmee, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robbins, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salituro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanfiz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Streckfuss, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watkins, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Struthers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edmondson, S. D.</span><span> </span><span class="NLM_article-title">Heterocyclic acetamide and benzamide derivatives as potent and selective β<sub>3</sub>-adrenergic receptor agonists with improved rodent pharmacokinetic profiles</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1895</span><span class="NLM_x">–</span> <span class="NLM_lpage">1899</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1895-1899&author=S.+D.+Gobleauthor=L.+Wangauthor=K.+L.+Howellauthor=A.+Bansalauthor=R.+Berger.author=L.+Brockunierauthor=J.+DiSalvoauthor=S.+Feighnerauthor=B.+Harperauthor=J.+Heauthor=A.+Hurleyauthor=D.+Hreniukauthor=E.+Parmeeauthor=M.+Robbinsauthor=G.+Salituroauthor=A.+Sanfizauthor=E.+Streckfussauthor=E.+Watkinsauthor=A.+E.+Weberauthor=M.+Struthersauthor=S.+D.+Edmondson&title=Heterocyclic+acetamide+and+benzamide+derivatives+as+potent+and+selective+%CE%B23-adrenergic+receptor+agonists+with+improved+rodent+pharmacokinetic+profiles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGoble%26aufirst%3DS.%2BD.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DHowell%26aufirst%3DK.%2BL.%26aulast%3DBansal%26aufirst%3DA.%26aulast%3DBerger.%26aufirst%3DR.%26aulast%3DBrockunier%26aufirst%3DL.%26aulast%3DDiSalvo%26aufirst%3DJ.%26aulast%3DFeighner%26aufirst%3DS.%26aulast%3DHarper%26aufirst%3DB.%26aulast%3DHe%26aufirst%3DJ.%26aulast%3DHurley%26aufirst%3DA.%26aulast%3DHreniuk%26aufirst%3DD.%26aulast%3DParmee%26aufirst%3DE.%26aulast%3DRobbins%26aufirst%3DM.%26aulast%3DSalituro%26aufirst%3DG.%26aulast%3DSanfiz%26aufirst%3DA.%26aulast%3DStreckfuss%26aufirst%3DE.%26aulast%3DWatkins%26aufirst%3DE.%26aulast%3DWeber%26aufirst%3DA.%2BE.%26aulast%3DStruthers%26aufirst%3DM.%26aulast%3DEdmondson%26aufirst%3DS.%2BD.%26atitle%3DHeterocyclic%2520acetamide%2520and%2520benzamide%2520derivatives%2520as%2520potent%2520and%2520selective%2520%25CE%25B23-adrenergic%2520receptor%2520agonists%2520with%2520improved%2520rodent%2520pharmacokinetic%2520profiles%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D1895%26epage%3D1899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Svendson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boll, P. M.</span><span> </span><span class="NLM_article-title">Naturally occurring lactones and lactames-V</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">4251</span><span class="NLM_x">–</span> <span class="NLM_lpage">4258</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1973&pages=4251-4258&author=A.+Svendsonauthor=P.+M.+Boll&title=Naturally+occurring+lactones+and+lactames-V"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSvendson%26aufirst%3DA.%26aulast%3DBoll%26aufirst%3DP.%2BM.%26atitle%3DNaturally%2520occurring%2520lactones%2520and%2520lactames-V%26jtitle%3DTetrahedron%26date%3D1973%26volume%3D29%26spage%3D4251%26epage%3D4258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Evans, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tedrow, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Downey, C. W.</span><span> </span><span class="NLM_article-title">Diastereoselective magnesium halide-catalyzed anti-aldol reactions of chiral <i>N</i>-acyloxazolidinones</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">124</span><span class="NLM_x">, </span> <span class="NLM_fpage">392</span><span class="NLM_x">–</span> <span class="NLM_lpage">393</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja0119548" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2002&pages=392-393&author=D.+A.+Evansauthor=J.+S.+Tedrowauthor=J.+T.+Shawauthor=C.+W.+Downey&title=Diastereoselective+magnesium+halide-catalyzed+anti-aldol+reactions+of+chiral+N-acyloxazolidinones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fja0119548&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0119548%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DD.%2BA.%26aulast%3DTedrow%26aufirst%3DJ.%2BS.%26aulast%3DShaw%26aufirst%3DJ.%2BT.%26aulast%3DDowney%26aufirst%3DC.%2BW.%26atitle%3DDiastereoselective%2520magnesium%2520halide-catalyzed%2520anti-aldol%2520reactions%2520of%2520chiral%2520N-acyloxazolidinones%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2002%26volume%3D124%26spage%3D392%26epage%3D393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Suzuki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kambe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokuyama, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuyama, T.</span><span> </span><span class="NLM_article-title">Enantioselective total synthesis of FR900482</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">2831</span><span class="NLM_x">–</span> <span class="NLM_lpage">2843</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo049862z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2004&pages=2831-2843&author=M.+Suzukiauthor=M.+Kambeauthor=H.+Tokuyamaauthor=T.+Fukuyama&title=Enantioselective+total+synthesis+of+FR900482"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjo049862z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo049862z%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DM.%26aulast%3DKambe%26aufirst%3DM.%26aulast%3DTokuyama%26aufirst%3DH.%26aulast%3DFukuyama%26aufirst%3DT.%26atitle%3DEnantioselective%2520total%2520synthesis%2520of%2520FR900482%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2004%26volume%3D69%26spage%3D2831%26epage%3D2843" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><div class="note"><p class="first last">The reason for comparing β<sub>3</sub>-AR EC<sub>50</sub>s and β<sub>1</sub>-AR and β<sub>2</sub>-AR IC<sub>50</sub>s as an assessment of selectivity is described in</p></div><span class="NLM_contrib-group">Mathvink, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolman, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chitty, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Candelore, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cascieri, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colwell, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feeney, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forrest, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hom, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacIntyre, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tota, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyvratt, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber., A. E.</span><span> </span><span class="NLM_article-title">Potent, selective 3-pyridylethanoloamine β<sub>3</sub> adrenergic receptor agonists possessing a thiazole benzenesulfonamide pharmacophore</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1971</span><span class="NLM_x">–</span> <span class="NLM_lpage">1973</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2000&pages=1971-1973&author=R.+J.+Mathvinkauthor=J.+S.+Tolmanauthor=D.+Chittyauthor=M.+R.+Candeloreauthor=M.+A.+Cascieriauthor=L.+F.+Colwellauthor=L.+Dengauthor=W.+P.+Feeneyauthor=M.+J.+Forrestauthor=G.+J.+Homauthor=E.+MacIntyreauthor=L.+Totaauthor=M.+J.+Wyvrattauthor=M.+H.+Fisherauthor=A.+E.+Weber.&title=Potent%2C+selective+3-pyridylethanoloamine+%CE%B23+adrenergic+receptor+agonists+possessing+a+thiazole+benzenesulfonamide+pharmacophore"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMathvink%26aufirst%3DR.%2BJ.%26aulast%3DTolman%26aufirst%3DJ.%2BS.%26aulast%3DChitty%26aufirst%3DD.%26aulast%3DCandelore%26aufirst%3DM.%2BR.%26aulast%3DCascieri%26aufirst%3DM.%2BA.%26aulast%3DColwell%26aufirst%3DL.%2BF.%26aulast%3DDeng%26aufirst%3DL.%26aulast%3DFeeney%26aufirst%3DW.%2BP.%26aulast%3DForrest%26aufirst%3DM.%2BJ.%26aulast%3DHom%26aufirst%3DG.%2BJ.%26aulast%3DMacIntyre%26aufirst%3DE.%26aulast%3DTota%26aufirst%3DL.%26aulast%3DWyvratt%26aufirst%3DM.%2BJ.%26aulast%3DFisher%26aufirst%3DM.%2BH.%26aulast%3DWeber.%26aufirst%3DA.%2BE.%26atitle%3DPotent%252C%2520selective%25203-pyridylethanoloamine%2520%25CE%25B23%2520adrenergic%2520receptor%2520agonists%2520possessing%2520a%2520thiazole%2520benzenesulfonamide%2520pharmacophore%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2000%26volume%3D10%26spage%3D1971%26epage%3D1973" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Driscoll, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shepard, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soglia, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atherton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mutlib, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munchhof, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiter, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doty, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trevena, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ripp, S. L.</span><span> </span><span class="NLM_article-title">A rational chemical intervention strategy to circumvent bioactivation liabilities associated with a nonpeptidyl thrombopoietin receptor agonist containing a 2-amino-4-arylthiazole motif</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1954</span><span class="NLM_x">–</span> <span class="NLM_lpage">1965</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx700270r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm4017224&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFKhtbfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2007&pages=1954-1965&author=A.+S.+Kalgutkarauthor=J.+Driscollauthor=S.+X.+Zhaoauthor=G.+S.+Walkerauthor=R.+M.+Shepardauthor=J.+R.+Sogliaauthor=J.+Athertonauthor=L.+Yuauthor=A.+E.+Mutlibauthor=M.+J.+Munchhofauthor=L.+A.+Reiterauthor=C.+S.+Jonesauthor=J.+L.+Dotyauthor=K.+A.+Trevenaauthor=C.+L.+Shafferauthor=S.+L.+Ripp&title=A+rational+chemical+intervention+strategy+to+circumvent+bioactivation+liabilities+associated+with+a+nonpeptidyl+thrombopoietin+receptor+agonist+containing+a+2-amino-4-arylthiazole+motif"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">A rational chemical intervention strategy to circumvent bioactivation liabilities associated with a nonpeptidyl thrombopoietin receptor agonist containing a 2-amino-4-arylthiazole motif</span></div><div class="casAuthors">Kalgutkar, Amit S.; Driscoll, James; Zhao, Sabrina X.; Walker, Gregory S.; Shepard, Richard M.; Soglia, John R.; Atherton, James; Yu, Linning; Mutlib, Abdul E.; Munchhof, Michael J.; Reiter, Lawrence A.; Jones, Christopher S.; Doty, Johnathan L.; Trevena, Kristen A.; Shaffer, Christopher L.; Ripp, Sharon L.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1954-1965</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The current study examd. the bioactivation potential of a nonpeptidyl thrombopoietin receptor agonist, 1-(3-chloro-5-((4-(4-fluoro-3-(trifluoromethyl)phenyl)thiazol-2-yl)carbamoyl)pyridine-2-yl)piperidine-4-carboxylic acid (1), contg. a 2-carboxamido-4-arylthiazole moiety in the core structure.  Toxicol. risks arising from P 450-catalyzed C4-C5 thiazole ring opening in 1 via the epoxidn. diol sequence were alleviated, since mass spectrometric anal. of human liver microsome and/or hepatocyte incubations of 1 did not reveal the formation of reactive acylthiourea and/or glyoxal metabolites, which are prototypic products derived from thiazole ring scission.  However, 4-(4-fluoro-3-(trifluoromethyl)phenyl)thiazol-2-amine (2), the product of hydrolysis of 1 in human liver microsomes, hepatocytes, and plasma, underwent oxidative bioactivation in human liver microsomes, since trapping studies with glutathione led to the formation of two conjugates derived from the addn. of the thiol nucleophile to 2 and a thiazole-S-oxide metabolite of 2.  Mass spectral fragmentation and NMR anal. indicated that the site of attachment of the glutathionyl moiety in both conjugates was the C5 position in the thiazole ring.  Based on the structures of the glutathione conjugates, two bioactivation pathways are proposed, one involving β-elimination of an initially formed hydroxylamine metabolite and the other involving direct two-electron oxidn. of the electron-rich 2-aminothiazole system to electrophilic intermediates.  This mechanistic insight into the bioactivation process allowed the development of a rational chem. intervention strategy that involved blocking the C5 position with a fluorine atom or replacing the thiazole ring with a 1,2,4-thiadiazole group.  These structural changes not only abrogated the bioactivation liability assocd. with 1 but also resulted in compds. that retained the attractive pharmacol. and pharmacokinetic attributes of the prototype agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxi1Bp9ve-TLVg90H21EOLACvtfcHk0lgN5kL3nL7GDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFKhtbfM&md5=97c144c6d3c621dcef18a76b63f1806e</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Ftx700270r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx700270r%26sid%3Dliteratum%253Aachs%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DDriscoll%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DS.%2BX.%26aulast%3DWalker%26aufirst%3DG.%2BS.%26aulast%3DShepard%26aufirst%3DR.%2BM.%26aulast%3DSoglia%26aufirst%3DJ.%2BR.%26aulast%3DAtherton%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DL.%26aulast%3DMutlib%26aufirst%3DA.%2BE.%26aulast%3DMunchhof%26aufirst%3DM.%2BJ.%26aulast%3DReiter%26aufirst%3DL.%2BA.%26aulast%3DJones%26aufirst%3DC.%2BS.%26aulast%3DDoty%26aufirst%3DJ.%2BL.%26aulast%3DTrevena%26aufirst%3DK.%2BA.%26aulast%3DShaffer%26aufirst%3DC.%2BL.%26aulast%3DRipp%26aufirst%3DS.%2BL.%26atitle%3DA%2520rational%2520chemical%2520intervention%2520strategy%2520to%2520circumvent%2520bioactivation%2520liabilities%2520associated%2520with%2520a%2520nonpeptidyl%2520thrombopoietin%2520receptor%2520agonist%2520containing%2520a%25202-amino-4-arylthiazole%2520motif%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2007%26volume%3D20%26spage%3D1954%26epage%3D1965" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lynch, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stupienski, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baskin, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beare, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appleby, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salata, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jurkiewicz, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanguinetti, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stein, R. B.</span><span> </span><span class="NLM_article-title">Cardiac electrophysiologic and antiarrhythmic actions of two long-acting spirobenzopyran piperidine class III agents, L-702,958 and L-706,000 [MK-499]</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">269</span><span class="NLM_x">, </span> <span class="NLM_fpage">541</span><span class="NLM_x">–</span> <span class="NLM_lpage">554</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=8&amp;doi=10.1021%2Fjm4017224&amp;key=7802864" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=32&amp;doi=10.1021%2Fjm4017224&amp;key=1%3ACAS%3A528%3ADyaK2cXkt1KmtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=269&publication_year=1994&pages=541-554&author=J.+J.+Lynchauthor=A.+A.+Wallaceauthor=R.+F.+Stupienskiauthor=E.+P.+Baskinauthor=C.+M.+Beareauthor=S.+D.+Applebyauthor=J.+J.+Salataauthor=N.+K.+Jurkiewiczauthor=M.+C.+Sanguinettiauthor=R.+B.+Stein&title=Cardiac+electrophysiologic+and+antiarrhythmic+actions+of+two+long-acting+spirobenzopyran+piperidine+class+III+agents%2C+L-702%2C958+and+L-706%2C000+%5BMK-499%5D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22aR"><div class="casContent"><span class="casTitleNuber">22a</span><div class="casTitle"><span class="NLM_cas:atitle">Cardiac electrophysiologic and antiarrhythmic actions of two long-acting spirobenzopyran piperidine class III agents, L-702,958 and L-706,000 [MK-499]</span></div><div class="casAuthors">Lynch, Joseph J., Jr.; Wallace, Audrey A.; Stupienski, Raymond F., III; Baskin, Elizabeth P.; Beare, Carolann M.; Appleby, Sandra D.; Salata, Joseph J.; Jurkiewicz, Nancy K.; Sanguinetti, Michael; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">269</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">541-54</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">The cardiac electrophysiol. and antiarrhythmic actions of two Class III ketone- and alc.-contg. spirobenzopyran piperidine analogs, L-702,958 and L-706,000 [MK-499], resp., were assessed in vitro and in vivo.  L-702,958 and L-706,000 [MK-499] selectively blocked the rapidly activating component of the delayed rectifier K+ current in guinea pig isolated ventricular myocytes (IC50 values, 14.6 and 43.9 nM, resp.), and prolonged effective refractory period in ferret isolated papillary muscles (EC25 values, 10.5 and 53.8 nM, resp.).  In anesthetized dogs, L-702,958 and L-706,000 [MK-499] increased ventricular refractory periods (ED20 values, 3.3 and 9.2 μg/kg i.v., resp.) and concomitantly increased ECG QT interval and left ventricular + dP/dt.  Cumulative i.v. administrations of ≤100 μg/kg of L-702,958 and 300 μg/kg L-706,000 [MK-499] in anesthetized dogs increased atrial and ventricular refractoriness and prolonged the ECG QT interval, but did not alter atrial, atrioventricular nodal, His-Purkinje or ventricular conduction indexes.  In anesthetized dogs studied chronically (9.2 days) after anterior myocardial infarction, the cumulative i.v. administrations of 100 μg/kg of L-702,958 and 300 μg/kg L-706,000 [MK-499] suppressed the induction of ventricular tachyarrhythmia by programmed ventricular stimulation (suppression rates: 8 of 10, 80% and 9 of 11, 82%, resp.) and reduced the incidence of lethal ventricular arrhythmias (incidences of lethal ischemic arrhythmias: 4 of 10, 40% and 1 of 11 9%, resp., compared to 34 of 40, 85%, in vehicle controls).  L-702,958 and L-706,000 [MK-499] (cumulative 100 and 300 μg/kg i.v., resp.) did not facilitate the induction of arrhythmias by programmed ventricular stimulation in postinfarction dogs.  After equivalently effective p.o. doses in conscious dogs, L-702,958 (10 μg/kg) and L-706,000 [MK-499] (30 μg/kg) increased ECG QT interval with long durations of action of approx. 9 and 14 h, resp.  L-706,000 [MK-499] elicited a more consistent and sustained prolongation of the QT interval than L-702,958.  These findings show that both L-702,958 and L-706,000 [MK-499] are potentially useful agents for the prevention of malignant ventricular arrhythmias in the setting of myocardial ischemic injury.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoodlHaDa4-FrVg90H21EOLACvtfcHk0lgN5kL3nL7GDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXkt1KmtLY%253D&md5=b13505c41ffd30d723860c4b9e13dfb8</span></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLynch%26aufirst%3DJ.%2BJ.%26aulast%3DWallace%26aufirst%3DA.%2BA.%26aulast%3DStupienski%26aufirst%3DR.%2BF.%26aulast%3DBaskin%26aufirst%3DE.%2BP.%26aulast%3DBeare%26aufirst%3DC.%2BM.%26aulast%3DAppleby%26aufirst%3DS.%2BD.%26aulast%3DSalata%26aufirst%3DJ.%2BJ.%26aulast%3DJurkiewicz%26aufirst%3DN.%2BK.%26aulast%3DSanguinetti%26aufirst%3DM.%2BC.%26aulast%3DStein%26aufirst%3DR.%2BB.%26atitle%3DCardiac%2520electrophysiologic%2520and%2520antiarrhythmic%2520actions%2520of%2520two%2520long-acting%2520spirobenzopyran%2520piperidine%2520class%2520III%2520agents%252C%2520L-702%252C958%2520and%2520L-706%252C000%2520%255BMK-499%255D%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1994%26volume%3D269%26spage%3D541%26epage%3D554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit22b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Schoemaker, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hicks, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langer, S.</span><span> </span><span class="NLM_article-title">Calcium Channel Receptor Binding Studies for Diltiazem and Its Major Metabolites: Functional Correlation to Inhibition of Portal Vein Myogenic Activity</span> <span class="citation_source-journal">J. Cardiovasc. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">173</span><span class="NLM_x">–</span> <span class="NLM_lpage">180</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1987&pages=173-180&author=H.+Schoemakerauthor=P.+Hicksauthor=S.+Langer&title=Calcium+Channel+Receptor+Binding+Studies+for+Diltiazem+and+Its+Major+Metabolites%3A+Functional+Correlation+to+Inhibition+of+Portal+Vein+Myogenic+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchoemaker%26aufirst%3DH.%26aulast%3DHicks%26aufirst%3DP.%26aulast%3DLanger%26aufirst%3DS.%26atitle%3DCalcium%2520Channel%2520Receptor%2520Binding%2520Studies%2520for%2520Diltiazem%2520and%2520Its%2520Major%2520Metabolites%253A%2520Functional%2520Correlation%2520to%2520Inhibition%2520of%2520Portal%2520Vein%2520Myogenic%2520Activity%26jtitle%3DJ.%2520Cardiovasc.%2520Pharmacol.%26date%3D1987%26volume%3D9%26spage%3D173%26epage%3D180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit22c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Hartmann, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiedeman, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirsh, G. E.</span><span> </span><span class="NLM_article-title">Effects of III–IV Linker Mutations on Human Heart Na<sup>+</sup> Channel Inactivation Gating</span> <span class="citation_source-journal">Circ. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">114</span><span class="NLM_x">–</span> <span class="NLM_lpage">122</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=1994&pages=114-122&author=H.+A.+Hartmannauthor=A.+A.+Tiedemanauthor=S.+F.+Chenauthor=A.+M.+Brownauthor=G.+E.+Kirsh&title=Effects+of+III%E2%80%93IV+Linker+Mutations+on+Human+Heart+Na%2B+Channel+Inactivation+Gating"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHartmann%26aufirst%3DH.%2BA.%26aulast%3DTiedeman%26aufirst%3DA.%2BA.%26aulast%3DChen%26aufirst%3DS.%2BF.%26aulast%3DBrown%26aufirst%3DA.%2BM.%26aulast%3DKirsh%26aufirst%3DG.%2BE.%26atitle%3DEffects%2520of%2520III%25E2%2580%2593IV%2520Linker%2520Mutations%2520on%2520Human%2520Heart%2520Na%252B%2520Channel%2520Inactivation%2520Gating%26jtitle%3DCirc.%2520Res.%26date%3D1994%26volume%3D75%26spage%3D114%26epage%3D122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Takusagawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ushigome, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerbusch, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyashita, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwatsubo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Usui, T.</span><span> </span><span class="NLM_article-title">Intestinal Absorption Mechanism of Mirabegron, a Potent and Selective β<sub>3</sub>-Adrenoreceptor Agonist: Involvement of Human Efflux and/or Influx Transport Systems</span> <span class="citation_source-journal">Mol. Pharmaceutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1783</span><span class="NLM_x">–</span> <span class="NLM_lpage">1794</span></span><div class="citationLinks">[<a href="/doi/10.1021/mp300582s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm4017224&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlsVeqs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2013&pages=1783-1794&author=S.+Takusagawaauthor=F.+Ushigomeauthor=H.+Nemotoauthor=Y.+Takahashiauthor=Q.+Liauthor=V.+Kerbuschauthor=A.+Miyashitaauthor=T.+Iwatsuboauthor=T.+Usui&title=Intestinal+Absorption+Mechanism+of+Mirabegron%2C+a+Potent+and+Selective+%CE%B23-Adrenoreceptor+Agonist%3A+Involvement+of+Human+Efflux+and%2For+Influx+Transport+Systems"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Intestinal Absorption Mechanism of Mirabegron, a Potent and Selective β3-Adrenoceptor Agonist: Involvement of Human Efflux and/or Influx Transport Systems</span></div><div class="casAuthors">Takusagawa, Shin; Ushigome, Fumihiko; Nemoto, Hiroyuki; Takahashi, Yutaka; Li, Qun; Kerbusch, Virginie; Miyashita, Aiji; Iwatsubo, Takafumi; Usui, Takashi</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1783-1794</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mirabegron, a weak-basic compd., is a potent and selective β3-adrenoceptor agonist for the treatment of overactive bladder.  Mirabegron extended release formulation shows dose-dependent oral bioavailability in humans, which is likely attributable to satn. of intestinal efflux abilities leading to higher absorption with higher doses.  This study evaluated the membrane permeability of mirabegron and investigated the involvement of human intestinal transport proteins in the membrane permeation of mirabegron.  Transcellular transport and cellular/vesicular uptake assays were performed using Caco-2 cells and/or human intestinal efflux (P-glycoprotein [P-gp], breast cancer resistance protein [BCRP], and multidrug resistance assocd. protein 2 [MRP2]) and influx (peptide transporter 1 [PEPT1], OATP1A2, and OATP2B1) transporter-expressing cells, vesicles, or Xenopus laevis oocytes.  The absorptive permeability coeffs. of mirabegron in Caco-2 cells (1.68-1.83 × 10-6 cm/s) at the apical and basal pH of 6.5 and 7.4, resp., were slightly higher than those of nadolol (0.97-1.41 × 10-6 cm/s), a low permeability ref. std., but lower than those of metoprolol and propranolol (both ranged from 8.49 to 11.6 × 10-6 cm/s), low/high permeability boundary ref. stds.  Increasing buffer pH at the apical side from 5.5 to 8.0 gradually increased the absorptive permeation of mirabegron from 0.226 to 1.66 × 10-6 cm/s, but was still less than the value in the opposite direction (11.0-14.2 × 10-6 cm/s).  The time- and concn.-dependent transport of mirabegron was obsd. in P-gp-expressing cells and OATP1A2-expressing oocytes with apparent Km values of 294 and 8.59 μM, resp.  In contrast, no clear BCRP-, MRP2-, PEPT1-, or OATP2B1-mediated uptake of mirabegron was obsd. in their expressing vesicles or cells.  These findings suggest that mirabegron has low-to-moderate membrane permeability and P-gp is likely to be involved in its efflux into the lumen in the intestinal absorption process.  The results also suggest that mirabegron could possibly be transported by intestinal influx transporters as well as simple diffusion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3wX4ewFwIjLVg90H21EOLACvtfcHk0lgL3xk7bcgQ-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlsVeqs7w%253D&md5=6ad3db6d889826db00eb7296a4b3d22b</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fmp300582s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp300582s%26sid%3Dliteratum%253Aachs%26aulast%3DTakusagawa%26aufirst%3DS.%26aulast%3DUshigome%26aufirst%3DF.%26aulast%3DNemoto%26aufirst%3DH.%26aulast%3DTakahashi%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DKerbusch%26aufirst%3DV.%26aulast%3DMiyashita%26aufirst%3DA.%26aulast%3DIwatsubo%26aufirst%3DT.%26aulast%3DUsui%26aufirst%3DT.%26atitle%3DIntestinal%2520Absorption%2520Mechanism%2520of%2520Mirabegron%252C%2520a%2520Potent%2520and%2520Selective%2520%25CE%25B23-Adrenoreceptor%2520Agonist%253A%2520Involvement%2520of%2520Human%2520Efflux%2520and%252For%2520Influx%2520Transport%2520Systems%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2013%26volume%3D10%26spage%3D1783%26epage%3D1794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Stearns, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwei, G. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathvink, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naylor, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chitty, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colandrea, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webber, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colletti, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strauss, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feeney, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iliff, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiu, S-H. L.</span><span> </span><span class="NLM_article-title">The Pharmacokinetics of a thiazole benzenesulfonomide β<sub>3</sub>-adrenergic receptor agonist and its analogys in rats, dogs and monkeys: improving oral bioavailbility</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">771</span><span class="NLM_x">–</span> <span class="NLM_lpage">777</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2002&pages=771-777&author=R.+A.+Stearnsauthor=R.+R.+Millerauthor=W.+Tangauthor=G.+Y.+Kweiauthor=F.+S.+Tangauthor=R.+J.+Mathvinkauthor=E.+M.+Naylorauthor=D.+Chittyauthor=V.+J.+Colandreaauthor=A.+E.+Webberauthor=A.+E.+Collettiauthor=J.+R.+Straussauthor=C.+A.+Keohaneauthor=W.+P.+Feeneyauthor=S.+A.+Iliffauthor=S-H.+L.+Chiu&title=The+Pharmacokinetics+of+a+thiazole+benzenesulfonomide+%CE%B23-adrenergic+receptor+agonist+and+its+analogys+in+rats%2C+dogs+and+monkeys%3A+improving+oral+bioavailbility"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStearns%26aufirst%3DR.%2BA.%26aulast%3DMiller%26aufirst%3DR.%2BR.%26aulast%3DTang%26aufirst%3DW.%26aulast%3DKwei%26aufirst%3DG.%2BY.%26aulast%3DTang%26aufirst%3DF.%2BS.%26aulast%3DMathvink%26aufirst%3DR.%2BJ.%26aulast%3DNaylor%26aufirst%3DE.%2BM.%26aulast%3DChitty%26aufirst%3DD.%26aulast%3DColandrea%26aufirst%3DV.%2BJ.%26aulast%3DWebber%26aufirst%3DA.%2BE.%26aulast%3DColletti%26aufirst%3DA.%2BE.%26aulast%3DStrauss%26aufirst%3DJ.%2BR.%26aulast%3DKeohane%26aufirst%3DC.%2BA.%26aulast%3DFeeney%26aufirst%3DW.%2BP.%26aulast%3DIliff%26aufirst%3DS.%2BA.%26aulast%3DChiu%26aufirst%3DS-H.%2BL.%26atitle%3DThe%2520Pharmacokinetics%2520of%2520a%2520thiazole%2520benzenesulfonomide%2520%25CE%25B23-adrenergic%2520receptor%2520agonist%2520and%2520its%2520analogys%2520in%2520rats%252C%2520dogs%2520and%2520monkeys%253A%2520improving%2520oral%2520bioavailbility%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2002%26volume%3D30%26spage%3D771%26epage%3D777" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Birder, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Groat, W. C.</span><span> </span><span class="NLM_article-title">Increased c-fos expression in spinal neurons after irritation of the lower urinary tract in the rat</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">4878</span><span class="NLM_x">–</span> <span class="NLM_lpage">4889</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm4017224&amp;key=1464772" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm4017224&amp;key=1%3ACAS%3A528%3ADyaK3sXht1aht7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1992&pages=4878-4889&author=L.+A.+Birderauthor=W.+C.+de+Groat&title=Increased+c-fos+expression+in+spinal+neurons+after+irritation+of+the+lower+urinary+tract+in+the+rat"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Increased c-fos expression in spinal neurons after irritation of the lower urinary tract in the rat</span></div><div class="casAuthors">Birder, Lori A.; De Groat, William C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4878-89</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    </div><div class="casAbstract">This study utilized neuronal c-fos expression to examine the spinal pathways involved in processing nociceptive and non-nociceptive afferent input from the lower urinary tract (LUT) of the urethane-anesthetized rat.  C-fos protein was detected immunocytochem. in only a small no. of cells (<2 cells/L6 section) in control animals.  However, chem. irritation with 1% acetic acid or mech. stimulation of the LUT markedly increased the no. of c-fos-pos. neurons (56-180 cells/L6 section) in four regions of the caudal lumbosacral (L6-S1) spinal cord: medial dorsal horn (MDH), lateral dorsal horn, dorsal commissure (DCM), and sacral parasympathetic nucleus (SPN).  Only small nos. of c-fos-pos. cells were detected in rostral lumbar segments, a region that is though to receive nociceptive input from the LUT via afferent pathways in sympathetic nerves.  The distribution of c-fos-pos. cells in the L6 spinal cord varied according to the stimulus (i.e., urethral catheter, bladder distension, or chem. irritation).  Distension of the urinary bladder increased the no. of c-fos-pos. cells mainly in DCM and SPN regions of the cord.  In contrast, irritation of the LUT increased c-fos expression largely in DCM and MDH areas.  Spinal cord transection (T8 level) did not alter the c-fos expression induced by a catheter or chem. irritation, indicating that gene expression was mediated by spinal pathways.  Denervation expts. showed that c-fos expression was induced by activation of afferent pathways in the pelvic and pudendal nerves.  These results suggest that neurons in several regions of the spinal cord are involved in processing afferent input from different parts of the LUT.  Neurons in the DCM appear to have an important role since they respond to both nociceptive and non-nociceptive inputs and to visceral (pelvic nerve) and somatic (pudendal nerve) afferent pathways.  Thus, these neurons may be involved in the mechanisms of visceral-somatic referred pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp23_bMKp_6CbVg90H21EOLACvtfcHk0lgL3xk7bcgQ-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXht1aht7o%253D&md5=89d69a06b5be4eff23c8e3b34d8e8804</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBirder%26aufirst%3DL.%2BA.%26aulast%3Dde%2BGroat%26aufirst%3DW.%2BC.%26atitle%3DIncreased%2520c-fos%2520expression%2520in%2520spinal%2520neurons%2520after%2520irritation%2520of%2520the%2520lower%2520urinary%2520tract%2520in%2520the%2520rat%26jtitle%3DJ.%2520Neurosci.%26date%3D1992%26volume%3D12%26spage%3D4878%26epage%3D4889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Nagabukuro, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Degenhardt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villa, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mistry, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gichuru, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jochnowitz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbadie, C.</span> <span class="citation_source-journal">Auton. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">156</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm4017224&amp;key=10.1016%2Fj.autneu.2010.02.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm4017224&amp;key=20335078" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm4017224&amp;key=1%3ACAS%3A528%3ADC%252BC3cXps1aqsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Nagabukuro%2C+H.%3B+Degenhardt%2C+A.%3B+Villa%2C+K.+L.%3B+Mistry%2C+S.+L.%3B+Gichuru%2C+L.%3B+Jochnowitz%2C+N.%3B+Abbadie%2C+C.Auton.+Neurosci.+2010%2C+156%2C+19%E2%80%9326"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Correlation between pharmacologically-induced changes in cystometric parameters and spinal c-Fos expression in rats</span></div><div class="casAuthors">Nagabukuro, Hiroshi; Degenhardt, Amanda; Villa, Katherine L.; Mistry, Shruti L.; Gichuru, Loise; Jochnowitz, Nina; Abbadie, Catherine</div><div class="citationInfo"><span class="NLM_cas:title">Autonomic Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">156</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">19-26</span>CODEN:
                <span class="NLM_cas:coden">ANUEB2</span>;
        ISSN:<span class="NLM_cas:issn">1566-0702</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The inhibition of bladder sensory transmission is crit. for the pharmacotherapy of urine storage symptoms.  The purpose of this study is to examine the correlation between pharmacol.-induced changes in cystometric parameters and spinal c-Fos expression in anesthetized rats with bladder hyperactivity induced by the intravesical infusion of acetic acid.  Animals were i.v. infused with either oxybutynin (OXY), a muscarinic receptor antagonist, tamsulosin (TAM), an α1-adrenoceptor antagonist, CL316243 (CL), a β3-adrenoceptor agonist, or saline.  Morphine (MOR) treatment served as a pos. control to inhibit bladder afferent activity.  Intermicturition intervals, micturition pressure and pressure threshold were measured after intravesical acetic acid infusion.  Animals were then perfused and spinal cords were removed.  Sections from the L6 spinal cord were immunostained with an anti-c-Fos antibody, and c-Fos pos. cells in the dorsal region were counted.  CL and MOR significantly increased intermicturition intervals, whereas OXY and TAM had no significant effect on intermicturition intervals.  While TAM and MOR did not affect the micturition pressure, OXY and CL caused a significant decrease.  Pressure threshold was significantly decreased by CL and increased by MOR.  All drugs significantly decreased the no. of c-Fos pos. cells with the following order of efficacy: MOR > CL > OXT > TAM.  The no. of c-Fos pos. cells in each animal from all treatment groups was neg. correlated with its av. intermicturition interval and pressure threshold, but not with its micturition pressure.  Bladder afferent activity is suppressed by several clin. proven mechanisms as measured by c-Fos expression, despite the varied effects on cystometric parameters of each pharmacol. treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2OrWBZy2DaLVg90H21EOLACvtfcHk0lhpUC7XaHAwyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXps1aqsrc%253D&md5=ba706884210b87c5c212b4b44335023a</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.autneu.2010.02.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.autneu.2010.02.006%26sid%3Dliteratum%253Aachs%26aulast%3DNagabukuro%26aufirst%3DH.%26aulast%3DDegenhardt%26aufirst%3DA.%26aulast%3DVilla%26aufirst%3DK.%2BL.%26aulast%3DMistry%26aufirst%3DS.%2BL.%26aulast%3DGichuru%26aufirst%3DL.%26aulast%3DJochnowitz%26aufirst%3DN.%26aulast%3DAbbadie%26aufirst%3DC.%26jtitle%3DAuton.%2520Neurosci.%26date%3D2010%26volume%3D156%26spage%3D19%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Strosberg, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietri-Rouxel, F.</span><span> </span><span class="NLM_article-title">Function and regulation of the β<sub>3</sub>-adrenoreceptor</span> <span class="citation_source-journal">Trends. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">373</span><span class="NLM_x">–</span> <span class="NLM_lpage">381</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm4017224&amp;key=10.1016%2FS0165-6147%2896%2980011-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm4017224&amp;key=8979772" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm4017224&amp;key=1%3ACAS%3A528%3ADyaK28Xnt1Khsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1996&pages=373-381&author=A.+D.+Strosbergauthor=F.+Pietri-Rouxel&title=Function+and+regulation+of+the+%CE%B23-adrenoreceptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Function and regulation of the β3-adrenoceptor</span></div><div class="casAuthors">Strosberg, A. Donny; Pietri-Rouxel, France</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">373-381</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review, with 64 refs., on functional and pharmacol. characterization, structure-function relationships, expression regulation, and role in obesity for β3-adrenoceptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcc8LGEACaNrVg90H21EOLACvtfcHk0lhpUC7XaHAwyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xnt1Khsro%253D&md5=c27ae9affbcbd8679bc6dad944d0da04</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2FS0165-6147%2896%2980011-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0165-6147%252896%252980011-3%26sid%3Dliteratum%253Aachs%26aulast%3DStrosberg%26aufirst%3DA.%2BD.%26aulast%3DPietri-Rouxel%26aufirst%3DF.%26atitle%3DFunction%2520and%2520regulation%2520of%2520the%2520%25CE%25B23-adrenoreceptor%26jtitle%3DTrends.%2520Pharm.%2520Sci.%26date%3D1996%26volume%3D17%26spage%3D373%26epage%3D381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="note"><p class="first last">Mass Spectrometer: Micromass ZQ single quadrupole, electrospray positive ionization, full scan mode (150–750 amu in 0.5 s). HPLC: Agilent 1100, binary pump. DAD UV detector: hardware/software Waters/Micromass MassLynx 4.0. Column: Waters Xterra, 2.1 mm width, 20 mm length, 3.5 μm packing material. Runtime: 4 min. Flow rate: 1.0 mL/min. Mobile phase A = water + 0.05% TFA, B = acetonitrile + 0.05% TFA. Gradient: time/%A/%B: 0.00/95/5, 3.00/2/98, 3.25/2/98, 3.26/95/5, 4.00/95/5.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-5"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i89"><a href="/doi/suppl/10.1021/jm4017224">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_42672"></div></div></div></div></div><hr /></hr><p class="last">Conditions for the separation of the isomers of <b>38a</b> and X-ray data collection on the isomer leading to more potent B<sub>3</sub>-AR agonists, and procedures and characterization for compounds <b>31a</b>–<b>g</b>, <b>32a</b>–<b>g</b>, <b>33a</b>, <b>37a</b>–<b>d</b>, <b>38a</b>, <b>41a</b>–<b>e</b>, <b>42a</b>–<b>e</b>, <b>43a</b>–<b>e</b>, <b>44a</b>–<b>e</b>, <b>45a</b>–<b>e</b>, <b>46a</b>–<b>e</b>, <b>47a</b>–<b>e</b>, <b>48a</b>–<b>e</b>, <b>49a</b>–<b>d</b>, <b>50a</b>. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm4017224/suppl_file/jm4017224_si_001.pdf">jm4017224_si_001.pdf (436.98 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm4017224&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2014.57.issue-4%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Fjm4017224" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm4017224" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                731KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67993e977bbcd1d7","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
